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Abstract 
This thesis describes the search for a practical skin dosimetry method for cardiac 
catheterization procedures, and the application of an optimisation strategy in barium 
enema imaging. 
Kodak EDR2 film was characterised across the range of exposure conditions used in 
the cardiac catheterization laboratory. Its dose-response curve was modelled using a 
novel equation, and overall uncertainty in film response was estimated. The film 
saturated at 1 Gy, limiting its usefulness for skin dosimetry. Its performance was 
found to be strongly dependent on beam filtration, an aspect that had not previously 
been studied. 
The film was then used to measure skin doses to patients undergoing coronary 
angiograms and angioplasties. For angiograms, all skin doses were well below 1 Gy. 
For angioplasties, 23% of films showed localised saturation, indicating peak skin 
doses of at least 1 Gy. Dose-area-product was shown to be a poor predictor of high 
peak skin dose. 
A mathematical model was developed and software written, to calculate patient skin 
dose maps from exposure and projection data stored in the image files. This offered a 
practical method for assessing the magnitude and approximate location of the peak 
skin dose. Accuracy was limited by a lack of information regarding fluoroscopic 
exposures, couch position and beam limitation. After including an estimated 
contribution from fluoroscopy, the model successfully identified those patients whose 
skin doses exceeded 1 Gy.  
Following a baseline survey of local barium enema practice, several dose reduction 
methods were considered. It was decided to introduce copper filtration. 0.1 mm 
copper reduced mean patient DAP by 37%, without any measurable difference in 
contrast detail detectability. A detailed phantom study determined the optimal copper 
thickness as 0.3 mm. This reduced mean patient DAP by 55%, relative to the baseline 
survey. A visual grading analysis study showed no significant difference in clinical 
image quality. 
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Chapter 1 - Introduction 
1.1 Thesis Outline 
X-ray imaging is a vital tool in modern healthcare. It allows the clinician to see inside 
the patients body, to diagnose injury and disease, to assess their severity and to 
measure the effectiveness of treatment given. It also plays a crucial role in positioning 
medical devices during surgery and minimally invasive interventions. All this is not 
without a price however, because exposure to ionising radiation carries a risk of 
detrimental health effects. 
Over the years, developments in X-ray imaging technology and in clinical practice 
have improved safety for both patients and staff. However, the most complex 
diagnostic and interventional procedures can still involve high radiation doses to the 
patient. In order to improve the care of patients undergoing these procedures, it is 
important both to be able to assess doses, and to reduce them as far as clinical image 
quality requirements allow. The complex nature of these imaging procedures makes 
dose assessment and optimisation particularly challenging.  
The thesis concentrates on two such imaging specialties. The first is cardiac 
catheterization, which can involve high radiation doses to the patients skin, and has 
been associated with skin burns. It is important to be able to identify patients who 
may be at risk of such adverse effects, in order to offer them appropriate counselling 
and after-care. Since many different imaging projections are used in a single 
procedure, it is difficult to determine the exact radiation dose received by each patient. 
The thesis deals with the development of practical techniques for skin dosimetry. 
The second specialty is barium enema imaging. Here, some of the most radiosensitive 
organs are often in the primary beam, leading to a relatively high risk of induced 
cancers. The thesis describes the application of an optimisation strategy to reduce 
doses to barium enema patients, whilst ensuring that image quality remained adequate 
for diagnosis. 
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Below is a brief outline of the purpose and content of each chapter. The first three 
provide a thorough introduction to the field of study. Chapters 4 to 6 describe the 
work on skin dosimetry in the cardiac catheterization laboratory, whilst 7 and 8 
describe the barium enema optimisation study. The final chapter summarises the 
research undertaken, brings together the individual chapter discussions and proposes 
relevant further work. The aims and objectives for each stage of the work are stated at 
the beginning of the experimental chapters. 
Chapter 1  Introduction 
This general introduction defines fluoroscopy and fluorography. It describes the 
technology used in dynamic X-ray imaging, and outlines some common clinical 
applications. The risks associated with exposure to ionising radiation are outlined, and 
methods for assessing patient radiation dose are summarised. Typical doses for 
common fluoroscopic and fluorographic procedures are compared with those from 
other types of radiological investigation. The need for optimisation of radiation dose 
and image quality is then introduced, and the legal requirements for optimisation are 
summarised. The main challenges associated with determining optimised practice are 
highlighted. The chapter concludes by reviewing equipment design features and 
operator techniques that reduce patient radiation dose, and considering their effects on 
image quality. 
Chapter 2  Image Quality Assessment 
This chapter addresses the problem of defining and measuring clinical image quality. 
A review of the literature summarises the various different methods for assessing 
imaging performance and comparing the efficacy of different imaging techniques. 
These range from physical measures and observer performance tests on simple 
phantoms, to large-scale investigations of diagnostic accuracy. The concept of 
quality criteria for clinical images is then discussed. 
Chapter 3  Skin Dose in Cardiac Catheterization 
The final introductory chapter explains the clinical background to cardiac 
catheterization procedures and describes the risk of skin injuries associated with them. 
A review of the literature identifies and compares the various methods by which skin 
dose can be measured. An overview of current literature on management of patients 
thought to have received high skin doses is also given. 
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Chapter 4  Calibration of Dosimetry Equipment 
This chapter describes the characterisation of Kodak EDR2 film, prior to its use for 
skin dosimetry in the cardiac catheterization laboratory. The film was characterised in 
detail across the range of typical exposure conditions, for the processor settings used 
in the local Radiology department. Its response was found to be strongly dependent on 
beam filtration, a factor that had not been investigated in previous studies. The 
relationship between optical density and radiation dose was defined using a novel 
equation, which gave a better fit to the measured data than any previously reported. 
The limitations of the film as a dosimeter are described, and the uncertainties in skin 
dose measurements are estimated. The dose-area-product meter was calibrated in 
parallel with the film, and its performance is also described. 
Chapter 5  Skin Dose Survey 
The film was then used to measure skin dose distributions for patients undergoing 
coronary angiography and angioplasty procedures. This was its first reported use for 
patient dosimetry at diagnostic X-ray energies within the UK. Peak skin doses for the 
coronary angiograms are presented. A significant proportion of angioplasty patients 
were found to be receiving skin doses in excess of 1 Gy, which is the threshold for 
dose recording recommended by the International Commission on Radiological 
Protection and the US Food and Drug Administration. Since the film saturated at 1 
Gy, it could not be used to assess these high radiation doses. The need for a more 
robust and flexible method for routine skin dosimetry is demonstrated. 
Chapter 6  Skin Dose Modelling 
A mathematical model was developed, to calculate the skin dose distribution across 
the patients back, from the exposure and projection information stored in the image 
files. This chapter describes the function of the model, and compares calculated peak 
skin doses with those measured on film. Since projection information was available 
only for the acquisition parts of the procedure, skin doses could be severely 
underestimated for procedures involving a large proportion of fluoroscopy. Three 
methods for estimating the contribution from fluoroscopy were proposed, and their 
accuracy compared. The model was shown to be a potentially powerful tool for 
estimation of patient skin doses. Its limitations are discussed. 
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Chapter 7  Barium Enema Dose Reduction 
The clinical background to barium enema examinations is outlined, and a baseline 
survey of clinical practice described. Perspex phantoms were used to model a typical 
examination and determine the relative dose contributions from fluoroscopy, digital 
spot and screen-film imaging. Several potential dose reduction methods were 
identified, and each was considered in partnership with clinical staff. Following 
discussions, it was agreed to introduce copper filtration to the X-ray beams. The 
effects of 0.1 mm copper on entrance dose and threshold contrast were determined 
using phantoms. The copper was then introduced in clinical practice, and the survey 
repeated.  
Chapter 8  Barium Enema Optimisation 
This chapter describes the search for the optimal quantity of copper filtration, to 
achieve the lowest patient radiation doses consistent with obtaining reliable diagnostic 
images. The effects of varying amounts of copper on patient dose and image quality 
were simulated using Perspex blocks and a contrast detail phantom. The optimal 
copper thickness was chosen, as that which gave the most appropriate balance 
between dose and image quality. Following clinical implementation, the adequacy of 
clinical image quality was verified by means of a visual grading analysis study. 
Chapter 9  General Discussion 
This chapter summarises the research described in the thesis, and discusses its main 
contributions to the field, as well as its strengths and weaknesses.  Proposals for 
further work are then set out. These include establishing protocols for management of 
patients who may be at risk of skin injuries, developing techniques for the assessment 
of clinical image quality, and optimisation of catheterization laboratory practice. 
Some of the research described in the thesis has also been reported in journal articles 
and conference papers. These are listed in Appendix II. 
1.2 Fluoroscopy and Fluorography 
Fluoroscopy and fluorography are forms of dynamic X-ray imaging. Both are very 
important in modern medicine. 
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Fluoroscopy is generally performed to aid in the positioning of medical devices 
within a patient, to localise sites for surgical excision, or to position the patient for 
static radiographs. It uses relatively low radiation dose rates, typically 10 to 80 
PGy/min at the detector face. This results in rather noisy images. Fluoroscopic images 
are not usually recorded.  
Fluorography is the acquisition of a series of high definition dynamic images. It is 
used primarily in angiography, the imaging of contrast-enhanced blood vessels. This 
is a demanding imaging task, requiring high contrast and sharp edge definition with 
low noise. Typically, much higher detector doses of around 100 to 300 PGy/min are 
used. Images were traditionally recorded using photographic film, but this has now 
been largely replaced by digital fluorography. Throughout this thesis, the term 
fluorography refers to digital fluorography. 
The basic components of fluoroscopic and fluorographic imaging units are: 
x An X-ray tube and generator, which are capable of producing a stable X-ray 
output over long exposure times; 
x A detector, capable of dynamic imaging, which is mounted opposite the X-ray 
tube; 
x Digital image processing and storage facilities; 
x A display system, for viewing real-time or recorded image sequences. 
The specification of each component of the imaging system depends on the clinical 
tasks for which it will be used. There are three broad categories of fluoroscopic and 
fluorographic imaging equipment. These are described in the following subsections, 
along with some of their clinical applications. 
1.2.1 Standard Radiography and Fluoroscopy 
Figure 1.1 shows a standard radiography and fluoroscopy unit. These are used mainly 
for contrast investigations of the gastrointestinal tract and urinary system. In barium 
meals and enemas, fluoroscopy is primarily used to ensure complete coating of the 
bowel with barium sulphate, and to position the patient for static radiographs. In 
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bladder pressure studies and cystourethrography, dynamic images are recorded and 
used for reporting. 
 
Figure 1.1: Radiography and Fluoroscopy Unit. 
The X-ray tube is mounted underneath the couch, and the detector above the patient. 
They have a limited range of motion, to allow superior-inferior and lateral panning.  
The couch can be tilted, to image the patient in the erect position. Older units have a 
carriage for film cassettes mounted below the detector, as shown here. Nowadays, 
static radiographs are usually captured digitally. Some of the most modern 
radiography and fluoroscopy units incorporate a digital acquisition facility for 
recording dynamic image series. 
1.2.2 Cardiovascular Imaging and Interventions 
Cardiovascular imaging requires the highest specification equipment, capable of 
extensive fluorographic as well as fluoroscopic imaging. It is used in radiology, 
cardiology and neurology, to obtain angiograms of the patients blood vessels, and to 
perform catheter-based interventions. 
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In angiography, a catheter is inserted into the origin of the vessel of interest. A radio-
opaque dye is then injected, and a sequence of fluorographic images acquired, to 
demonstrate the vessel lumen. Cardiovascular interventions performed through a 
catheter include widening of occluded blood vessels and insertion of stents, occlusion 
of enlarged or bleeding vessels, and insertion of cardiac pacemakers. Some 
interventional procedures can take up to several hours to complete. The X-ray tube 
must be built to a high specification, with an advanced cooling mechanism, to enable 
prolonged usage at high outputs. 
 
Figure 1.2: Cardiovascular Imaging Unit. 
Figure 1.2 shows a single plane cardiovascular unit. The tube and detector are 
mounted on a C-arm gantry, anchored to the ceiling of the catheterization 
laboratory. The gantry can be angled to image the patient from an almost continuous 
range of projections. Single plane units such as this one are generally used in adult 
cardiac procedures and interventional radiology, since they provide easy access to the 
patient for cardiac and haemodynamic monitoring, nursing care and emergency 
resuscitation. 
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An alternative configuration is the biplane unit, which has a pair of tube and detector 
assemblies, mounted in different planes. These have the advantage of being able to 
obtain images in two different projections for each injection of contrast agent. 
However, they do not allow such flexibility of access to the patient. They are most 
often used in neuroradiology, and in paediatric coronary interventions. 
1.2.3 Mobile Fluoroscopy 
Mobile fluoroscopy units are widely used in arthroscopy, endoscopy and other 
surgical interventions. Here, the X-ray tube and detector are mounted on a wheeled 
cart, with the generator and viewing monitors on a second cart, as shown in Figure 
1.3. Mobile units cannot withstand such high tube loading, so do not usually offer 
fluorography. Again, the tube and detector are mounted on a C-arm gantry, to allow 
free rotation about the patient. 
 
Figure 1.3: Mobile Fluoroscopy Unit. 
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1.2.4 Imaging Technology 
Good descriptions of the basic construction and function of X-ray tubes and 
generators are given in textbooks by Forster (1985), Dowsett et al (1998), and Dendy 
and Heaton (1999). Design features specific to fluoroscopic and fluorographic units 
include efficient anode heat dissipation and cooling mechanisms, to allow prolonged 
exposures, facilities for pulsing the X-ray beam, and automatic switching of the focal 
spot size to provide the best compromise between spatial resolution and tube output, 
as the patient thickness varies. 
Until recently, the image intensifier was the only type of detector available for 
fluoroscopic and fluorographic imaging. Its basic structure is shown in Figure 1.4. 
The incoming X-ray photons interact with the input phosphor to produce light. When 
this is absorbed by the photocathode, electrons are emitted. These are then 
accelerated, so that they gain energy, and focused down onto the output phosphor. 
Here they are absorbed, with the emission of many more light photons. The resulting 
image is captured using a video camera or charge-coupled device (CCD). The 
imaging units shown in Figure 1.1 and Figure 1.3 have image intensifiers. 
Focusing Electrodes
Anode
Output Phosphor
Photocathode
Input Phosphor
Extreme Electron Path
Aluminium Foil
Vacuum Tube
X-Ray 
Photons
 
Figure 1.4: Image Intensifier Construction. 
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In the last few years, direct digital detectors have become available for clinical use, 
and these have already taken over the market in cardiovascular imaging. Most of these 
so-called flat panel detectors use a layer of scintillating material (caesium iodide), 
backed by an array of amorphous silicon thin film transistors (TFT), as shown in 
Figure 1.5. Light produced in the scintillating layer is absorbed in an adjacent TFT 
element, causing a build-up of charge. The stored charge is then read out 
electronically. The imaging unit shown in Figure 1.2 has a flat panel detector. 
X-Ray Photons
Caesium Iodide 
Scintillator
Amorphous Silicon 
Photo Diode
Switch
Line 
Drivers Amplifiers, Multiplexers, 
Analogue to Digital Converters
 
Figure 1.5: Cutaway diagram showing part of a flat panel detector. 
The direct digital detector is slightly more efficient than an image intensifier, which 
allows a corresponding reduction in patient dose. Since the detector array is 
immediately adjacent to the scintillator, sharper spatial resolution is maintained and 
the images are not subject to distortion. A more detailed description of the 
construction and operation of direct digital detectors is given by Moy (2000), Spahn et 
al (2000) and Holmes et al (2004). 
An anti-scatter grid is usually positioned in front of the detector, to reduce the amount 
of scattered radiation contributing to the image. On mobile units, the grid is usually 
fixed. On radiography and fluoroscopy units and on some cardiovascular units, the 
grid can easily be moved in and out of the beam during clinical procedures. 
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1.3 Patient Radiation Dose 
Fluoroscopic and fluorographic procedures are complex in nature, and can involve 
relatively high radiation doses to the patient. This is a matter of concern, since 
exposure to ionising radiation is associated with detrimental health effects.  
1.3.1 Stochastic Effects 
When ionising radiation interacts with living tissue, some of the electrons are ejected 
from their orbits, breaking chemical bonds. Individual cells can often repair this 
damage, but the repair process is occasionally faulty, resulting in mutations. If the 
chromosomes are damaged, the fault can propagate when the cell divides. In the early 
stages of pregnancy, this increases the risk of genetic disease in the developing fetus. 
In all patients, it increases the risk of developing cancers in later life. 
These are termed stochastic effects, since there is not thought to be any dose threshold 
below which they cannot occur. On exposing an organ to ionising radiation, the risk 
of malignancies developing within that organ is increased by an amount proportional 
to the dose received. 
Symptoms often do not appear until years or even decades after the initial radiation 
exposure. This makes it impossible to determine which cancers were caused by 
medical exposures. The National Radiological Protection Board has published 
estimated risk factors for carcinogenesis, in its document Estimates of Late Radiation 
Risks to the UK Population (National Radiological Protection Board, 1993). These 
are based largely on studies of atomic bomb survivors and radiation workers. 
1.3.2 Deterministic Effects 
If a large number of cells in one part of the body are killed or sterilised, deterministic 
effects such as skin burns and ocular cataracts can occur. Such injuries only develop 
after a certain dose threshold has been exceeded. Their severity depends on the 
magnitude of the dose received. 
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Interventional radiology and cardiology procedures can involve prolonged irradiation 
of particular areas of the patients skin, and are known to carry a risk of radiation 
burns. This was the primary motivation for the skin dosimetry work described in this 
thesis. The issue is addressed in detail in Chapter 3. 
1.3.3 Measures of Radiation Dose 
The fundamental dose quantity used in radiology is the absorbed dose to a tissue or 
organ. This is defined as the energy absorbed per unit mass of tissue, and is given the 
special unit Gray (Gy), where 1 Gy is equivalent to 1 Joule per kilogram. 
Patient radiation dose is commonly measured using a dose-area-product (DAP) meter. 
This is a transmission ionisation chamber that is fitted at the output window of the X-
ray collimator assembly, so as to intercept the whole of the X-ray beam. The charge 
collected in the chamber is proportional to both radiation dose and beam area. DAP 
meters are now fitted as standard to new X-ray units, to comply with The Ionising 
Radiations Regulations 1999. The integral DAP for an examination gives a general 
indication of the total dose received by the patient, but offers no information about the 
breakdown of dose to individual organs. 
More precise measurements of the doses to particular tissues or organs may be 
obtained using thermoluminescence dosimeters, scintillation detectors, diodes or 
radiographic films, all of which are described in more detail in Chapter 3. Direct 
measurements can be made for organs that are readily accessible. Doses to 
inaccessible organs can be measured in an anthropomorphic phantom, for typical 
exposures associated with the procedure of interest. 
Alternatively, doses to internal organs may be estimated using Monte-Carlo 
modelling. This is a computational technique, in which the paths of a large number of 
photons are tracked in a mathematical model of the human body, and the absorbed 
dose to each organ is calculated. The National Radiological Protection Board has 
produced tables of Monte-Carlo data for a series of standard radiographic projections 
(Hart et al, 1994), and these may be interrogated using software such as XDOSE 
(National Radiation Laboratory, Ministry of Health, Christchurch, New Zealand). 
There are now also a small number of commercially available software packages for 
performing Monte-Carlo dose calculations. These are much more flexible, since they 
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allow the user more control over radiographic parameters such as field size and 
projection, tube voltage and beam filtration. Examples include PCXMC (STUK, 
Helsinki, Finland) and ODS-60 (Rados Technology, Turku, Finland). 
Effective or whole body dose is a measure of the total dose to all the organs of the 
body, weighted according to their radiation sensitivity (International Commission on 
Radiological Protection, 1991b). It is an indicator of the risk of inducing stochastic 
effects, such as cancer (National Radiological Protection Board, 1993). It may be 
estimated using the Monte-Carlo dosimetry software described above. Effective dose 
uses a special unit, called the Sievert (Sv). 
1.3.4 Typical doses 
The National Radiological Protection Board regularly conducts national patient dose 
surveys, using data from a wide selection of UK hospitals. Table 1.1 shows dose-area-
products for a range of fluoroscopic and fluorographic procedures from their most 
recent survey, published as report NRPB-W14 (Hart et al, 2002). Estimated effective 
doses, from report NRPB-W4, are also shown (Hart & Wall, 2002). 
Procedure Type Mean DAP (Gycm
2
) Effective Dose (mSv) 
Barium Enema 23.5 7.2 
Barium Swallow 8.0 1.5 
Urethrogram 4.9 1.1 
Coronary Angiogram 30.4 3.1-10.6 
Coronary Angioplasty 63.4 5.3-19.5 
Nephrostogram 10.4 1.6 
Table 1.1: Mean DAP and estimated effective dose for selected fluoroscopic and fluorographic procedures, from 
NRPB reports W14 (Hart et al, 2002) and W4 (Hart & Wall, 2002). 
These values may be compared with the other common radiographic procedures listed 
in Table 1.2. Both DAP and effective dose tend to be much larger for fluoroscopic and 
fluorographic procedures than for general radiographic examinations. Effective doses 
are comparable with those obtained in computed tomography (CT). 
Chapter 1 - Introduction  13
Procedure Type Mean DAP (Gycm
2
) Effective Dose (mSv) 
Abdomen AP 2.5 0.8 
Chest PA 0.10 0.02 
CT Head N/A 2 
CT Chest N/A 8 
CT Abdomen N/A 10 
Table 1.2: Mean DAP and estimated effective dose for selected general radiography and computed tomography 
(CT) examinations, from NRPB reports W14 (Hart et al, 2002) and W4 (Hart & Wall, 2002). (AP: 
anteroposterior; PA: posteroanterior; N/A: not applicable.) 
Table 1.1 also demonstrates a wide variation in both DAP and effective dose for 
different types of fluoroscopic and fluorographic procedures. Coronary angioplasties 
and other vascular interventions are associated with the highest radiation doses, since 
they can involve prolonged fluoroscopic imaging as well as large numbers of 
fluorographic image series. Barium enemas carry a relatively high mean DAP and 
effective dose, since they combine fluoroscopy with multiple radiographs. 
1.4 Optimisation 
Given the adverse effects associated with exposure to ionising radiation, it is 
important both to be able to measure patient radiation doses, and to reduce them 
where possible. Over the years, reductions in patient dose have been achieved through 
advances in technology and changes in clinical practice. In the UK, repeated national 
dose surveys by the National Radiological Protection Board have shown a significant 
lowering of patient dose for individual procedure types (Shrimpton et al, 1986; Hart et 
al, 1996; Hart et al, 2002). However, whilst some dose reduction measures have a 
positive effect on image quality, others degrade contrast or increase noise. Thus, it is 
important not just to reduce doses but to optimise each imaging technique, 
maximising its efficiency and determining the right balance between dose and image 
quality. 
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European Union directive 97/43/Euratom stipulates that: All doses due to medical 
exposure for radiological purposes except radiotherapeutic procedures shall be kept 
as low as reasonably achievable consistent with obtaining the required diagnostic 
information (The Council of the European Union, 1997). Member states are 
required to pay special attention to exposures involving high doses to the patient, such 
as those considered in this study. These requirements have been incorporated into UK 
legislation in the form of The Ionising Radiation (Medical Exposure) Regulations 
2000, which extend the obligations to cover therapeutic as well as diagnostic 
exposures: The operator shall select equipment and methods to ensure that for each 
medical exposure the dose of ionising radiation to the individual undergoing the 
exposure is as low as reasonably practicable and consistent with the intended 
diagnostic or therapeutic purpose. 
Thus, radiology providers are under a legal obligation to use the lowest dose that is 
consistent with obtaining the required clinical information. This raises some important 
questions, which unfortunately have no straightforward answers. 
What image quality is required? 
Whilst it is relatively easy to define which structures the clinician needs to be able to 
see in an image, it is much more difficult to describe how well (s)he needs to be able 
to see them. There is a conceptual gap between the clinicians perception of the 
structures present, and any objective, measurable quantities that the scientist can 
describe and work with. 
The image quality that is required depends strongly on the nature of the imaging task. 
For example, in interventional cardiology very clear edge definition is needed when 
imaging the coronary vessels. However, much lower image quality is sufficient for 
coarse positioning of catheters and guide wires. 
How can image adequacy be assessed? 
The technical performance of imaging equipment is usually measured using simple 
test objects, containing regular details of varying size and/or contrast. These tests are 
both practical and repeatable. However, it is much more difficult to quantify and 
compare the quality of clinical images, which contain complex structures and varied 
anatomies and pathologies. Although physical and clinical image quality are clearly 
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linked, the relationship between them is highly complex and little studied. The issue 
of image quality assessment is addressed much more fully in Chapter 2. 
How can the lowest dose be achieved? 
There are a number of different methods for reducing radiation dose, and these affect 
image quality in different ways. The challenge is to make the most effective use of the 
imaging equipment, so that the requisite clinical information can be obtained using 
the lowest practicable dose. Additional factors that may need to be considered when 
implementing changes in clinical practice are financial cost, impact on clinical 
workflow, and the maximum load at which the X-ray tube is able to consistently 
operate.  
Some dose reduction methods are well documented and have been adopted as 
standard practice; others require further exploration. The introduction of new, digital 
detector technologies presents new opportunities and challenges. 
1.5 Dose Reduction Measures 
The radiation dose received by the patient depends on both the performance of the 
imaging equipment, and the technique employed by the operator. This section 
considers first the design features of modern imaging equipment that limit patient 
radiation doses, and then the measures that can and should be taken by the operator, to 
minimise doses wherever possible. 
1.5.1 Design Features for Dose Limitation 
Modern fluoroscopic and fluorographic imaging systems have a number of design 
features aimed at minimising patient radiation dose whilst providing good image 
quality. These include: 
Digital image recording. On even the most basic fluoroscopy systems, the final 
image remains on the screen following termination of the exposure. This allows the 
operator to spend time studying aspects of the patients anatomy, without further 
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adding to their radiation burden. On fluorographic units, digital acquisition provides a 
permanent record of real-time image series. 
Pulsed fluoroscopy. Instead of irradiating the patient and detector continuously, X-
rays are emitted in short bursts, which are synchronised with read-out from the 
detector. More photons are emitted during each pulse than would be emitted in the 
same time scale during continuous fluoroscopy. This improves the signal to noise 
ratio, and the spatial resolution of moving objects. The time-averaged dose rate is 
often lower than for continuous fluoroscopy, resulting in a proportional dose saving. 
Spectral filtration. Increasing the amount of X-ray beam filtration can substantially 
reduce the entrance dose to the patient. This method was used in the optimisation 
study of Chapters 7 and 8, and is described in detail in Section 1.5.2. 
Automatic exposure control. The output from the detector is constantly monitored, 
and kept to a preset value by adjusting the tube voltage (kVp) and current (mA). This 
automatically compensates for changes in attenuation as different imaging projections 
are used. The effects on patient dose and image quality depend on the algorithm 
relating kVp and mA. 
Recursive filtering. Image noise can be reduced by means of recursive filtering. 
Several frames are combined to form each displayed image. This in turn allows a 
reduction in the dose rate at the detector. However, recursive filtering has a negative 
impact on both temporal resolution and contrast, for moving objects. 
Equalisation filter. If the X-ray beam passes through tissues having very different 
attenuation properties, or if a portion of the beam misses the patient altogether, glare 
from the brighter regions of the image can detract from low contrast detail in the 
darker regions. The purpose of an equalisation filter is to reduce this glare and 
improve the distribution of displayed pixel values. A metal filter with a wedge-shaped 
profile is inserted into the X-ray beam, such that the thickest part of the filter covers 
the low attenuation region. This improves visualisation of low contrast detail. As well 
as improving diagnostic accuracy, this may allow the observer to reduce the exposure 
time and hence radiation dose. The filter itself substantially reduces the dose to tissues 
in its shadow. 
Real-time display of radiation dose. All new X-ray units are now fitted with a dose-
area-product (DAP) meter. In addition, new cardiovascular units display an indication 
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of cumulative dose at a fixed point in the X-ray beam, intended to represent the 
patient skin surface. Such measures are intended to raise operator awareness of patient 
radiation dose, as this has been shown to encourage more sparing use of radiation 
(Vehmas, 1997; Yu et al, 2001). 
Direct digital detectors. At present, the most common type of detector used in 
fluoroscopy and fluorography is the image intensifier. Direct digital, or flat panel 
detectors have been introduced in recent years. They have inherently greater detection 
efficiency than image intensifiers, and this should allow some dose reduction. 
1.5.2 Beam Filtration 
The beam emitted from an X-ray tube consists of a spectrum of photon energies. The 
peak energy (kVp) is determined by the potential applied across the tube. A voltage of 
80 kV will produce a spectrum something like the blue line in Figure 1.6. It contains a 
large proportion of low energy photons, including two very large peaks below 10 
keV. These photons are readily absorbed in the patients body, thus contributing to 
radiation dose, but not to the formation of the image. 
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Figure 1.6: Effect of filtration on X-ray spectrum. Data generated using IPEM Report 78 Spectrum Processor 
(Reilly & Sutton, 1997). 
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Absorbent material placed between the X-ray source and the patient can be used to 
filter out the lowest energy photons. The most common filter material is aluminium. 
According to the UK Medical and Dental Guidance Notes (Institute of Physics and 
Engineering in Medicine, 2002), filtration equivalent to at least 2.5 mm aluminium 
must be fitted as standard to medical X-ray tubes. It removes the low energy peaks 
and raises the mean energy of the X-ray spectrum, as shown by the red line in Figure 
1.6. As more filtration is added, the mean spectral energy increases further. Whilst 
this reduces patient radiation dose, it also degrades image contrast and increases the 
loading on the X-ray tube, as explained in the following paragraphs. 
In X-ray imaging, the most important interaction processes are photoelectric 
absorption and Compton scatter. Photoelectric absorption occurs more readily in 
materials with higher atomic numbers, and this is the primary mechanism responsible 
for imaged contrast between the different structures in the body. It is more likely to 
take place at low photon energies. As the average spectral energy increases, fewer 
photons are absorbed and more undergo Compton scattering. Scattered radiation 
incident on the detector degrades both spatial resolution and contrast. The combined 
effect of reduced photoelectric absorption and increased Compton scatter can result in 
loss of visibility of low contrast details. Where additional beam filtration is employed, 
image contrast may be maintained by reducing the tube voltage. 
A further effect of increased filtration is a reduction in photon yield. This may be seen 
in Figure 1.6, as a reduction in the area under the curve. Since a proportion of the 
photons are stopped by the filter, the X-ray tube has to work harder to maintain the 
photon flux at the detector. Thus, tube heat capacity and cooling rate need to be 
considered, to ensure that the X-ray tube is not overloaded. In order to increase the 
tube output, many fluoroscopic units automatically raise the tube voltage. Since this 
degrades image contrast, it may limit the amount of filtration that can be used. 
Copper has been recognised as an effective filter material since the nineteen fifties 
(Trout et al, 1952). It has a higher atomic number than aluminium, and 10% greater 
absorption efficiency (Jennings, 1988). It is physically and chemically stable under 
normal atmospheric conditions, readily available and inexpensive. Until recently, its 
application in radiology has been limited, mainly due to the increased tube loading 
required to maintain image contrast. Although some studies have recommended 
copper filters of up to 0.3 mm in thickness for chest (Rossi et al, 1982; Dobbins et al, 
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2003) and barium enema (Kohn et al, 1988; Hansson et al, 1997; Geleijns et al, 1997; 
Pärtan et al, 2000) examinations, their use has not been widely adopted in clinical 
practice. 
Around the nineteen seventies and eighties, there was considerable interest in filters 
with higher atomic numbers. Several studies advocated the use of heavy metals such 
as erbium, gadolinium, holmium and samarium (Atkins et al, 1975; Villagran et al, 
1978; Chakera et al, 1982; Fleay et al, 1984; Cranage et al, 1992). These act as 
bandpass filters, removing not only the low energy photons from the X-ray spectrum, 
but also high energy photons above their k-edges, which contribute little to image 
contrast but add considerable scatter. Reductions in patient entrance dose of up to 
50% were reported. However, more detailed studies comparing the performance of a 
wide range of filter materials have found conventional filters such as copper and iron 
to be just as effective, whilst placing a smaller load on the X-ray tube (Koedooder & 
Venema, 1986; Kohn et al, 1988; Gagne et al, 1994; Sandborg et al, 1994a; Hansson 
et al, 1997; Dobbins et al, 2003). 
In recent years, imaging equipment manufacturers have developed X-ray tubes with 
advanced cooling mechanisms, which can withstand the increased loads needed to 
support considerable quantities of beam filtration. This is particularly advantageous in 
interventional radiology and cardiology, where high quality images are needed to 
visualise the detailed structure of the small blood vessels, but the patient is at risk of 
high radiation doses to the skin. A combination of copper filtration with a higher 
output operating mode has been shown to offer improved iodine contrast for the same 
patient entrance dose, or reduced dose at the same level of contrast (Hoornaert & 
Kroon, 1993; den Boer et al, 1994a; den Boer et al, 1994b). Modern cardiovascular 
imaging systems are often fitted with optional copper filters up to 0.9 mm in 
thickness. 
A further consequence of this improved X-ray tube technology is that higher atomic 
number filter materials are receiving renewed attention. The latest cardiovascular 
imaging systems from Toshiba (Toshiba Medical Systems Corporation, Tochigi, 
Japan) now employ tantalum k-edge filters. 
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1.5.3 Operator Practice 
The operator has considerable influence over patient radiation dose, and should seek 
to minimise it by a series of measures such as: 
x Minimising the overall exposure time, by working as efficiently as possible 
and making exposures only when necessary; 
x Collimating the beam to the area of interest; as well as reducing the volume of 
tissue irradiated, this improves low contrast detectability by reducing scatter; 
x Minimising the use of high dose rate modes, designed to give enhanced image 
quality but with an increased dose burden to the patient; 
x Minimising the use of magnification modes, which often require a higher dose 
rate at the detector; 
x Using a good spread of X-ray projections, to avoid excessive exposure of any 
one area of the skin; 
x Appropriate use of methods of scatter removal, such as grids. Whilst these 
remove primarily scattered radiation, they also attenuate the primary beam, so 
the patient dose must be increased in order to maintain the photon flux at the 
detector. 
1.6 Summary 
This chapter introduced fluoroscopy and fluorography, and outlined some of their 
clinical applications. Basic descriptions of the specialised equipment used in dynamic 
X-ray imaging were presented. 
The risks to the patient from exposure to ionising radiation were described, and the 
differences between stochastic and deterministic effects explained. The various 
different methods for assessing patient radiation dose were outlined in brief. Typical 
doses for fluoroscopic and fluorographic procedures were presented, and compared 
with typical doses from other radiological investigations. Procedures involving 
dynamic imaging tend to result in much higher patient doses than are encountered in 
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general radiography, and to correspond more closely with those found in computed 
tomography. Cardiac catheterizations and barium enemas were identified as being 
among the particularly high dose procedures.  
The need for optimisation of patient radiation dose and image quality was introduced, 
and the legal requirements for optimisation were outlined. The law requires that the 
radiation dose to the patient should be the minimum necessary to give the required 
clinical information. This implies a need to define image quality requirements for 
medical exposures. The challenges associated with defining and measuring clinical 
image quality were highlighted. 
The various dose limiting features built into modern fluoroscopic and fluorographic 
equipment were described, and the effects of each on image quality were considered. 
The effects of beam filtration were examined in some detail. Dose limitation methods 
that can and should be employed by the operator were then outlined. 
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Chapter 2 - Image Quality 
Assessment 
2.1 Introduction 
The goal of radiographic imaging is to demonstrate patient anatomy and pathology 
well enough to enable reliable, accurate diagnosis or intervention. If the balance 
between dose and image quality is to be optimised, suitable measures of image quality 
must first be defined. 
This chapter describes several different approaches to image quality assessment. 
These range from objective, physical measures, and simple estimates of detail 
visibility, to more sophisticated tests of observer performance, using both phantom 
and clinical images. Whilst some of these tests are designed to evaluate technical 
aspects of imaging performance, others are aimed at comparing the information 
content of clinical images, and assessing observer accuracy in making diagnoses. The 
various merits and limitations of each method are outlined. 
The concept of image quality criteria is then introduced and some examples are 
given. Finally, some general principles for improving the accuracy and repeatability 
of observer performance tests are presented. 
2.1.1 Image Quality Characteristics 
The fundamental characteristics that define image quality are described below. 
Contrast. This is essentially the difference in signal intensity on imaging objects that 
have different attenuation coefficients. The greater the contrast between neighbouring 
structures, the more readily they can be distinguished. When the primary beam 
interacts with the patient, some of the X-ray photons are absorbed or scattered, and 
some pass through the patient to reach the detector. Photoelectric absorption occurs 
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preferentially in materials with higher atomic numbers, and is the most important 
interaction process for diagnostic X-ray imaging. The probability of Compton 
scattering depends on electron density. Hence, it also contributes to image contrast. 
However, those scattered photons that reach the detector produce a uniform increase 
in signal intensity across the image, and this has a detrimental effect on contrast. 
Noise. This describes the variation in pixel values across an image of a uniform 
object. The greater the noise, the more difficult it is to distinguish fine detail, and low 
contrast structures. There are three main sources of noise in a fluoroscopic or 
fluorographic imaging system. The first is quantum noise, caused by the random 
nature of the interactions involved in the production and detection of the X-rays. 
Since X-ray detection follows Poisson statistics, the signal-to-noise ratio can be 
improved by increasing the X-ray exposure. The second is noise arising from the 
structure of the detector itself, for example the graininess of the phosphor screens in 
an image intensifier. The third is electronic noise, which affects applied voltages in 
the detector, as well as the readout circuitry. 
Resolution. In a digital imaging system, resolution is limited by the pixel size, by the 
inherent structure of the detector, and by processes such as scattering of the 
information carriers within it. Practical image resolution is also limited by geometric 
unsharpness; the X-ray focal spot has a finite size, and this causes a penumbra at the 
edges of imaged objects. Another factor affecting the resolution of medical images is 
motion unsharpness. This can be minimised by asking the patient to keep still and, 
where relevant, to hold their breath during image acquisition. In coronary imaging, 
motion unsharpness due to the beating of the heart is minimised by using pulsed 
imaging, with a rapid frame rate and short pulses. 
2.1.2 Image Quality Assessment 
In order to optimise imaging techniques, it is essential to be able to define and 
measure the quality of clinical images, and to assess whether or not they are adequate 
for their intended purpose. These tasks are particularly challenging, since it is difficult 
to connect objective measures of technical image quality with clinicians reading and 
perception of the medical image. 
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Clinical image quality depends on a combination of factors, such as the technical 
performance of the imaging system, patient cooperation, the skill of the operator and 
the nature of the imaging task. Image quality requirements can only be understood in 
relation to a particular medical task, since they depend on the size and contrast of the 
objects to be imaged, and on the precise clinical question that needs to be answered. 
What is important is whether the relevant information is contained in the image and 
can be extracted and interpreted by the viewer. Does the image convey sufficient 
information for the clinician to make a medical decision with a reasonable degree of 
accuracy? 
The gold standard test of diagnostic accuracy is the clinical outcomes audit. At a 
defined time interval after exposure, the patients notes are retrieved and the results of 
the imaging test are compared with subsequent clinical events or diagnostic 
investigations. If these studies are to be meaningful, large numbers of patients must be 
included, and the audit must be performed after an appropriate time interval for the 
clinical investigation. If the imaging task of interest is early detection of a slowly 
progressing disease, this may be several months or even years. 
For optimisation studies, it is also necessary to have more immediate methods for 
assessing image adequacy. Before a new technique is trialled on patients, the 
researchers need to know what its technical effects on image quality will be, in order 
to predict the likelihood of any changes in the appearance of clinical images. 
Following implementation, it is important to be able to verify quickly that clinical 
images continue to fulfil their purpose. 
The following sections describe a number of different approaches to image quality 
assessment. It will be seen that each has both advantages and limitations, and that the 
fundamental problem of defining what degree of image quality is needed is very 
difficult in practice. 
2.2 Physical Measures and Modelling 
The most objective and repeatable way to assess image quality is to measure physical 
quantities associated with it. This is difficult for clinical images, which are highly 
complex in nature. Optimisation studies have commonly used simple Perspex 
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phantoms, with Perspex or iodine-containing details added, to represent clinical 
imaging tasks such as the detection of low contrast lesions, or visualisation of 
contrast-filled blood vessels. 
2.2.1 Signal-to-Noise Ratio 
A systematic approach to optimisation is to compare signal-to-noise ratios for a 
particular imaging task, using various different imaging conditions. Signal-to-noise 
ratio (SNR) has been defined by Tapiovaara and Wagner (1985) and later by 
McParland and Boyd (2000) as 
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Equation 2.1 
where 1S  and 2S  represent the mean signal intensity in background and signal 
regions of the image, V(S1) and V(S2) the standard deviation in these regions. Other 
investigators have chosen to consider only the noise in the signal or background 
regions of the image, not both. Many authors who quote SNR do not state which 
definition they have used. 
Provided that the imaging procedure is quantum noise limited, i.e. the pixel-to-pixel 
variation in the number of photons detected is greater than the system noise, the SNR 
varies with the square root of the detector dose. Many researchers have chosen to use 
the ratio (SNR)
2
/Dose as a figure of merit for optimisation, since it is independent of 
exposure level (Zamenhof, 1982; Boone, 1992; Gagne et al, 1994; Tapiovaara & 
Sandborg, 1995; Dobbins et al, 2003; Samei et al, 2005; Ullman et al, 2005b). For 
any given procedure type, there will be a series of imaging protocols for which this 
figure of merit is maximised. An appropriate protocol is then selected from within this 
set, to give the desired balance between SNR and dose. The dose quantity used in the 
figure of merit can be tailored to suit the examination type. 
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2.2.2 Contrast 
Contrast is another metric that is commonly used to assess image quality. It is usually 
defined as the difference between background intensity Ib and signal intensity Is, 
divided by background intensity (Kroon, 2003; Samei et al, 2005). 
b
sb
I
II
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Equation 2.2 
An alternative definition adopted by McParland and Boyd (2000) is the ratio of the 
difference between signal and background intensities, to the sum of the signal and 
background intensities. Again, many authors who quote contrast values do not specify 
how they have defined contrast. 
2.2.3 Monte Carlo Modelling 
Several groups have developed software for mathematical simulation of the imaging 
process. These generally use Monte Carlo modelling. This powerful computational 
technique follows the histories of hundreds of thousands of photons as they interact 
with a virtual phantom and then with a model detector. It enables large-scale studies 
to be performed quickly and easily, comparing many different combinations of 
imaging parameters. Whilst many investigators modelled simple Perspex or water 
phantoms containing contrast details (Zamenhof, 1982; Sandborg & Alm Carlsson, 
1992; Tapiovaara & Sandborg, 1995; McParland & Boyd, 2000), others have 
improved applicability to the clinical situation by using voxel phantoms, developed 
from computed tomography scans of human subjects (Sandborg et al, 2001; Ullman et 
al, 2005a). 
The most sophisticated simulations allow the investigator to vary the detector type 
and efficiency, and the properties of the anti-scatter grid (Sandborg & Alm Carlsson, 
1992; Sandborg et al, 1993; Sandborg et al, 1994b; Kroon, 2003; McVey et al, 2003). 
These can be powerful tools for developing new imaging equipment, tailored to 
specific clinical applications.  
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2.2.4 Limitations 
Physical measures and modelling of image quality are valuable tools for optimisation. 
However, each relies on simplifications or assumptions, which limit its accuracy for 
predicting clinical imaging performance. The outcomes of modelling studies need to 
be verified empirically, before new techniques are introduced into clinical practice. 
Physical measures such as SNR and contrast do not include any consideration of the 
display and observation stages of the imaging process. They relate to perfect 
observers of the fluoroscopic signal. It is important also to consider the efficiency of 
(imperfect) human observers, using a real display system. Several different 
approaches to this are described in the following sections. 
2.3 Contrast Detail Tests 
Subjective measures of low contrast detectability can be made using standard or 
custom-built phantoms, and viewing the images by eye. The simplest phantoms 
contain fixed details of varying size and contrast. Some of the best known are the 
Leeds test objects developed by Hay et al (1985) and currently marketed by Leeds 
Test Objects Limited (Boroughbridge, UK). 
Figure 2.1 shows a radiographic image of the Leeds TO.10 test object. This 
contains twelve rows of attenuating discs. Each row comprises discs of a different 
diameter, and the contrast varies from left to right, along each row. The observer 
views the image under a set of standard conditions, and counts the number of details 
visible in each row. The results are then compared with tabulated data, relating the 
number of details seen to threshold contrast, for given X-ray beam quality. 
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 Figure 2.1: Radiographic image of Leeds test object TO.10. 
The tests are quick and easy to perform. They can be reliably used to detect large 
changes in system performance, and to rank systems according to their contrast and 
noise characteristics (Cohen et al, 1984; Marshall et al, 1992; Tapiovaara & 
Sandborg, 2004). However, they have limited accuracy and reproducibility in 
identifying absolute threshold contrast, since they depend on the observers subjective 
visualisation threshold. This leads to inevitable variation between even the most 
experienced observers, and between viewing sessions, especially if they are separated 
by long time intervals. 
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2.4 Forced Choice Experiments 
The forced choice experiment seeks to remove observer bias, by asking the observer 
to indicate the locations of the details. For each detail size and contrast, an example of 
the details appearance is usually presented to the observer, who is then asked to 
identify the position of a similar detail, from a fixed number of possible locations. 
 
Figure 2.2: Radiographic image of CDRAD phantom, kindly supplied by KCARE (Kings College Hospital, 
London, UK). 
A popular phantom for forced choice experiments is CDRAD (Artinis Medical 
Systems B.V., Andelst, Netherlands). A radiographic image of this test object is 
shown in Figure 2.2. It consists of a grid of squares. Apart from the top three rows, 
each square contains two identical details. One is in the centre of the square, and the 
other is in one of the corners. For each square, the observer must state which corner is 
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occupied. An image quality factor is then calculated, on the basis of the number of 
correct responses. Whilst the details are again in fixed positions, their layout is 
irregular compared to the Leeds phantoms, and the observer is unlikely to remember 
many of the detail positions. 
Another approach is to use phantoms with moveable details, such as those 
manufactured by ALVIM Research & Development Ltd (Jerusalem, Israel). Figure 
2.3 shows a photograph of their general radiographic phantom, TRG. Each column 
contains 10 discs, five of which have a hole of a particular diameter and depth drilled 
into them. The positions of the discs can be interchanged, and the observer must 
decide which discs contain the holes. The numbers of true and false positives are used 
to calculate detection accuracy for each detail size. 
 
Figure 2.3: TRG phantom (ALVIM R&D, Jerusalem, Israel). 
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Wilson et al (2003) and Jiang and Wilson (2004) used more clinically relevant forced-
choice experiments, in which the observers were asked to locate simulated images of 
vascular stents or guidewires. 
The forced choice experiment identifies threshold contrast more reliably than the 
constant stimulus tests of Section 2.3, since it does not depend on a subjective 
decision threshold. Image scoring is quick, and the results are reproducible. 
Tapiovaara and Sandborg (2004) found that observers were able to detect objects of 
much lower contrast in a forced choice experiment than they reported as visible in 
contrast detail tests. 
2.5 Receiver Operating Characteristic (ROC) 
Studies 
Experiments using contrast detail phantoms, although useful for comparing the 
performance of different imaging systems or techniques, have no direct relation to the 
effectiveness of a clinical imaging task. Whilst they can indicate which sets of 
exposure conditions give the most information per unit of dose, they cannot assess 
which give adequate image quality for diagnosis. 
2.5.1 Methodology 
Receiver Operating Characteristic (ROC) studies seek to measure observer 
performance in clinically relevant imaging tasks. In the most basic tests, the observer 
is presented with a series of images, some of which are normal, and some of which 
contain real or simulated pathologies. For each one, they are asked to indicate their 
confidence in the presence or absence of pathology. Scoring is commonly done on a 
five-point scale, along the lines of the following: 
0% - definitely negative (normal) 
25% - probably negative 
50% - possibly positive 
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75% - probably positive 
100% - definitely positive (abnormal) 
For each level in the scoring system, the true positive rate (sensitivity) is then plotted 
against the false positive rate (1-specificity), and a curve is fitted to the data. Figure 
2.4 shows an example of an ROC plot. The blue line shown is the line of pure chance, 
representing total inability of the test to distinguish between normal and diseased 
patients. The red curve is a typical ROC curve for a diagnostic test with 80% 
accuracy. Each point on the curve corresponds to the sensitivity and false positive rate 
at a different decision threshold. As the test accuracy improves, the curve moves 
towards the top left-hand corner of the plot. 
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Figure 2.4: Example ROC plot. 
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The area under the curve indicates the accuracy of the imaging technique. An area of 
0.5 would indicate pure guesswork, whereas an area of 1.0 would correspond to a 
perfect diagnostic test, having 100% sensitivity and specificity. 
Basic ROC studies require the observer to make a yes/no decision, which does not 
reflect the clinical situation. A more realistic approach is Free-response ROC (FROC). 
Here, there can be an arbitrary number of pathologies in each image. The observer 
must indicate the positions at which (s)he perceives abnormalities to be present. True 
positive scores require abnormalities to be identified at the correct locations. 
For a more comprehensive explanation of ROC methodology, the reader is referred to 
Metz (1978) or Obuchowski (2003; 2005). Free-response ROC and associated 
methods for data analysis are described in detail by Chakraborty and Winter (1990), 
and Chakraborty and Berbaum (2004). 
Two reported studies have performed ROC analysis on images from coronary 
angiograms (Baker et al, 1997; Kerensky et al, 2000). Observers were asked to 
identify features such as filling defects, thrombi, dissections, calcifications and stents. 
In one study, they were also asked to provide a visual estimate of stenosis severity at a 
designated location (Kerensky et al, 2000). 
2.5.2 Practical Considerations 
ROC studies are usually performed using selected, randomised clinical images. In 
order to measure sensitivity and specificity, the investigators need to know the 
correct diagnosis for each image, and this may not be easy to ascertain. Where 
possible, the patients disease status is determined from the outcomes of other clinical 
tests. Failing this, the diagnosis is agreed for each case by a panel of experts. However 
an inadequate image could result in an incorrect diagnosis by the expert panel, and 
this may mask poor diagnostic accuracy. 
Some investigators have added simulated pathologies to anatomical phantoms, or real 
clinical images (Strotzer et al, 1998a; Strotzer et al, 1998b; Strotzer et al, 2000; 
Tingberg et al, 2000; Ludwig et al, 2002; Goo et al, 2002). This makes it easy to 
define the correct diagnosis for each case. However, simulated images do not reflect 
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natural variations in the appearance of normal anatomy and in pathological changes 
within the patient population. 
ROC analysis does not depend on observer decision threshold. In fact, the ROC curve 
has an infinite number of points, corresponding to every possible decision threshold. 
It is not affected by disease prevalence, and can be used to compute useful summary 
measures of test accuracy. However, it does require large-scale studies, involving at 
least 100 patients. The actual sample size depends upon the disease prevalence in the 
study population. Observers must be trained in the interpretation of clinical images. 
2.6 Visual Grading Analysis (VGA) 
Perhaps the simplest method for comparing different imaging techniques is visual 
grading analysis (VGA). Here, images or features within them are given a relative 
score, reflecting how well details are visualised. Two different approaches to VGA 
are described in the literature. 
The first approach is to compare each image with a reference image, and score it 
according to the observers preference. The most common scoring system is a five-
point scale, with gradations essentially as follows (Oda et al, 1996; Silber et al, 1997; 
Almen et al, 2000; Sund et al, 2000; Sandborg et al, 2001; Fink et al, 2002; Lanhede 
et al, 2002): 
(1)  much poorer than reference image 
(2)  slightly poorer than reference image 
(3)  equivalent to reference image 
(4)  slightly better than reference image 
(5)  much better than reference image. 
Such tests are most powerful if paired images are used. This generally involves 
subjecting patients to an increased radiation burden. 
The second approach is to grade individual images according to how well structures 
can be seen. Scoring is usually done on a four or five point scale, with gradations 
corresponding to excellent, good, moderate, poor and sometimes very poor 
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(Cranage et al, 1992; Ross et al, 1997; Volk et al, 2000; Fink et al, 2002; Uffmann et 
al, 2005). 
Some investigators have graded radiographs according to several aspects of image 
quality, such as contrast, noise and resolution (Ross et al, 1997; Persliden et al, 1997; 
Pärtan et al, 2000). The observers are often asked to state whether or not each image 
is acceptable for diagnosis. Kerensky et al (2000) asked observers to rate their 
confidence in interpreting coronary angiograms, on a scale of 0 to 10. 
Visual grading analyses are clearly subjective. Their reliability may be improved by 
employing multiple observers and averaging their scores. Several studies have 
calculated normalised visual grading analysis scores (VGAS) (Almen et al, 2000; 
Sund et al, 2000; Sandborg et al, 2001; Lanhede et al, 2002). These may be defined 
by the equation 
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Equation 2.3 
where the relative ratings (R) of the images are summed over the number of observers 
(o), images (i), and structures (s). No is the total number of observers, Ni the total 
number of images, and Ns the total number of structures compared. 
Visual grading analysis is sensitive to small changes in image quality, especially if 
paired images are used (Tingberg et al, 2004). Comparative studies have shown the 
results to correlate well with ROC analysis (Sund et al, 2000; Tingberg et al, 2000). It 
is especially useful for comparing image processing techniques, since paired images 
can be produced simply by applying different processing algorithms to the same 
image, without any additional exposure of the patient. Its main disadvantage is that 
image scoring does not correspond to the clinical imaging task, which is usually 
lesion detection. 
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2.7 Image Quality Criteria 
In the late eighties, the Radiation Protection Programme of the Commission of the 
European Communities (CEC) initiated a project to establish radiographic quality 
criteria for a range of common examination types. These were then subjected to an 
extensive clinical trial across the European Union, and a set of European Guidelines 
on quality criteria were published (European Commission, 1996). These set out to 
define the necessary requirements for an image of standard diagnostic quality. 
Quality criteria were defined for standard chest, skull, lumbar spine, pelvis, urinary 
tract and breast images. 
2.7.1 Cardiac Criteria 
A preliminary set of quality criteria for coronary angiograms has since been proposed 
by the Italian Society of Invasive Cardiology and the Italian Society of Physics in 
Medicine, and adopted by the DIMOND group (Bernardi et al, 2001b). These are 
based on the style of the European Guidelines, and use the same terms for degree of 
visualisation of the relevant structures. The criteria for left coronary angiography are 
listed below. 
1. Performed at full inspiration if necessary to avoid diaphragm superimposition 
or to change anatomic relationship (in apnoea in any case). 
2. Arms should be raised clear of the angiographic field. 
3. Visually sharp reproduction of vessel walls. 
4. Simultaneous and full opacification of the vessel lumen at least until the first 
critical lesion (70% by visual estimation). 
5. Panning should be limited. If necessary, pan in steps rather than continuously, 
or make subsequent cine runs to record remote structures. 
6. Visually sharp reproduction of the origin, proximal, mid and distal portion of 
the left anterior descending and circumflex arteries, in at least two orthogonal 
views. 
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7. Visually sharp reproduction of side branches 1.5mm of the left anterior 
descending and circumflex arteries in at least two orthogonal views; the origin 
should be seen in at least one projection. 
8. Visually sharp reproduction of lesions in vessels 1.5mm in at least two 
orthogonal views. 
9. Visualization of collateral circulation when present. 
10. When criteria 6-9 have been fulfilled, avoid extra projections (mainly LAO 
semi-axial). 
The degrees of clarity with which the various features must be visualised are defined 
as follows. 
Visualization  features just visible  characteristic features are detectable, but details 
are not fully reproduced. 
Reproduction  details emerging  details of anatomical structures are visible, but 
not necessarily clearly defined. 
Visually sharp reproduction  details clear  anatomical details are clearly defined. 
2.7.2 Image Criteria Score 
Bernardi et al (2001a) designed a weighted scoring system for evaluating compliance 
with the DIMOND cardiac criteria. Each arterial branch was scored in turn, with 1 
given for each fulfilled criterion and 0 for each unfulfilled criterion. The scores were 
then summed to give a total quality score for the whole examination. This approach 
of combining scores based on quality criteria into a single index has also been adopted 
by Almen et al (2000), Sund et al (2000), Sandborg et al (2001) and Lanhede et al 
(2002). Image criteria score (ICS) is usually defined as an average of the actual 
scores, over the maximum total score. 
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where the assigned scores S are summed over number of observers (o), images (i), and 
criteria (c). No is the total number of observers, Ni the total number of images, and Nc 
the total number of criteria. 
Vano et al (1995) recommended that the criteria must be sufficiently complete to 
avoid all films valid for diagnosis meeting all criteria. This implies a very different 
understanding of image quality criteria from that originally intended by the CEC 
Radiation Protection Programme. The criteria were established as requirements that 
should be met to ensure that a standard image provides adequate diagnostic 
information. However, these investigators used them as a means of grading diagnostic 
images according to their relative merit. 
The practice of using quality criteria scoring to differentiate degrees of excellence has 
also been adopted by Almen et al (2000) and Lanhede et al (2002). Visual grading 
analysis based on the features defined in the image quality criteria has been found to 
be an especially sensitive approach to comparing image quality (Almen et al, 2000; 
Tingberg et al, 2000; Tingberg et al, 2004). 
2.7.3 Recommendations Arising from Clinical Experience 
A number of general recommendations arising from the initial European trial of the 
CEC criteria are discussed in detail in European Union report EUR 16635 EN 
(Maccia et al, 1996). The consensus in the literature is that image quality criteria 
should be as precise and objective as possible, to avoid ambiguity and maximise 
observer agreement. At the same time, they need to be clinically meaningful, and 
readily understood and applied in the clinical environment. The wording should be 
very clear and should relate directly to visualisation or reproduction of specific parts 
of the anatomy. The criteria should include a range of important feature types, 
including small structures and low contrast structures, to assess global imaging 
performance. 
Studies using both the CEC chest criteria and the DIMOND cardiac criteria observed 
that most images failed to satisfy all of the quality criteria, despite being judged 
adequate for their clinical purpose (Bernardi et al, 2001a; Lanhede et al, 2002). In 
some cases, the criteria on which the image fails may not be relevant to that patients 
clinical condition. However, it may also be that some features are still considered 
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clinically acceptable if the standard is not met. The European Guidelines on Quality 
Criteria for Diagnostic Radiographic Images (European Commission, 1996) 
acknowledge that the criteria do not define acceptability for particular clinical 
indications, since in some cases lower image quality may be sufficient. 
Martin et al (1999), and Redlich et al (2005), point out that it may not be sufficient to 
use a system of quality criteria based only on the reproduction of normal anatomical 
structures, since the image quality requirements for viewing pathologies may be more 
stringent. Bernardi et al (2001a) recognized that to fully test the robustness of a 
scoring system based on image quality criteria, a trial should also include some 
examinations that are deemed clinically unacceptable. 
2.8 Observer Variation 
One of the limitations of any observer-based method for evaluating image quality is 
that the results are subject to both intra- and inter-observer variation. An individual 
observers perception of an image is conditioned by their own expectations and 
preferences. Their decision thresholds will also change as they gain experience in 
scoring the images, and become more familiar with the questions and issues raised by 
the trial. Studies in which observers were asked to re-evaluate some of the images 
after a significant time interval reported that up to 20% of answers changed between 
the two reading sessions (Almen et al, 2000; Lanhede et al, 2002). 
As has already been described, some image quality tests are more prone to these types 
of variation than others. Measures that can be taken to reduce the influence of 
observer error include employing multiple observers, repeating observation sessions 
and averaging observer scores, allowing a substantial time interval between 
observation sessions (to reduce memory bias), training the observers in using the 
scoring system, and familiarising them with the types of images they are likely to see, 
before commencing the study. 
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2.9 Summary 
The chapter began by defining the fundamental descriptors of image quality: contrast, 
noise and resolution. A review of the literature then considered various methods for 
assessing image quality and for determining the adequacy of clinical images. 
Objective measurements of physical quantities such as signal-to-noise ratio or contrast 
give the most reproducible results, but do not include the display and observation 
steps of the imaging process. Monte-Carlo simulations are a particularly efficient 
means of seeking an optimized imaging technique. The results should always be 
verified empirically, before introducing changes to clinical practice. 
Contrast detail tests provide a quick and easy check for large changes in system 
performance, but suffer from considerable intra- and inter-observer variation, since 
detail visibility depends on the observers subjective decision threshold. Forced 
choice experiments remove observer bias, by asking observers to identify the position 
of a known object, from a number of possible locations. This improves the reliability 
of the test results. 
Receiver operating characteristic (ROC) analysis is a well-established method for 
determining the diagnostic accuracy of clinical images. However, it requires large-
scale clinical studies, and relies on the investigator knowing the correct diagnosis for 
each case. 
In visual grading analysis (VGA), observers are asked either to rate each image 
against a reference image, or to grade individual images according to their merit. 
Although subjective, these tests are sensitive to small changes in image quality. 
Normalised VGA scores provide a direct measure for comparing imaging techniques. 
Image quality criteria define the necessary requirements for a standard diagnostic 
image. They are based on the degree of visualization of important anatomical 
structures. Some studies have used quality criteria to grade images according to their 
relative merit, although this seems to deviate considerably from their original purpose. 
The chapter concluded with some general principles for improving the accuracy and 
repeatability of observer performance tests. These included employing multiple 
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observers, repeating viewing sessions, and providing suitable training and 
familiarization for observers prior to starting the study. 
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Chapter 3 - Skin Dose in Cardiac 
Catheterization 
3.1 Introduction 
This chapter gives a clinical background to the two most common cardiac 
catheterization procedures, coronary angiography and coronary angioplasty. It then 
reports some of the cases of radiation skin injuries cited in the literature, and 
summarises what is currently known about the relationship between radiation dose 
and the severity of skin effects. It outlines the various professional guidelines and 
legislation that have been put in place to tackle the problem of excessive skin doses. A 
number of different approaches to skin dosimetry have been adopted in the past, and 
these are described and compared. Finally, the current literature on management of 
patients thought to be at risk of adverse skin effects is summarised. 
3.2 Clinical Background 
Coronary heart disease is the most common cause of death in the western world. It is 
caused by narrowing or occlusion of the coronary arteries, which supply blood to the 
muscles of the heart. Catheter-based imaging and interventional techniques are now 
widely used in its diagnosis and treatment. 
3.2.1 Coronary Angiography 
The coronary angiogram is a diagnostic procedure, performed to image the lumen of 
one or more of the coronary arteries. It may be used for diagnosis of heart disease, to 
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assess treatment feasibility, or to evaluate treatment outcomes. It is currently the gold 
standard technique for assessment and classification of coronary plaques. 
A catheter with a radio-opaque tip is inserted into the arterial system, usually through 
the femoral artery. The catheter tip is manipulated into the artery of interest, using 
fluoroscopic guidance. An iodine-based contrast agent is injected via the catheter, and 
the artery imaged using fluorography (an acquisition run). The X-ray tube and 
detector are then rotated around the patient, and further acquisition runs performed in 
different projections through the heart, to enable visualisation of all segments of the 
artery. 
 
Figure 3.1: Coronary angiographic image, with arrow demonstrating stenosis of the right coronary artery. 
Figure 3.1 is an image taken from a coronary angiogram. It is a left anterior oblique 
view of the right coronary artery. A narrowing (stenosis) is clearly seen at the point 
indicated by the arrow. 
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3.2.2 Coronary Angioplasty 
Percutaneous transluminal coronary angioplasty (PTCA) is the process of opening up 
an arterial narrowing, using a specially designed balloon. A catheter is inserted into 
the affected coronary artery under fluoroscopic guidance, as described above. A 
contrast agent is injected and the artery imaged using fluorography, to locate the 
stenosis. An angioplasty balloon is inserted into the stenosis and inflated to increase 
the vessel lumen. After balloon deflation, the artery is imaged again, to assess the 
effectiveness of the procedure. Balloon inflation may need to be repeated, if the 
diameter of the arterial lumen is still insufficient. 
 
Figure 3.2: Angioplasty balloon, inflated at site of narrowing. 
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Figure 3.2 shows an inflated angioplasty balloon, at the site of the narrowing shown in 
Figure 3.1. Figure 3.3 is a post-angioplasty image, demonstrating that the diameter of 
the vessel has been increased successfully. 
 
Figure 3.3: Improved blood flow, following coronary angioplasty. 
A stent may also be implanted at the angioplasty site, to prevent elastic recoil of the 
arterial wall. This is a cylindrical scaffold, which is flat-packed and inserted into 
position via a catheter, and is then expanded using a balloon to match the lumen of the 
artery. 
Each stage of the procedure is documented pictorially, using acquisition runs. Images 
are taken to demonstrate the anatomy of the coronary arteries before and after the 
intervention, the positions of balloons and stents, and any complications or transient 
adverse effects that occur during the procedure. 
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In 2003, a total of 53,261 percutaneous coronary interventions were performed in the 
UK (www.heartstats.org), the vast majority of which were coronary angioplasties. 
This number increases by around 15% each year. 
3.3 Skin Dose and Deterministic Injuries 
Adverse skin reactions are a familiar side effect in radiotherapy, but are not usually 
encountered in diagnostic or interventional radiology, where the radiation doses are 
generally much lower. However, a number of cases of severe skin injuries have been 
reported following cardiac catheterization procedures. The majority of these were 
coronary angioplasties (Sovik et al, 1996; Shope, 1996; D'Incan et al, 1997; Widmark 
& Hellesnes, 1997; Kawakami et al, 1999; Miralbell et al, 1999; Dehen et al, 1999; 
Vanõ et al, 2001a; Koenig et al, 2001a) or radiofrequency catheter ablations (Shope, 
1996; Rosenthal et al, 1997; Vanõ et al, 1998a; Wong & Rehm, 2004), although a 
small number of cases have been associated with particularly difficult coronary 
angiograms (Dehen et al, 1999; Koenig et al, 2001a). Many of the incidents were 
caused by out-dated or faulty equipment, or poor radiographic practice, but some were 
simply due to difficult or repeated procedures resulting in a high cumulative dose. 
Deterministic effects such as skin burns only occur above a certain dose threshold, i.e. 
after a minimum number of cells have been damaged. This threshold depends on a 
number of factors including patient age, skin site and area of skin affected, and pre-
disposing conditions such as diabetes (Food and Drug Administration, 1994; Mayr et 
al, 1997; Wagner et al, 1999; World Health Organization., 2000; Vanõ et al, 2001a; 
Koenig et al, 2001b). If exposures are separated by long time intervals, the severity of 
skin damage is reduced, since some sub-lethal cell damage can be repaired between 
fractions. 
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Effect Typical 
Dose 
Time to 
onset 
Description 
Transient 
erythema 
2 Gy Hours Skin reddening, peaking at ~ 24 hours. 
Temporary 
epilation 
3 Gy 3 weeks Temporary hair loss, caused by depletion 
of germinal layers of the hair follicles. 
Main 
erythema 
6 Gy 10 days Reddening and oedema of the skin. 
Burning, tenderness and itching. 
Permanent 
epilation 
7 Gy 3 weeks Permanent hair loss. 
Dry 
desquamation 
10 Gy 4 weeks Flaky skin, due to depletion of 
proliferative cells in basal layer. 
Invasive 
fibrosis 
10 Gy ----- Skin and subcutaneous fat replaced with 
inflexible, fibrous scar tissue. Skin is 
tender & movement restricted. 
Dermal 
atrophy 
11 Gy > 14 weeks Epidermis reduced to a few layers of cells. 
Hair follicles disappear. Scattered focal 
discolouration. Irradiated area contracts. 
Telangiectasis 12 Gy > 52 weeks Atypical dilatation of superficial dermal 
capillaries. 
Moist 
desquamation 
15 Gy 4 weeks Blistering and sloughing of superficial 
skin. Continuous weeping from deep 
cutaneous layers. Pain, and exposure to 
infection. 
Late 
erythema 
15 Gy 6-10 weeks Dusky or mauve skin discolouration. 
Dermal 
necrosis 
18 Gy > 10 weeks Microvascular damage leads to 
progressive vascular insufficiency of the 
dermis. 
Secondary 
ulceration 
20 Gy > 6 weeks Delayed healing. Reduction in thickness 
of the new epidermis. 
Table 3.1: Radiation-induced skin injuries, dose thresholds, times to onset and description of symptoms 
(McLean, 1973; Hopewell, 1990; International Commission on Radiological Protection, 1991a; Wagner et al, 
1994; Food and Drug Administration, 1994; National Radiological Protection Board, 1996; World Health 
Organization., 2000; Koenig et al, 2001b). 
Chapter 3 - Skin Dose in Cardiac Catheterization 48
Typical threshold doses are given in Table 3.1, with the time-to-onset and symptoms 
of associated adverse effects.  There can be a considerable time delay between 
radiation exposure and the onset of symptoms. This means that radiation-induced skin 
injuries are not always correctly identified, and as a result patients may not receive 
appropriate treatment and counselling. A number of studies have reported cases of 
skin injury in which the patients themselves or the dermatologists to whom they were 
referred were unaware of their exposure to ionising radiation (Lichtenstein et al, 1996; 
D'Incan et al, 1997; Vanõ et al, 1998a; Koenig et al, 2001b). This led to considerable 
delays in diagnosis and treatment. It is likely that many other such cases have 
occurred, but have never been identified. 
Advances in technology have led to improved dose-efficiency in modern imaging 
equipment. However, at the same time rapid development of new percutaneous 
treatment techniques and improved procedural outcomes have led to more and more 
difficult cases being undertaken. By their nature, these tend to be associated with 
longer fluoroscopy times and greater numbers of acquisition runs. As the number of 
interventional devices continues to grow, the trend towards tackling more complex 
cases is likely to continue. 
A growing number of patients now undergo multiple catheterization procedures. A 
diagnostic angiogram may identify the need for an angioplasty, which will in turn 
require a follow-up angiogram to check the efficacy of the treatment. In addition, re-
stenosis of the artery can occur following angioplasty, and this may necessitate a 
further intervention. In-stent re-stenosis has been variously estimated to occur in 10 to 
50% of cases (Bailey, 2002; Garza et al, 2002; Lowe et al, 2002; Radke et al, 2003). 
Strategies now being used to combat re-stenosis include long-term drug therapies, 
intra-vascular brachytherapy, mechanical cutting devices, laser treatments and novel 
stent designs (Bailey, 2002; Kandzari et al, 2002; Garza et al, 2002; Gunn et al, 2003; 
Sousa et al, 2003a; Sousa et al, 2003b). One of the most promising developments is 
that of drug-eluting stents, which target drug therapy to the vessel wall where they are 
implanted. However, at present multiple procedures continue to be a reality for many 
patients. 
Those patients who undergo multiple procedures may well receive cumulative doses 
above the threshold for deterministic effects. Shope (1996) described one particularly 
extreme case where the patient underwent two coronary angiograms and one 
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angioplasty on the same day, and developed severe tissue necrosis. There is usually a 
time interval of at least a few days (if not months or years) between procedures, 
allowing the skin time for recovery. There is however some evidence that the damage 
responsible for late radiation effects may be residual, so that the first exposure reduces 
the skins tolerance to subsequent radiation (Hansson & Karambatsakidou, 2000; 
Koenig et al, 2001b). 
3.4 Legislation and Guidance 
In response to the reported incidents, regulatory and advisory agencies have put a 
range of measures in place to limit patient skin doses from complex catheterization 
procedures, and to promote good management of patients who may be at risk of 
radiation induced skin injuries. Of particular relevance to this work are the guidelines 
published by the US Food and Drug Administration (1994; 1995) and the 
International Commission on Radiological Protection (2000). 
These recommend that: 
x Patients undergoing procedures that may cause deterministic effects should be 
counselled on the risk of skin injuries, and this risk should be addressed on the 
patient consent form. 
x Information should be recorded in the patients notes, which permits the skin 
dose from individual procedures to be estimated. This is particularly important 
for patients who may have received doses sufficient to cause adverse skin 
reactions. The FDA recommend recording the dose if it exceeds 1 Gy, for all 
procedures. ICRP Report 85 suggests that recording doses of 3 Gy or more is 
sufficient, unless the patient is likely to undergo repeat catheterisation, in 
which case the lower recording threshold of 1 Gy should be used. The 
physician should record the location and extent of the skin sites irradiated to 
these levels, and estimate the magnitude of the dose to each one. 
x Patients thought to have received a dose that may cause deterministic effects 
should be counselled after the procedure, on the signs and symptoms they 
should look out for, and what action to take should any skin changes occur. 
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Additionally, ICRP Report 85 recommends that patients receiving skin doses 
of 3 Gy or more should be followed up 10 to 14 days after exposure, to check 
for any signs of erythema. 
The guidelines have several implications for patient dose assessment. Firstly, 
physicians performing cardiac catheterization procedures need to know the typical 
skin doses associated with them, so that they can give patients appropriate 
information on radiation risks, to fulfil the requirements for fully informed consent. 
Secondly, they must have a means of identifying individual procedures that exceed 
the dose recording thresholds and put the patient at risk of skin injuries. Thirdly, a 
method is needed for estimating the magnitude of the skin doses received by these 
patients, and the location of any high dose regions on the skin. Given the large 
proportion of patients who now undergo more than one catheterization procedure 
(around 20% locally), it is advisable to record these details for all procedures resulting 
in a peak skin dose of more than 1 Gy. 
Since cardiac catheterizations are relatively high dose procedures, they must be 
considered a priority for optimisation under The Ionising Radiation (Medical 
Exposure) Regulations 2000. The assessment of skin dose is an essential step in this 
optimisation process, since it informs the development of dose reduction strategies to 
minimise the potential for skin injuries. Skin dose information for individual patients 
can also assist the operator in planning subsequent procedures, so as to minimise 
further irradiation of areas of the skin that have already been subjected to high doses. 
3.5 Skin Dosimetry 
This section outlines the various methods that have been used for skin dosimetry in 
the cardiac catheterization laboratory, and considers the merits and limitations of 
each. The dose indicators most commonly used are dose-area-product and fluoroscopy 
time, since these are conveniently displayed on the imaging unit. However, these take 
no account of the wide variation in imaging projections used. 
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3.5.1 Dose Area Product 
Table 3.2 and Table 3.3 summarise mean dose-area-products reported in recent 
literature, for coronary angiograms and angioplasties. These are arranged in order of 
increasing DAP. 
Reference Number of Patients DAP 
(Gycm
2
) 
Kuon et al (2003) 140 13 
Clark et al (2000) 117 14 
Arthur et al (2002) 368 16 
Katritsis et al (2000) 16 27 
Paisley et al (2004) 3273 27 
Efstathopoulos et al (2003) 20 29 
Hart et al (2002) 8000 30 
Neofotistou et al (2003) 600 39 
Tsapaki et al (2003) 195 47 
Karambatsakidou et al (2005) 20 49 
den Boer et al (2001) 322 52 
Lobotessi et al (2001) 18 58 
van de Putte et al (2000) 62 61 
Fransson and Persliden (2000) 65 63 
Hansson and Karambatsakidou (2000) 78 73 
Delichas et al (2005) 93 79 
Table 3.2: Reported mean DAP values for coronary angiograms. 
There are many different factors affecting mean DAP, including the age, construction 
and performance of the imaging equipment used, patient caseload, local imaging 
protocols and variations in individual operator technique. Rapid changes in practice 
and improvements in technology have taken place during the period over which these 
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data were collected. The more recent studies are likely to have been performed on 
newer imaging equipment, which tends to have more inbuilt dose reduction features. 
However, they are also likely to include more complex cases, with more vessels 
treated and more stents implanted per procedure, which may explain why mean DAP 
has not necessarily reduced with time. 
Reference Number of Patients DAP (Gycm
2
) 
Kuon et al (2002) 46 10 
Kuon et al (2003) 116 13 
Katritsis et al (2000) 10 36 
Karambatsakidou et al (2005) 10 40 
Paisley et al (2004) 479 41 
Fransson and Persliden (2000) 24 48 
Neofotistou et al (2003) 600 55 
Hart et al (2002) 334 63 
Padovani et al (2001) 232 
117 
46 
67 (simple) 
96 (medium) 
133 (complex) 
Tsapaki et al (2003) 97 68 
Efstathopoulos et al (2003) 20 75 
Delichas et al (2003) 102 86 
Widmark et al (2001) 281 89 
van de Putte et al (2000) 13 
10 
115 (without stent) 
166 (with stent) 
Table 3.3: Reported mean DAP values for coronary angioplasties. The data from Padovani et al (2001) is divided 
into three groups, according to a complexity index defined in their paper. 
The various studies may also have used different systems for classifying examination 
types. For example, one cardiology department might routinely include left 
ventriculography as part of the coronary angiogram, where another does not. Some of 
the angiograms will include both left and right heart catheterisation, whilst in other 
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cases only one coronary artery was examined. Some of the quoted data for coronary 
angioplasty includes placement of one or more stents, and this will tend to increase 
the DAP. 
Whilst DAP is a useful indicator of stochastic risk, it is not directly linked to skin 
dose. During each procedure, the heart is imaged using a number of different 
projections. The distribution of dose across the patients skin depends on which 
projections are used, and for what proportion of the procedure. This can vary greatly 
from one patient to the next, depending on operator preference, the anatomy of the 
patients coronary arteries, and the location and severity of lesions. Thus, there may in 
fact be a very poor relationship between skin dose and DAP, as reported by van de 
Putte et al (2000), Vanõ et al (2001b), Waite and Fitzgerald (2001), and Delichas et al 
(2005). 
The newest interventional X-ray units also display the cumulative dose at a fixed 
point in the X-ray beam. This is usually at the interventional reference point defined 
by the international standard IEC 60601-2-43:2000 (International Electrotechnical 
Commission, 2000). This point is intended to represent the entrance surface of the 
patient, and is situated on the central axis of the beam, 15 cm from the centre of 
rotation of the gantry, in the direction of the focal spot. This quantity only indicates 
the skin dose that would be received if the whole procedure were performed in a 
single projection, and gives no information about the actual dose distribution on the 
skin. 
3.5.2 Fluoroscopy Time 
Fluoroscopy time has often been used as a patient dose indicator for fluoroscopic and 
fluorographic procedures. This approach may be reasonable for examination types 
involving a large quantity of fluoroscopy with a small, set number of radiographs. In 
cardiac catheterization procedures, a large portion of the dose comes from the 
acquisition runs, so fluoroscopy time is likely to give a poor indication of patient dose 
(Hansson & Karambatsakidou, 2000; Lobotessi et al, 2001; Neofotistou et al, 2003; 
Efstathopoulos et al, 2003). As with DAP, fluoroscopy time takes no account of the 
different projections used. Fluoroscopy time alone cannot be expected to provide a 
useful estimate of skin dose. 
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3.5.3 Thermoluminescence Dosimetry 
Thermoluminescence dosimetry (TLD) is a well-established technique in general 
radiography. Small chips or sachets containing a thermoluminescent material such as 
lithium fluoride are attached to the patients skin, and store energy when exposed to 
X-rays. They are later heated under carefully controlled conditions, and emit light in 
proportion to the energy stored. 
R eference Number of Patients Maximum Dose (mGy) 
Delichas et al (2005) 39 428 
van de Putte et al (2000) 62 
15 
412 (without LV) 
725 (with LV) 
Verdun et al (1998) t 40 847 
Waite and Fitzgerald (2001) 9 330 
Table 3.4: Maximum skin doses for coronary angiography, measured using TLD. (LV: left ventriculography.) 
Reference Number of Patients Maximum Dose (mGy) 
van de Putte et al (2000) 13 
10 
760 (without stent) 
1800 (with stent) 
Verdun et al (1998) 20 2215 
Waite and Fitzgerald (2001) 19 940 
Table 3.5: Maximum skin doses for coronary angioplasty, measured using TLD. 
A few investigators have reported using TLD to measure skin dose in cardiac 
catheterization procedures (Verdun et al, 1998; van de Putte et al, 2000; Waite & 
Fitzgerald, 2001; Delichas et al, 2005). Dosimeters were located at various landmarks 
on the patients skin, where the regions of peak dose were expected to occur. 
Maximum skin doses measured for coronary angiograms and angioplasties are shown 
in Table 3.4 and Table 3.5. For the angiograms, all measured doses were less than 1 
Gy. However, each study found skin doses approaching or exceeding 1 Gy for some 
angioplasties. 
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Since each procedure uses a number of different projections, it is impossible to predict 
the exact location of the peak skin dose in advance. Skin injuries reported in the 
literature occurred on both sides of the patients upper back (Sovik et al, 1996; Shope, 
1996; Widmark & Hellesnes, 1997; Kawakami et al, 1999; Miralbell et al, 1999; 
Vanõ et al, 2001a; Koenig et al, 2001a), on the patients right side (Koenig et al, 
2001a) and on the posterior surface of the right arm (Wong & Rehm, 2004). Even if 
several TLD are used, there is a danger of missing the region of peak skin dose, and 
thus underestimating the risk of skin injuries. Studies using TLD in conjunction with 
slow radiographic film have demonstrated that incorrect placement of TLD can lead 
to large errors in dosimetry (Geise & Ansel, 1990; Vanõ et al, 2001b). 
In addition, TLD are labour-intensive to use, since each batch requires careful 
calibration and the chips must be individually prepared and read out each time they 
are used. Thermoluminescence dosimetry is not a sufficiently practical method for 
routine dose monitoring in the cardiac catheterization laboratory. 
One way to improve coverage of the skin is to use a large array of finely spaced TLD. 
Geise et al (1997) evaluated a 30 cm x 30 cm array of laser heated TLD, and found it 
to be an accurate tool for skin dosimetry. However, such a system requires specialist 
equipment, which was not available for the present study.  
3.5.4 Scintillation Detectors and Diodes 
Hwang et al (1998) and Waite and Fitzgerald (2001) evaluated a commercially 
produced Skin Dose Monitor (McMahon Medical, San Diego, CA). This device 
contained a small zinc-cadmium scintillator, linked to a light meter. It was attached to 
the patients skin using a disposable pad, and could be used to monitor localised skin 
dose in real-time. Mean doses reported by Hwang et al (1998) are shown in Table 3.6. 
On average, patients received skin doses of more than 1 Gy for angioplasties without 
stent insertion, and more than 2 Gy for the most complex angioplasties. 
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Procedure Type Number of 
Patients 
Mean Skin Dose 
(mGy) 
CA 135 180 
PTCA 35 1021 
PTCA with single stent 25 1529 
PTCA with multiple stents & rotational 
atherectomy 
5 2496 
Table 3.6: Mean skin doses measured using a scintillation detector, reported by Hwang et al (1998). (CA: 
coronary angiography; PTCA: percutaneous transluminal coronary angioplasty.) 
Karambatsakidou et al (2005) reported use of an Unfors Patient Skin Dosimeter 
(Unfors Instruments, Billdal, Sweden). This had three diodes, which could be placed 
on the patients skin prior to exposure. 
Since neither of these detectors were transparent to radiation, their use may interfere 
with clinical imaging. In addition, the detector positions may not correspond to the 
regions of peak skin dose. 
3.5.5 Film Dosimetry 
A more robust method of capturing the peak skin dose is to map the dose distribution 
over a large area, using slow radiographic film. Any regions of high dose can be 
easily identified and, providing that the film is not saturated, absolute dose 
measurements can also be made. 
Industrial films were used to assess radiation dose from fluoroscopic procedures as 
early as the nineteen sixties (Blatz & Epp, 1961; Yoshinaga et al, 1967). In recent 
years there has been a growing market for specialist slow films in radiotherapy. 
Designed for treatment verification imaging and quality control of megavoltage X-ray 
and electron beams, these films are relatively insensitive to diagnostic X-ray energies. 
They are supplied paper-wrapped and can be processed in standard radiographic film 
processors, making them a convenient choice for film dosimetry applications in 
radiology. 
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Until recently, the least sensitive of these radiotherapy films was Kodak XV-2, also 
known as X-OMAT V (Eastman Kodak Company, Rochester, New York). This 
saturated at around 700 mGy, for exposures in the diagnostic energy range (Fajardo et 
al, 1995; Vanõ et al, 2001b). Vanõ et al (2001b) used a combination of XV-2 film 
and TLD to measure skin doses from coronary angiograms and angioplasties. The 
results are summarised in Table 3.7. Film saturation occurred in two out of the seven 
angioplasties, indicating that XV-2 film was too sensitive for skin dose measurement 
in long or complex cardiac catheterization procedures. 
Procedure Type Number of 
Patients 
Dose (mGy)
CA 26 49-711 
PTCA 7 169-700+ 
Table 3.7: Peak skin doses reported by Vanõ et al (2001b), measured using a combination of film and TLD. 
(CA: coronary angiography; PTCA: percutaneous transluminal coronary angioplasty.) 
Kodak have now developed an extended dose range film, EDR2 (Eastman Kodak 
Company, Rochester, New York). This has been used for skin dosimetry in the 
cardiac catheterization laboratory by Vanõs group (Vanõ et al, 2003; Guibelalde et 
al, 2003). They reported its saturation point at 1.2 to 1.5 Gy, depending on the 
processing conditions applied. In a study including complex angioplasties, 
intravascular brachytherapy and cardiac ablation procedures, film saturation occurred 
in only about 1% of cases. The film is supplied in 35 x 43 cm sheets, which should be 
large enough to map the dose distribution across the whole of the patients upper 
back. This type of film appeared to be the most suitable for skin dosimetry in the 
cardiac catheterization laboratory, and was therefore used in the film dosimetry study 
of Chapters 4 and 5. 
An alternative range of dosimetry films are the Gafchromic films from International 
Specialty Products (Wayne, New Jersey). Specifically designed for patient dosimetry, 
these are non-light-sensitive, and change colour on exposure to X-rays. At the time of 
the present study, none were sufficiently sensitive for practical assessment of doses 
around 1 and 2 Gy. In addition, they were prohibitively expensive at around £30 per 
sheet. 
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Studies using film and TLD simultaneously have found the two methods to agree to 
within about 15 to 20%, for unsaturated areas of the film (Geise & Ansel, 1990; 
Nicholson et al, 2000; Vanõ et al, 2001b) This indicates that film dosimetry is a 
reasonably accurate method for determination of absolute skin doses. 
3.5.6 Dose Modelling 
Both den Boer et al (2001) and Chugh et al (2004) have developed real-time dose 
monitoring systems, to calculate and display cumulative skin dose maps during 
cardiac catheterization procedures. These alert the operator to any high doses that may 
be accumulating in particular areas of the skin. This may allow him/her to modify the 
projections used for the remainder of the procedure, to avoid over-irradiation of those 
areas, and hence reduce the risk of deterministic effects. 
The system developed by den Boer et al (2001) was marketed by Siemens Medical 
Solutions (Munich, Germany) for a while, under the name CareGraph. Miller et al 
(2002) described it as a valuable tool for minimising peak skin dose, and 
recommended that all manufacturers provide such real-time dose monitoring facilities. 
However, it has subsequently been withdrawn, due to apparent lack of customer 
demand. At the time of the present study, there was no commercially available 
software for mapping skin dose distributions. 
Modern cardiovascular imaging units store detailed exposure and projection data in 
the image files. Vanõ et al (2003) extracted this data and used it to calculate skin 
doses from individual acquisition runs. It should also be possible, using this data, to 
generate a cumulative dose map for the whole procedure, either retrospectively or in 
real-time. 
Dose modelling is an attractive option, as data could be obtained retrospectively for 
any patient. The dose maps would provide details of the location and magnitude of the 
peak skin dose, as recommended by the International Commission on Radiological 
Protection (2000) and the Food and Drug Administration (1995). If sufficiently well 
automated, dose modelling could be used as a routine dosimetric tool, with minimal 
demands on staff time. 
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Accuracy would be limited by the quantity of information stored by the imaging unit 
and made available to the user. For example, at present most interventional units store 
only acquisition runs and not fluoroscopic image sequences. This means that no 
information is available on the projections used for fluoroscopy. These gaps in the 
data would require certain assumptions to be made. 
3.6 Dose Management 
Having implemented a suitable method for patient dosimetry, it is important to 
establish a protocol for identification and follow-up of patients who may be at risk of 
deterministic injuries. For convenience, some centres have chosen to use DAP trigger 
levels for identifying at-risk patients. These are summarised in Table 3.8 and have 
generally been chosen to correspond to peak skin doses of either 1 or 2 Gy. 
Reference DAP Trigger (Gycm
2
) 
Cook et al (2004) 100 
Hansson and Karambatsakidou (2000) 530 (CA) 
250 (PTCA) 
Karambatsakidou et al (2005) 470/570 (CA) 
210 (PTCA) 
McFadden et al (2002) 100 
Neofotistou et al (2003) 300 
Skinner (2002) 150 
Vanõ et al (2003) 180 
Table 3.8: Reported DAP trigger levels for identifying patients at risk of skin injuries, following cardiac 
catheterization procedures. (CA: coronary angiography; PTCA: percutaneous transluminal coronary 
angioplasty.) The two values given by Karambatsakidou et al (2005) for coronary angiography are operator-
specific DAP reference values for their two primary operators. 
Vanõ et al (2003) routinely measure skin dose for intra-coronary brachytherapy, using 
a combination of film and TLD. Other authors attempt to estimate skin doses for those 
patients who exceed their DAP trigger levels. Cook et al (2004) designed a 
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spreadsheet to estimate the total dose incident on the patients skin, from recorded 
exposure factors. This took no account of the different imaging projections used, but 
assumed the worst possible case of all exposures using a single projection. 
Whilst some hospitals simply advise patients to report any skin effects (Mooney, 
2000; Koenig et al, 2001b; McFadden et al, 2002), others have procedures in place 
for formally inspecting the patients skin if a certain dose or DAP threshold is 
exceeded (Vanõ et al, 2003; Neofotistou et al, 2003; Cook et al, 2004). No skin 
injuries have yet been seen at any of these routine checks. However, in most cases the 
skin dose was estimated, not measured. Hospitals are likely to over-estimate rather 
than under-estimate skin doses, since it is better to err on the side of caution when 
assessing whether there is potential for detrimental health effects. Certainly the 
software used by Cook et al (2004) assumed the worst possible case: that of all 
radiation exposures coming from the same projection. 
The protocol for consenting patients should include information on the risk of 
deterministic effects associated with the procedure they are about to undergo. In 
preparing this risk information, consideration should be given to the radiation doses 
and incidence of skin injuries arising from the procedure at that particular facility. 
Thus, a thorough local survey of skin dose and deterministic effects is needed, to 
prepare appropriate risk information that enables fully informed consent.  
3.7 Summary 
It has been shown that cardiac catheterization procedures can result in high radiation 
doses to the patients skin. There are a number of reports of deterministic skin injuries 
following particularly lengthy or difficult procedures. In order to identify at-risk 
patients and provide them with appropriate information and clinical follow-up, the US 
Food and Drug Administration and the International Commission on Radiological 
Protection have published recommendations that the location and magnitude of high 
skin doses are recorded in the patients notes. 
The dose quantities most commonly used are dose-area-product and fluoroscopy time. 
Since many different projections are used in a single procedure, these are unlikely to 
give an adequate indication of peak skin dose. 
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Several different dosimeters have been used to obtain direct measurements of skin 
dose in the cardiac catheterization laboratory. Of these, slow radiographic film seems 
the most practical, since it captures the dose distribution over a large area, is relatively 
quick to position and read out, and is invisible on the radiographs. Another dosimetry 
method offering great potential is skin dose modelling, i.e. calculation of the dose 
distribution on the patients skin from the exposure and projection data stored in the 
image files. 
Once a method for assessing skin dose has been adopted, it is important to establish 
protocols for providing information and follow-up to patients identified as being at 
risk.
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 Chapter 4 - Calibration of Dosimetry 
Equipment 
4.1 Introduction 
This chapter describes the detailed characterisation of Kodak EDR2 film, in 
preparation for its use as a skin dosimeter in the cardiac catheterization laboratory. 
The film was calibrated across the range of typical exposure conditions, and its useful 
range identified. The relationship between dose and optical density was defined using 
a novel equation, for a standard set of exposure and processing conditions. The 
consistency of its response with variations in film batch, time between exposure and 
processing, and day-to-day variations in processor performance, was investigated. The 
effects of field size, exposure rate, beam energy and filtration were quantified. The 
overall uncertainty in dose, for a given optical density, was estimated. The X-ray 
units integral dose-area-product meter was calibrated along with the film, and its 
performance characteristics are also presented. 
In the past, several different models have been used to describe film response. Perhaps 
the best-known is the logit function, described by Willis and Bencomo (1990). This 
function may be expressed as 
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Equation 4.1 
where OD is optical density, ODmin is the density of an unexposed part of the film, 
and ODmax is the density of a saturated part of the film. The logit function has a linear 
relationship with the natural logarithm of the radiation dose. 
 DabLn ln  
Equation 4.2 
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 where D is dose, and a and b are constants. By plotting Ln against ln(D) and 
determining the gradient and intercept of the regression line, the relationship between 
dose and optical density can be defined. Combining Equation 4.1 with Equation 4.2 
and rearranging gives optical density in terms of dose. 
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Equation 4.3 
Zhu et al (2003) proposed the following equation specifically for EDR2 film. 
 DeODOD D 1max  
Equation 4.4 
As before, OD stands for optical density. D is dose in mGy, and D is a constant. The 
equation may be rearranged to give 
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Equation 4.5 
Thus, the value of D may be determined by plotting the logarithmic term against dose, 
and finding the gradient. Guibelalde et al (2003) took the simpler approach of 
assuming a linear response for doses of up to 500 mGy. Whilst mathematically 
convenient, this did not make full use of the films responsive range. More recently, 
Karambatsakidou et al (2005) approximated dose as a simple exponential function of 
optical density. 
4.1.1 Objectives 
The objectives of this investigation were: 
x To determine the dose response of Kodak EDR2 film for typical exposure 
conditions used in the cardiac catheterization laboratory, with the local 
processing protocol; 
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 x To investigate how the films response varied with exposure conditions, film 
batch and processor performance, and hence to estimate the uncertainties in 
dosimetry measurements; 
x To characterise the performance of the X-ray units integral dose-area-product 
meter across the range of typical exposure conditions. 
4.2 Method 
All exposures were performed using a Philips Integris H5000F cardiac imaging unit 
(Philips Medical Systems, Best, Netherlands), which was subject to routine quality 
control checks as recommended by the Institute of Physics and Engineering in 
Medicine, Report 77 (1997). The X-ray tube potential (kVp) and spectral filter were 
selected by reprogramming one of the modes on the imaging unit. 
Doses were measured using Radcal 9010 series dose meters (Radcal, Monrovia, 
California), with 6 cc or 60 cc ionisation chambers as appropriate. These were 
calibrated annually against a secondary standard, and all readings were corrected by 
the most recent calibration factors. Measurement accuracy quoted by the manufacturer 
was r4%, with energy and dose rate dependence at r5% over much wider ranges than 
were used in this study. For the purpose of error analysis, dose meter performance 
was considered independent of energy and dose rate. 
The experimental set-up used for the majority of exposures is shown in Figure 4.1. 
The gantry was oriented with the X-ray tube pointing vertically upwards. The couch 
was positioned at its minimum height, and the detector at its maximum height. The 
mattress was removed, and two cardboard boxes were stacked on their sides, on the 
thick part of the couch. The film was positioned inside the lower box, and a flat, 60 cc 
ionisation chamber inside the upper box. The radiation field was then centred on the 
ionisation chamber. A two millimetre sheet of lead on top of the boxes drove the X-
ray tube current (mA) up to maximum, to keep exposure times down, whilst 
protecting the image intensifier from over-exposure. 
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 Image Intensifier
Lead Sheet
Ionisation Chamber
Film
X-ray Tube
Cardboard 
Boxes
35 cm
35 cm
Focal Spot to Film 
Distance: 46.5 cm.
Imaging Couch
 
Figure 4.1: Experimental set-up. 
The cardboard boxes enabled easily reproducible geometry, whilst maximising the 
dose rate at the film to minimise exposure times, ensuring that the entire dose meter 
was irradiated, and avoiding backscatter from the chamber onto the film, or from the 
lead sheet into the chamber. The dose at the film Df was calculated from that 
measured by the ionisation chamber Dc, using an inverse square law correction for 
distance (Equation 4.6), where xc was the distance from the focal spot to the chamber, 
and xf the distance from the focal spot to the film. 
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Equation 4.6 
In order to provide a means of correcting for variations in processor performance, the 
leading and trailing edges of each film were exposed twelve times using a Kodak 
Process Control Sensitometer (Eastman Kodak Company, Rochester, New York). 
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 Unless otherwise stated, they were then stored in a dark room hopper for 24 hours, 
prior to processing in a Kodak X-OMAT M6B processor (Eastman Kodak Company, 
Rochester, New York), with Photosol developer and fixer (Photosol Limited, 
Basildon, UK). The processor was subject to bi-daily quality control checks, in 
accordance with the Institute of Physics and Engineering in Medicine, Report 77 
(1997). 
 
Figure 4.2: Positions of optical density measurements. 
Optical densities were measured using a Pehamed Densoquick 2 densitometer 
(Pehamed, Sulzbach, Germany). According to the manufacturers specification, 
accuracy was within 1.5%, for densities greater than one. For full-field exposures, the 
density was measured in the centre of the irradiated area and approximately 1 cm in 
from each edge, as shown in Figure 4.2(a), and the mean taken. For films with the 
equalisation filter in place, three measurements were taken for each of the wedged and 
non-wedged areas, about 1 cm in from the edge, as shown in Figure 4.2(b). To 
determine base-plus-fog, optical density was measured approximately 2 cm inside 
each corner of the film, and the four readings were averaged. 
4.2.1 Film Response Curve 
The film was calibrated at 60, 80 and 110 kVp, at a range of doses from 20 to 1000 
mGy. These beam energies were chosen to represent the minimum, typical and 
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 maximum values used in clinical practice. The X-ray tube and its housing, together 
with the collimator assembly, provided around 2.7 mm aluminium equivalent 
filtration. The couch provided a further 1.7 mm aluminium equivalent. Measurements 
were initially made with no additional filtration selected. 
In order to define the relationship between dose and optical density, attempts were 
made to fit first the logit model (Equation 4.1to Equation 4.3) and then Zhus model 
(Equation 4.4 and Equation 4.5) to the data. A new equation was then developed, 
which was based on Zhus equation, but normalised so that zero dose corresponded to 
base-plus-fog, instead of zero density (Equation 4.7). 
  DD eODeODOD DD   minmax 1  
Equation 4.7 
OD was the optical density due to the X-ray exposure, ODmax the saturation density of 
the film, ODmin base-plus-fog, and D radiation dose. This could be rearranged to give 
the constant D (Equation 4.8). 
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Equation 4.8 
For each kVp, D was determined by plotting the logarithmic term against dose, fitting 
a regression line and determining its gradient. 
4.2.2 Film Consistency 
A series of exposures were made at 80 kVp, 160 mGy, to investigate the consistency 
of the films response and its variation with field size, exposure rate, film batch and 
day-to-day variations in processor performance. 
In order to investigate the stability of the emulsion post-exposure, a number of films 
were subjected to identical X-ray exposures, and stored in a dark room hopper or in 
their packets for various time intervals before processing. 
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 The maximum spectral filtration was then selected, and one measurement repeated for 
each kVp, at 160 mGy. This additional filter consisted of 0.4 mm copper, plus 1.5 mm 
aluminium. 
4.2.3 Equalisation Filter 
The X-ray units equalisation filter was a semi-circular brass disc, with a tapered 
straight edge that could be driven into the beam from any direction. Its uniform region 
had equivalent filtration of 22 mm aluminium, at 80 kVp. 
To determine its effect on film response, the filter was positioned with its edge 
parallel to the anode-cathode axis, and covering approximately half of the image. Two 
6 cc ionisation chambers were positioned side-by-side, one in the fully wedged and 
one in the non-wedged part of the beam (Figure 4.3). At each kVp, two films were 
exposed, to give doses of 160 mGy first in the wedged, and then in the non-wedged 
parts of the beam. 
 
Figure 4.3: Dose meter positions for wedge filter measurements. 
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 4.2.4 Backscatter 
To quantify the effect of backscatter on film response, the film was placed directly on 
the couch, with the 60 cc ionisation chamber on top of it. A 20 cm stack of Perspex 
was positioned above the ionisation chamber, supported by 2 cm blocks at either side 
(Figure 4.4). Exposures were made at each kVp, first with no additional filtration, and 
then with the maximum spectral filtration selected. Each film was exposed to around 
160 mGy. The Perspex was then removed, and the exposures repeated. 
Detector
Perspex
Ionisation Chamber
X-ray Tube
67 cm
(fsd)
20 cm
2 cm
Imaging Couch
Film
 
Figure 4.4: Set-up for backscatter investigation. 
4.2.5 DAP Meter 
The X-ray unit was fitted with an integral PTW-Diamentor-M1 DAP meter (PTW-
Freiburg, Freiburg, Germany). In order to characterise its performance, displayed 
DAP was noted before and after each film exposure. The field size was calculated 
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 from the irradiated area on the film, and the ratio of displayed DAP to measured DAP 
computed for each set of exposure conditions. 
4.3 Results 
4.3.1 Film Response Curve 
Figure 4.5 shows how the optical density varied with dose, at each of 60, 80 and 110 
kVp, with no additional filtration. The error bars indicate the accuracy associated with 
the measuring instruments; r4% for the dose meters, and r1.5% for the densitometer. 
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Figure 4.5: Optical density versus dose, for each of 60, 80 and 110 kVp. Error bars indicate accuracy of measuring 
instruments: r4% for dose, and r1.5% for optical density. 
Figure 4.6 to Figure 4.8 show the three different models fitted to the data, at 80 kVp. 
The logit function gave a poor fit to the film response. Zhus equation represented the 
data more accurately, but overestimated doses below 100 mGy, since it assumed zero 
density for zero dose. The new equation offered the best fit to measured data, with 
improved accuracy at low doses. 
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(b) 
Figure 4.6: Logit fit to measured data, at 80 kVp. (a) Logit function versus ln(Dose). (b) Resulting relationship 
between dose and optical density, shown with empirical data points. Error bars indicate accuracy of measuring 
instruments: r4% for dose, and r1.5% for optical density. 
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(b) 
Figure 4.7: Zhus model fitted to measured data, at 80 kVp. (a) Logarithmic term plotted against dose, to 
determine D. (b) Resulting relationship between dose and optical density, shown with empirical data points. Error 
bars indicate accuracy of measuring instruments: r4% for dose, and r1.5% for optical density. 
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(b) 
Figure 4.8: The new equation fitted to measured data, at 80 kVp. (a) Logarithmic term plotted against dose, to 
determine D. (b) Resulting relationship between dose and optical density, shown with empirical data points. Error 
bars indicate accuracy of measuring instruments: r4% for dose, and r1.5% for optical density. 
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 The calibration curve defined using the new equation had the same form at each kVp, 
but slightly different values of D. At each optical density, predicted and measured 
doses agreed to within r4% at 60 kVp, r10% at 80 kVp and r6% at 110 kVp. 
Since an exposure of 160 mGy gave an optical density close to the centre of the films 
range, this was chosen as the standard exposure level for all further characterisation 
measurements. 
4.3.2 Film Consistency 
Five exposures at 80 kVp, 160 mGy and 23 cm field size, on films from four different 
batches, processed on different days, showed mean sensitivity of 94.5 mGy per unit of 
optical density (mGy/OD). The maximum deviation was 4.1 mGy/OD or 4.4%. 
Analysis of the sensitometry strips on these films showed considerable variation 
between the densities of the strips on the leading and trailing edges. In addition, the 
mean densities of step 17 (the speed step) for individual films varied by up to 0.27 
units of optical density, or 26%. Thus, the optical densities due to light exposure 
appeared far more sensitive to variations in film batch and processor performance 
than those due to X-ray exposure. 
Standard (80 kVp, 160 mGy) exposures made at each of the 17 cm and 23 cm field 
sizes showed consistency of film response to within 1%. Similar exposures at 5.8, 20 
and 190 mA also showed consistency to within 1%. 
Table 4.1 shows the film sensitivity measured at 160 mGy, with each kVp and 
spectral filter combination. The mean sensitivity was 101 mGy/OD. This matched the 
films response at 110 kVp, with no additional filtration. 
mGy/OD 
Spectral Filter 
60 kVp 80 kVp 110 kVp
Filter 0 (no added filtration) 89 94 101 
Filter 1 (0.4 mmCu + 1.5 mmAl) 88 106 130 
Table 4.1: Effect of kVp and spectral filter on films exposed to 160 mGy, without backscatter. 
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 For each of the exposures detailed in Table 4.1, the mean spectral energy was 
estimated using the IPEM Report 78 Spectrum Processor (Reilly & Sutton, 1997). 
Figure 4.9 demonstrates that the dose required per unit of optical density increased 
with mean photon energy. 
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Figure 4.9: Film sensitivity versus mean spectral energy, for the exposures detailed in Table 4.1. The error bars 
indicate the expected variation of ± 4.4% due to film batch and processor performance. 
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 Figure 4.10 shows the variation in film response with time interval between exposure 
and processing. The horizontal line indicates mean sensitivity, and the error bars show 
the expected variation of ± 4.4% due to film batch and processor performance. It 
appeared that films processed in the first few minutes following exposure were 
slightly paler, with an additional 4 mGy required per unit of optical density. 
Considering only the data for one hour or more, the maximum variation from the 
mean was 2.6 mGy/OD or 2.7%. 
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Figure 4.10: Effect of time-to-processing on film sensitivity, at 80 kVp and 160 mGy. The error bars indicate the 
expected variation of ± 4.4% due to film batch and processor performance. The horizontal line shows mean 
sensitivity. 
Several films in one batch showed irregular dark patches, as demonstrated in Figure 
4.11(a). Where the artefact extended across the exposed area of the film, this made 
dose assessment impossible. Three films in another batch demonstrated discrete dark 
spots, such as that shown in Figure 4.11 (b). These corresponded to localised faults in 
the light-proofing of the film packets. An image of the printed text from the film 
packet was visible on several films, but this made negligible difference to measured 
optical density. 
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 (a) (b) 
Figure 4.11: Artefacts seen on films. (a) Irregular dark patches around film edges. (b) Discrete dark spot in bottom 
right-hand corner. 
4.3.3 Equalisation Filter 
Table 4.2 shows film sensitivity measured in the wedged and non-wedged parts of the 
beam, with the equalisation filter in place. The sensitivity of 61 mGy/OD measured in 
the wedged part of the beam at 60 kVp was obtained using a dose of 47 mGy. It may 
be compared with the sensitivity of 58 mGy/OD, measured at a dose of 40 mGy 
without the wedge filter in place (Figure 4.5). All other measurements were 
performed at 160 mGy. The right hand column shows the dose ratio between the fully 
wedged and non-wedged parts of the beam, for a single exposure. The wedge filter 
reduced the dose to objects in its shadow by a factor of at least six. 
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 mGy/OD 
kVp 
wedged non-wedged
»¼
º«¬
ª
wedged-nonDose
wedgedDose
60 61 (at 47 mGy) 91 1/26 
80 113 103 1/12 
110 147 104 1/6 
Table 4.2: Effects of equalisation filter on film sensitivity and dose. All sensitivity measurements 
made at 160 mGy, unless otherwise stated. 
Comparing Table 4.2 with the top row of Table 4.1, the exposure required to give a 
particular optical density was increased by up to 47 mGy/OD, or 47%, in the shadow 
of the wedge filter. The film sensitivity in the non-wedged part of the beam was also 
reduced slightly (higher dose per OD), compared with that for a beam with no wedge 
filter in place. 
4.3.4 Backscatter 
Table 4.3 shows film sensitivity measured with 20 cm Perspex backscattering 
material, for each kVp and spectral filter. Film sensitivity was reduced (higher dose 
required to produce a given optical density), compared to Table 4.1. The mean 
sensitivity was 111 mGy/OD. Again, this matched the films performance at 110 kVp, 
with no spectral filtration. Individual measurements varied from the mean by 10% to 
+24%, across the range of beam qualities investigated. 
mGy/OD 
Spectral Filter 
60 kVp 80 kVp 110 kVp
Filter 0 (no added filtration) 110 100 110 
Filter 1 (0.4 mmCu + 1.5 mmAl) 103 108 138 
Table 4.3: Effect of kVp and spectral filter on films exposed to 160 mGy, with 20cm Perspex 
backscattering material. 
These films showed a backscatter image of the ionisation chamber. As a result, the 
optical density varied by up to 0.1 between the centre and periphery of the irradiated 
area. A similar effect was seen in the absence of the Perspex, when the ionisation 
chamber was positioned directly on top of the film. 
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 4.3.5 DAP Meter 
With the ionisation chamber on the couch top, in the absence of backscattering 
material, the mean ratio of displayed DAP to measured DAP was 1.33.  
Measurements made at 80 kVp, with no additional filtration, showed reproducibility 
to within r3.3%. Variations in performance with radiation field size, exposure rate 
and dose were all within this range. The DAP meters response varied with kVp and 
spectral filtration by up to r10% about the mean. 
4.4 Discussion 
4.4.1 Film Response Curve 
The film saturated at around 1 Gy. This is the threshold recommended by the 
International Commission on Radiological Protection (2000) and the US Food and 
Drug Administration (1995), above which the potential for radiation skin injuries 
should be recorded. The film may be used to identify patients receiving skin doses of 
1 Gy or more, but cannot assess peak skin doses for these patients. 
The approach taken by Vanõ et al (2003) and Guibelalde et al (2003) of minimising 
the developer temperature to increase the films saturation point was not practical in 
the present study, since the only available film processor was used primarily for 
diagnostic films. Besides, their reported saturation point of between 1.2 and 1.5 Gy 
remained inadequate for assessing doses up to the 2 Gy threshold for deterministic 
skin effects. 
The logit function offered a poor fit to the dose response of EDR2 film. Zhus model 
(Equation 4.4) gave a good fit to the data at higher optical densities. However, it 
associated a dose of zero with an optical density of zero and this caused doses to be 
overestimated at the bottom end of the range. In reality, the minimum density was 
given by base-plus-fog, which was about 0.2. 
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 The new model described by Equation 4.7 represented the films response more 
accurately, especially at the lower end of the dose range. At 110 kVp, calculated and 
measured doses agreed to within r 6% at each optical density. 
4.4.2 Film Consistency 
Variations in film batch and processor performance caused the films response to vary 
by up to 4.4%, at 160 mGy. Film sensitivity was consistent to within 1% across the 
range of field sizes and exposure rates in clinical use. Since this was well within the 
uncertainty due to film batch and processor performance, film sensitivity may be 
assumed independent of field size and exposure rate. 
The root mean square uncertainty due to the variations in film batch and processing 
conditions (4.4%), errors in curve fitting (6%), and the accuracy of the measuring 
instruments (dose meter 4%, densitometer 1.5%), was 8.6%. 
The optical densities due to light exposures were far more sensitive to changes in 
processing conditions than those from X-ray exposures. Given that the films 
performance when exposed to X-rays was fairly consistent with day-to-day 
fluctuations in processing conditions, it seemed unlikely that any correction via light 
sensitometry would improve accuracy. As a result, it was not pursued further. 
With no additional filtration, the films energy dependence was within the root mean 
square uncertainty reported above. This is in agreement with the findings of 
Guibelalde et al (2003) and of earlier studies using Kodak XV-2 film (Geise & Ansel, 
1990; Vanõ et al, 1997; Nicholson et al, 2000), which reported energy dependence of 
5% or less. However, the present study found the relationship between dose and 
optical density to be strongly dependent on beam filtration, especially at the high end 
of the energy range. This effect had not previously been reported. It is an important 
consideration in the cardiac catheterization laboratory, where heavily filtered beams 
are often used in some imaging modes. 
Throughout the study, the response of the Radcal dose meters was assumed to be 
independent of filtration. This may not be strictly true. No definitive information was 
available regarding the dose meters filtration dependence, although the supplier 
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 advised that it was insignificant. Given their low energy dependence of r5% over the 
range 20 keV to 1.33 MeV, this would seem reasonable. 
Optical density appeared to increase slightly during the first few minutes following X-
ray exposure, and to stabilise within the first hour. After this, the maximum variation 
from the mean was 2.7%, which was well within the uncertainty attributable to 
variations in film batch and processor performance. This phenomenon has recently 
been reported by Childress and Rosen (2004), for EDR2 film exposed to megavoltage 
photons. In order to allow the emulsion to stabilise, films should be processed at least 
one hour after exposure. 
Three of the films showed discrete dark spots outside the irradiated area, and these 
were identified with localised faults in the light-proofing of the film packets. It 
seemed most likely that the irregular dark patches shown in Figure 4.11(a) were also 
caused by faulty light-proofing. Films showing such artefacts could not be used for 
dosimetry. Since this investigation, Kodak have changed the design of EDR2 film 
packets. It may be hoped that this will reduce the incidence of light-leakage artefacts. 
4.4.3 Equalisation Filter 
At 60 kVp, the films response was unaffected by the equalisation filter. At higher 
energies, the dose required to give a particular optical density increased by up to 47% 
in its shadow. 
Although the equalisation filter was often used in clinical procedures, the imaging unit 
stored no information about when it was used, or about its position in the beam. 
Whilst in some cases it would be possible to determine its position from the dosimetry 
film, this would be impossible in regions of the film where several fields overlapped. 
For the purpose of film dosimetry therefore, it was necessary to assume that the 
equalisation filter was never used. This would result in skin doses being 
underestimated. The magnitude of this error was estimated as follows. 
The total dose D at any point on the film may come from several fields, some of 
which are intercepted by the equalisation filter. It may be represented by the sum of 
the wedged (Dw) and non-wedged (Dn) dose contributions at that point. 
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Equation 4.9 
The wedge filter attenuates the beam by a factor of at least 6. Thus, even if it is in 
place for every field, on average the contribution from the wedged parts will not be 
more than about 1/6 of the contribution from the non-wedged parts. 
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Equation 4.11 
Assuming a linear response over the dose range of interest, optical density is related to 
dose by 
¦ ¦| nnww DcDcOD  
Equation 4.12 
where cw is the calibration factor for the wedged part of the beam, and cn the 
calibration factor for the non-wedged part. At 160 mGy, cw had a minimum value of 
about nc
3
2
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Equation 4.13 
However, when calculating skin dose from measured optical density, it is necessary to 
assume that 
nc
OD
D |  
Equation 4.14 
Substituting in the optical density from Equation 4.13 gives 
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Equation 4.15 
The difference between this calculated dose and the actual dose (defined in Equation 
4.11) is 
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Equation 4.16 
Thus, the dose determined from measured optical density is likely to underestimate 
the actual dose by up to 181 , or 6%. The actual dose will be up to 6% higher than 
that measured using the film. 
This error could be larger for regions of the film where the wedged parts of several 
fields overlap. However, these regions are unlikely to correspond to peak skin dose, 
since the equalisation filter reduces doses in its shadow by a factor of at least six. 
With the equalisation filter in place, the dose per OD in the non-wedged part of the 
beam was slightly higher than when the filter was not being used. Given the 
uncertainties due to film batch and processor performance, this result was not 
significant. However, a possible explanation is the scatter of high energy photons 
from the filter into the non-wedged part of the field. 
4.4.4 Backscatter 
The presence of backscattering material reduced film sensitivity, raising the dose 
required per unit of optical density by up to 24%. This effect was most pronounced 
for the softest beams. 
A backscattered image of the ionisation chamber was visible, even when 20 cm 
Perspex were positioned close above it. This indicated that the film was not receiving 
the full amount of backscatter from the Perspex. In order to provide full backscatter 
conditions, the Perspex would need to be in direct contact with the film. The DAP 
meter could be used to determine the dose to the film, if it were first calibrated against 
an ionisation chamber positioned in contact with the Perspex. However, characterising 
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 the film under these conditions would involve considerably more manual handling of 
the heavy Perspex, which would need to be removed from the couch each time a fresh 
film was required. For the purpose of the current study, it was assumed that the errors 
introduced by placing the ionisation chamber between the film and the Perspex would 
be small compared with the range of film responses due to variations in beam energy 
and filtration. 
4.4.5 Definitive Calibration and Overall Uncertainty 
The definitive calibration should reflect the films performance in the presence of 
backscatter, since this best represents the clinical situation. On varying the tube 
potential and spectral filtration, average film performance most closely matched that 
at 110 kVp, with no additional filtration. This was the case both with and without 
backscatter. The mean dose required to produce a given optical density increased by 
10% in the presence of backscatter. The definitive calibration was therefore modelled 
on the response curve measured at 110 kVp, with the dose values scaled up by 10%, 
to simulate the effect of backscatter. 
The value of D for the re-scaled data was 2.70 x 10-3. The mean values of ODmin and 
ODmax on the films used to determine D were 0.21 and 3.92 respectively. On 
rearranging Equation 4.8, this gave a definitive relationship between dose D (in mGy) 
and optical density OD of  
¹¸
·
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71.3
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1 OD
D  
Equation 4.17 
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 Source(s) Uncertainty 
Film batch, processor performance, 
curve fitting, instrument calibrations 
± 8.6% 
Beam energy and spectral filtration - 10% to + 24% 
Equalisation filter 0% to + 6% 
Overall - 19% to + 39% 
Table 4.4: Overall uncertainty in film response, at 160 mGy. 
Table 4.4 summarises the sources of uncertainty in the films response. Linear 
combination of the expected variations seemed the most realistic approach to 
estimating overall uncertainty, since the variations in film performance with energy 
and filtration represented a range of responses rather than statistical uncertainties in 
the measurements. This gave an overall uncertainty of 19 to +39%, at 160 mGy, 
which corresponded to a dose range of 30 to +61 mGy. 
The uncertainty (in mGy) was assumed to scale linearly with the gradient of the film 
response curve, described by 
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Equation 4.18 
Figure 4.12 shows the definitive calibration curve, with error bars indicating the 
overall uncertainty at each calibration point. At 1 Gy, the uncertainty was estimated at 
about 280 to +570 mGy, or 26 to +53%. This was of the same order of magnitude 
as the uncertainty of ± 30 to 40% reported by Vanõ et al (2003) at the high end of the 
dose range, although these authors had not considered the effects of spectral filtration. 
The uncertainty interval in the present study was skewed towards higher doses than 
indicated by the film, due to the enhanced effects of filtration on high energy beams. 
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Figure 4.12: Definitive calibration curve, with error bars showing overall uncertainty in dose at each measured optical 
density. 
4.4.6 DAP Meter 
The mean ratio of displayed DAP to measured DAP was 1.33. The difference between 
the two values arose mainly from the service engineers practice of calibrating the 
DAP meter without the couch in the beam. Since in clinical practice most of the 
radiation fields pass through the couch before interacting with the patient, the 
calibration method used in the present study seemed more appropriate. 
With fixed beam quality, the DAP meters performance was reproducible to within 
r3.3%. Its response varied with kVp and filtration by r10% about the mean. A linear 
combination of this range of responses, with the random variations in performance, 
gave an overall uncertainty of around r13%. This was greater than the expected 
variations of up to 10% reported in the literature (Broadhead et al, 1997; Vanõ et al, 
1998b; Hansson & Karambatsakidou, 2000; Kuon et al, 2003; Delichas et al, 2005). 
However, previous studies had not considered the effects of beam filtration on DAP 
meter performance. 
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 4.5 Summary 
Kodak EDR2 film was characterised across the range of exposure conditions used in 
the cardiac catheterization laboratory. Its dose-response curve was successfully 
modelled, using a novel equation. The film saturated at around 1 Gy, limiting its 
usefulness as a dosimeter. 
Beam filtration was found to be the main factor affecting film sensitivity. Variations 
in spectral filtration and tube voltage together accounted for a range in dose per 
optical density of 10% to +24%, at 160 mGy. The effects of beam filtration had not 
previously been considered by other studies. The equalisation filter altered film 
sensitivity, but also greatly reduced the dose in its shadow. Its use may cause doses to 
be underestimated by up to 6%. 
Film performance was relatively insensitive to variations in film batch, processor 
performance, field size and exposure rate. Optical density increased slightly in the 
first few minutes following exposure, but had stabilised after about an hour. Artefacts 
were seen on several films, due to faults in the light-proofing of the film packets. 
A definitive calibration curve was produced, by re-scaling the response curve 
measured at 110 kVp to match the film response in the presence of backscatter. 
Overall uncertainty in the film calibration was estimated at 30 to +61 mGy, at 160 
mGy. This uncertainty was expected to increase as the film approached its saturation 
point. 
The X-ray units integral dose-area-product meter was characterised along with the 
film. The mean ratio of displayed DAP to measured DAP was 1.33. Again, the DAP 
meters performance was most strongly influenced by beam filtration, giving an 
overall uncertainty in DAP of around r13%. 
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 Chapter 5 - Skin Dose Survey 
5.1 Introduction 
This chapter presents a survey of skin doses for patients undergoing coronary 
angiograms and coronary angioplasties. The dose distribution across each patients 
back was mapped using Kodak EDR2 film. At the time of the study, no UK 
researchers had reported using this film for dosimetry at diagnostic energies. The peak 
skin dose was determined for each patient, and the results are presented by procedure 
type. There were a number of incidences of film saturation, and the implications of 
this are discussed.  
Dose-area-product (DAP) is the dose quantity most commonly used in the cardiac 
catheterization laboratory. Its relationship with peak skin dose was examined, to 
investigate whether it could reliably be used to predict high skin doses. Several 
authors have reported correlations between DAP and clinical or technical factors 
related to the complexity of the procedure, such as the number of lesions treated, the 
condition of the vessel under treatment, the number of stents deployed, and patient 
weight or body mass index (Bakalyar et al, 1997; Bernardi et al, 2000; Kuon et al, 
2003; Larrazet et al, 2003). In the present study, potential complexity indicators 
were identified, and tested to see whether they could improve prediction of peak skin 
dose from DAP. 
The limitations of both the film and dose-area-product measurements are discussed, 
and the need for a more robust method of assessing skin dose is identified. 
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 5.1.1 Objectives 
The objectives of this study were: 
x To determine typical peak skin doses for patients undergoing coronary 
angiograms and coronary angioplasties at Nottingham City Hospital; 
x To estimate the percentage of procedures resulting in peak skin doses above 
the 1 Gy recording level recommended by the International Commission on 
Radiological Protection and the US Food and Drug Administration; 
x To investigate whether peak skin dose could be predicted using DAP, together 
with some function of procedure complexity. 
5.2 Method 
Doses were measured for 20 coronary angiograms and 32 coronary angioplasties, 
performed on the Philips Integris H5000F C-arm imaging unit referred to in Chapter 
4. Patients were selected sequentially, and the study included only those procedures 
performed by in-house consultant cardiologists and the registrars working under their 
supervision. Fluoroscopy was performed using the low continuous factory setting, 
which had a nominal input dose rate at the detector of 740 nGy/s and employed 0.4 
mm copper filtration. All acquisition runs were performed on the 12.5 FPS 
Coronary setting, which had a nominal detector input dose rate of 870 nGy/s and 
used no copper filter. 
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 5.2.1 Film Measurements 
Before commencing each procedure, a 
sheet of 35 x 43 cm EDR2 film was 
positioned on the imaging table, underneath 
the mattress. The dotted rectangle in Figure 
5.1 illustrates the position and orientation 
of the film. Its long axis was perpendicular 
to the long axis of the table, and its top 
edge was approximately level with the 
patients shoulders. Each film packet was 
labelled to indicate which side was face-up, 
and which edge closest to the patients 
head. Following exposure, a pinhole was 
made in the corner of the film packet 
corresponding to the patients left shoulder, 
to identify the orientation of the processed 
film. 
The radiographer or nurse controlling the 
X-ray unit wrote the patients name, height 
and weight, and the procedure code on the 
film packet. The codes were retrospectively 
checked against the images stored on the 
server, and altered where necessary. Any procedure involving the use of a balloon and 
wires was classified as angioplasty. Those where no balloons or wires were seen were 
designated angiograms. 
Film
 
Figure 5.1: Film position and orientation. 
All films were stored in their packets overnight before processing, to allow the 
emulsion to stabilise. They were then processed in a Kodak X-OMAT M6B processor 
(Eastman Kodak Company, Rochester, New York), with Photosol developer and fixer 
(Photosol Limited, Basildon, UK). The processor was subject to bi-daily quality 
control checks, in accordance with the Institute of Physics and Engineering in 
Medicine, Report 77 (1997). 
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 The maximum optical density of each film was determined manually, using a 
Pehamed Densoquick 2 densitometer (Pehamed, Sulzbach, Germany), with readings 
taken at small increments across the darkest regions. The dose associated with the 
peak density was then calculated using the films definitive calibration curve, 
described in Chapter 4. 
5.2.2 Dose Area Product 
The DAP for each procedure was measured using the X-ray units integral PTW 
Diamentor M1 dose-area-product meter (PTW-Freiburg, Freiburg, Germany). All 
readings were divided by the units calibration factor of 1.33, determined in Chapter 
4. Dose-area-product and fluoroscopy time, together with details of the procedure 
carried out and equipment used, were stored in a database managed by the Cardiology 
Department. The number of acquisition runs for each case was obtained 
retrospectively, from the number of files stored on the image server. 
Mean dose-area-products for the two procedure types were compared with values 
reported in recent literature, as presented in Tables 3.2 and 3.3. For those films that 
showed no saturation, Pearson correlation coefficients were calculated to determine 
the degree of association between peak skin dose and each of DAP, fluoroscopy time, 
number of runs and patient weight, for each procedure type. The significance of the 
correlations was determined using Students t-test (Armitage, 1971). In each case the 
t-statistic (t) was calculated using Equation 5.1, where N was the number of 
procedures included in the analysis and R was the Pearson correlation coefficient. 
21
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R
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Rt 
  
Equation 5.1 
For each procedure type, the ability of DAP to predict peak skin dose was investigated 
using a modified version of Bland and Altmans technique for method comparison 
(Bland & Altman, 1986; Bland & Altman, 1999). Whilst their papers describe how to 
assess agreement between two methods for measuring the same quantity, the modified 
technique allows two measurement methods using different units to be compared. It is 
described in detail on Martin Blands website (http://www-
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 users.york.ac.uk/~mb55/meas/diffunit.htm), and summarised in the following 
paragraph. 
The equation of the regression line linking peak skin dose with DAP was computed, 
and then used to calculate a predicted peak skin dose from each DAP measurement. 
The standard error SEi associated with each predicted dose was calculated using 
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Equation 5.2 
where xi was the measured DAP, x  the mean DAP for all data points, n the number of 
observations, and s
2
 the variance of empirical data points about the regression line. 
Since this standard error varied very little across the measurement range, its mean 
value was used to calculate the limits of prediction. These were r1.96 standard errors 
above and below the regression line. 
5.2.3 Complexity Indicators 
For angioplasties only, the database included information on the number of diseased 
vessels, the number and severity of the lesions treated, and the number of stents 
deployed. The association between each of these parameters and the ratio of peak skin 
dose to DAP was determined using the Spearman rank-order correlation coefficient, 
with a correction for tied rankings. Lesion severity was scored against the 
classification system published by the American College of Cardiology and the 
American Heart Association (Ryan et al, 1988). For the purpose of statistical analysis, 
the lesion severity scores of A, B1, B2 and C were transferred onto a numerical scale 
of 1 to 4. The significance of the correlations was again determined using Students t-
test. 
Only one significant correlate was found. The equation of its regression line was 
determined, and used to predict the ratio of peak skin dose to DAP for each procedure. 
This was then multiplied by measured DAP, to generate a predicted skin dose. 
Predicted and measured doses were compared using a Bland-Altman plot (Bland & 
Altman, 1986; Bland & Altman, 1999). 
Chapter 5  Skin Dose Survey 93
 5.3 Results 
5.3.1 Film Measurements 
Figure 5.2 shows a dosimetry film from a coronary angioplasty, viewed as if looking 
at the patients back. The patients left shoulder is indicated by the small black spot in 
the top left-hand corner of the image. The region of peak skin dose can be readily 
identified as the darkest patch, in the top right-hand quadrant. 
 
Figure 5.2: A dosimetry film from a coronary angioplasty, viewed as if looking at the patients back. The black 
spot in the top left-hand corner indicates the patients left shoulder. 
One film from each procedure type showed abnormally large numbers of radiation 
fields, with extensive areas of saturation. Since the corresponding dose-area-products 
were not particularly high, it seemed likely that these films had been left on the 
imaging table for more than one procedure. Both were excluded from the analysis. 
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 Figure 5.3 shows the distribution of peak skin doses for coronary angiography and 
angioplasty. Peak skin doses for the angiograms ranged from 70 to 520 mGy, with a 
mean value of 195 mGy. Seven of the angioplasty films showed localised areas of 
saturation, implying skin doses of 1 Gy or more. 
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Figure 5.3: Peak skin doses for coronary angiography (CA) and angioplasty (PTCA). 
5.3.2 Dose Area Product 
One of the angioplasties did not have a DAP value recorded in the database, so was 
excluded from further data analysis. Table 5.1 shows the mean DAP in Gycm
2
 for 
each procedure type, along with maximum and minimum values.  
Procedure Type Mean  Maximum Minimum
CA 26 64 12 
PTCA 57 215 8 
Table 5.1: Mean, maximum and minimum DAP (Gycm2) for coronary angiography (CA) and angioplasty 
(PTCA). 
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 Table 5.2 and Table 5.3 summarise the strength of the correlations between peak skin 
dose and other procedural variables, for the two procedure types. They show the 
number of procedures included in the analysis, the Pearson correlation coefficient and 
Students t-statistic. The final column indicates whether the correlation was 
significant, at a P-value of 0.05. The critical value of the t-statistic varied between 
2.06 and 2.09, for the sample sizes used in the study. 
Variable N R t Significant at P = 0.05? 
Dose Area Product 19 0.76 4.83 Yes 
Fluoroscopy Time 19 0.22 0.91 No 
Number of Runs 19 0.28 1.19 No 
Patient Weight 19 0.29 1.24 No 
Table 5.2: Procedural variables correlated against peak skin dose, for coronary angiograms. N is the number of 
procedures included in the analysis, R the Pearson correlation coefficient and t is Students t-statistic. 
For coronary angiography, DAP was the only variable that demonstrated a significant 
association with peak skin dose. For angioplasty, both DAP and patient weight 
showed significant association with peak skin dose. These two variables were not 
independent, since a greater patient entrance dose is needed when the radiation beam 
has to pass through a greater thickness of tissue. 
Variable N R t Significant at P = 0.05? 
Dose Area Product 23 0.61 3.54 Yes 
Fluoroscopy Time 23 0.38 1.89 No 
Number of Runs 23 0.01 0.05 No 
Patient Weight 21 0.44 2.16 Yes 
Table 5.3: Procedural variables correlated against peak skin dose, for coronary angioplasties. N is the number of 
procedures included in the analysis, R the Pearson correlation coefficient and t is Students t-statistic. 
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 For coronary angiograms, the equation of the regression line linking peak skin dose 
(PSD) in mGy with dose-area-product (DAP) in Gycm
2
 was 
21.259.7 u DAPPSD  
Equation 5.3 
For angioplasties that did not result in film saturation, the corresponding equation was 
20985.6 u DAPPSD  
Equation 5.4 
Figure 5.4 and Figure 5.5 are scatter plots of peak skin dose against DAP, for these 
procedures. The error bars indicate overall uncertainty in the measurements, as 
described in Chapter 4. The graphs also show regression lines, and 95% prediction 
limits calculated by the modified Bland-Altman method. These were 176 mGy above 
and below the regression line for coronary angiography, and 356 mGy for coronary 
angioplasty. 
Chapter 5  Skin Dose Survey 97
 -200
-100
0
100
200
300
400
500
600
700
800
900
0 10 20 30 40 50 60 70 80 9
Dose Area Product (Gycm
2
)
P
e
a
k
 S
k
in
 D
o
s
e
 (
m
G
y
)
0
 
Figure 5.4: Peak skin dose versus dose-area-product, for coronary angiograms. Error bars indicate overall 
uncertainty in the measurements, as described in Chapter 4. Also shown are linear regression, and 95% prediction 
limits calculated by the modified Bland-Altman method. 
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Figure 5.5: Peak skin dose versus dose-area-product, for coronary angioplasties that did not result in film 
saturation. Error bars indicate overall uncertainty in the measurements, as described in Chapter 4. Also shown are 
linear regression, and 95% prediction limits calculated by the modified Bland-Altman method. 
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 Peak skin doses predicted from DAP, for all of the coronary angioplasties, are shown 
in Figure 5.6. For films that showed no saturation, the predicted doses were all less 
than 1 Gy. Of the seven films having saturated areas, only two had a predicted dose of 
more than 1 Gy. 
0
2
4
6
8
10
12
14
16
18
0-200 200-400 400-600 600-800 800-1000 1000+
Predicted Peak Skin Dose (mGy)
N
u
m
b
e
r 
o
f 
p
a
ti
e
n
ts
Film not saturated
Film saturated
 
Figure 5.6: Peak skin doses predicted from dose-area-product, for angioplasties with and without film saturation. 
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 5.3.3 Complexity Indicators 
Table 5.4 summarises the strength of association between the potential complexity 
indicators and the ratio of peak skin dose to DAP, for coronary angioplasty. The only 
indicator that gave a significant correlation was the number of lesions treated. The 
value of the correlation coefficient was negative, because the ratio of peak skin dose 
to DAP decreased as the number of lesions increased. 
Variable N RS t Significant at P = 0.05? 
Number of Diseased Vessels 22 0.31 1.47 No 
Number of Lesions Treated 22 -0.60 -3.36 Yes 
Number of Stents 22 -0.17 -0.77 No 
Lesion Severity 20 0.05 0.22 No 
Table 5.4: Potential complexity indicators correlated against the ratio of peak skin dose to DAP, for coronary 
angioplasties. N is the number of procedures included in the analysis, RS the Spearman rank-order correlation 
coefficient and t is Students t-statistic. 
The regression line relating PSD/DAP with the number of lesions treated had a 
gradient of 3.19 and an intercept of 19.3. The equation used to predict peak skin dose 
in mGy from a combination of DAP in Gycm
2
 and the number of lesions treated was 
therefore 
 lesionsDAPPSD uu 19.33.19  
Equation 5.5 
Figure 5.7 shows measured versus predicted peak skin doses for those coronary 
angioplasties that did not result in film saturation. Agreement between measured and 
predicted values is displayed in Figure 5.8. Predicted peak skin doses were, on 
average, 15 mGy higher than measured values. The limits of agreement were r 308 
mGy. 
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Figure 5.7: Measured versus predicted peak skin dose, calculated using DAP and number of lesions treated, for 
those coronary angioplasties that did not result in film saturation. The line of equality is shown. Error bars indicate 
overall uncertainty in the measurements, as described in Chapter 4. 
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Figure 5.8: Bland-Altman plot comparing predicted and measured peak skin dose (PSD). The solid line indicates 
the mean difference between the two methods, and the broken lines are the 95% limits of agreement. 
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 Peak skin doses predicted from DAP and number of lesions treated, for all of the 
coronary angioplasties, are shown in Figure 5.9. Those procedures that did not result 
in film saturation all had predicted peak doses of less than 1 Gy. Of the seven films 
having saturated areas, five had predicted doses of more than 1 Gy. The minimum 
predicted peak skin dose for the saturated films was 777 mGy. 
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Figure 5.9: Peak skin doses predicted from dose-area-product and number of lesions treated, for angioplasties with 
and without film saturation. 
5.4 Discussion 
5.4.1 Film Measurements 
For the 19 coronary angiograms for which a valid dosimetry film was obtained, all 
peak skin doses were well below 1 Gy. This indicated that patients undergoing these 
diagnostic investigations are unlikely to receive doses sufficient to cause deterministic 
effects. The maximum observed skin dose was 520 mGy. This was comparable with 
the results of previous studies using thermoluminescence dosimetry and film, 
summarised in Tables 3.4 and 3.7. 
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 For the 31 coronary angioplasties, 23% of patients received skin doses of 1 Gy or 
more, sufficient to saturate the film. It was no surprise to find some incidences of film 
saturation, given that all three thermoluminescence dosimetry studies listed in Table 
3.5 found some skin doses approaching or exceeding 1 Gy. However, it was not 
expected that such a large proportion of patients would be affected. This was at 
variance with the findings of Guibelalde et al (2003), who reported film saturation in 
only about 1% of all cardiac catheterization procedures, including complex 
angioplasties. The difference may be explained at least in part by the higher film 
saturation point of up to 1.5 Gy obtained with their processing conditions (Vanõ et al, 
2003; Guibelalde et al, 2003). The saturation point of 1 Gy found in the present study 
is likely to be more typical for radiology departments, since few can afford the luxury 
of running a dedicated film processor set up exclusively to maximise the range of 
dosimetry film. 
For most patients, the radiation fields appeared to be centred reasonably well on the 
film. This indicated that film positioning was appropriate for the procedure types 
investigated. The large area of the film should ensure that most of the radiation fields 
incident on the patients back are captured. However, when using lateral views and 
the widest obliques, the radiation beam would not pass through the film. Any high 
dose regions on the patients sides would therefore go undetected. 
EDR2 film was found to be a relatively convenient medium for measuring skin doses 
of up to 1 Gy, and for identifying patients who had received doses of 1 Gy or more. It 
could easily be positioned under the mattress, was invisible on the clinical images, 
and had no detriment to patient comfort. However, it was not capable of measuring 
doses of more than 1 Gy when used with a processor set up for diagnostic films. Even 
if its useful range were extended by adjusting the processing conditions, as described 
by Guibelalde et al (2003), its usefulness would still be limited by its saturation point 
of at most 1.5 Gy. 
5.4.2 Dose Area Product 
The mean DAP for coronary angiography was 26 Gycm
2
. This fell below the centre of 
the range of mean values published in recent literature (Table 3.2). It compared 
favourably with typical UK practice, as represented by the most recent national dose 
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 survey from the National Radiological Protection Board, which found a mean DAP of 
30 Gycm
2
 (Hart et al, 2002). 
The angioplasties demonstrated a wider variation in DAP, due to the inherent 
complexity of positioning the balloons and stents, ascertaining their correct positions, 
and checking procedural outcomes. This was reflected in the wider range of mean 
DAPs reported in the literature for these interventional procedures (Table 3.3). Again, 
the local mean value of 57 Gycm
2
 fell below the centre of the range. It was slightly 
lower than the mean DAP of 63 Gycm
2
 identified by the National Radiological 
Protection Board during their national dose survey (Hart et al, 2002). 
Both procedure types demonstrated a significant correlation between peak skin dose 
and DAP, for doses of less than 1 Gy. However, for coronary angioplasty in 
particular, some of the data points deviated considerably from the regression line. The 
95% limits of prediction were r 176 mGy for coronary angiography and r 360 mGy 
for coronary angioplasty, indicating that DAP could be used to predict skin doses to 
within these limits 95% of the time. 
On using DAP to predict skin dose, only two of the seven angioplasties resulting in 
film saturation had predicted doses of more than 1 Gy. Those procedures associated 
with the highest skin doses often involve a large proportion of imaging in a small 
number of projections, so that much of the entrance dose is concentrated over a fairly 
small area of the skin. The equation for predicting peak skin dose from DAP was 
based on typical practice, and did not take this high field concentration into account. It 
therefore tended to give poor dose estimates towards the high end of the dose range. 
5.4.3 Complexity Indicators 
The ratio of peak skin dose to DAP was found to correlate negatively with the number 
of lesions treated. When a single lesion is treated, the majority of the radiation fields 
may be concentrated over a fairly small area of the skin, resulting in a high ratio of 
peak skin dose to DAP. If there are two or more lesions at different locations in the 
arterial tree, these will need to be imaged from different projections. The skin 
exposure is therefore likely to be more evenly spread over a larger area, giving a 
lower PSD/DAP ratio. 
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 On using the number of lesions in combination with DAP to predict peak skin doses 
for coronary angioplasties, accuracy improved considerably. The 95% prediction 
limits for unsaturated films were r 308 mGy. Five of the saturated films were 
associated with predicted doses of more than 1 Gy, and the other two with predicted 
doses of at least 777 mGy. 
A major limitation of any system based on DAP is that it provides no information 
about the dose distribution on the patients skin. Whilst a combination of DAP and 
number of lesions can give a rough estimate of the magnitude of the peak skin dose, it 
cannot identify the locations on the skin where injuries may occur. 
5.4.4 Implications 
About a quarter of the coronary angioplasty patients included in this study received 
peak skin doses of 1 Gy or more. It was therefore likely that a similar proportion of 
patients were subjected to doses of at least 1 Gy in routine clinical practice. In order to 
comply with the recommendations of the US Food and Drug Administration (1995) 
and the International Commission on Radiological Protection (2000), these patients 
peak skin doses should be assessed and recorded. 
Given the large proportion of patients receiving skin doses of 1 Gy or more, it seemed 
likely that some may exceed the 2 Gy threshold for skin erythema. These patients 
should be monitored for evidence of skin effects, and informed about potential 
symptoms, and appropriate actions to take should any symptoms occur. At the time of 
this study however, there was no reliable means of identifying these patients in order 
to offer them appropriate follow-up. 
Thus, the present study clearly identified the need for a more robust dosimetry method 
that could reliably assess skin doses of more than 1 Gy, and identify the location of 
such high doses on the patients skin. The small area dosimeters mentioned in the 
literature review (thermoluminescence dosimeters, scintillation detectors and diodes) 
would not meet these requirements, as there is a danger of missing the region of peak 
skin dose. Other possibilities include Gafchromic films, or the extended dose range 
computed radiography plates now available for radiotherapy verification imaging. 
However, both would have considerable cost implications. The option that seemed 
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 most practical was that of dose modelling, since this would have the minimum impact 
on resources, and on the workload for busy clinical staff. 
The high incidence of skin doses of 1 Gy or more also highlighted the need for 
optimisation of radiological practice in the cardiac catheterization laboratory. Any 
measures that can reduce the radiation dose to the patients skin whilst maintaining 
adequate visualisation of the coronary arteries should be implemented, to minimise 
the risk of adverse skin reactions. 
Mean dose-area-products for both procedure types were below the centre of the 
ranges reported in recent literature. It seems likely that those facilities operating at 
higher mean DAPs than those reported here also have a higher incidence of skin doses 
exceeding 1 Gy. There is a pressing need for improved skin dosimetry methods, and 
optimisation of radiological practice, across the wider interventional cardiology 
community. 
5.5 Summary 
Patient skin doses were measured using Kodak EDR2 film, for 19 coronary 
angiograms and 31 coronary angioplasties. For coronary angiography, all skin doses 
were well below 1 Gy, indicating that deterministic skin injuries were unlikely to 
occur following this type of procedure. For coronary angioplasty, 23% of the films 
showed some areas of saturation, indicating that these patients had received peak skin 
doses of at least 1 Gy. It was possible that some of these patients doses were 
sufficient to cause deterministic effects. Given that the International Commission on 
Radiological Protection (ICRP) and the US Food and Drug Administration (FDA) 
recommend recording doses of more than 1 Gy in the patients notes, a means for 
assessing these higher doses is needed. 
The results of the study indicated that EDR2 film did not have a sufficient dose range 
for skin dosimetry in the cardiac catheterization laboratory. This was also likely to be 
the case at many other facilities, where mean dose-area-products were higher than 
those reported here. The film may be used to identify patients receiving doses of 1 Gy 
or more, and who may therefore be at risk of deterministic injuries. However, another 
method is needed to assess these patients peak skin doses. 
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 Mean dose-area-products for both procedure types were found to compare favourably 
with typical UK and European practice. Dose-area-product was shown to be a poor 
predictor of peak skin dose for coronary angioplasty. Whilst there was a significant 
correlation between the two quantities, the use of dose-area-product to predict peak 
skin dose failed to identify most of the patients receiving doses of 1 Gy or more. 
The ratio of peak skin dose to DAP correlated negatively with the number of lesions 
treated. On using a combination of DAP with the number of lesions to predict skin 
dose for coronary angioplasty, accuracy was improved, with calculated doses for 
saturated films increasing to at least 777 mGy. However, as with other methods based 
on DAP, this could not identify the locations of high doses on the patients skin. 
Practical compliance with ICRP and FDA recommendations requires a method for 
assessment of skin dose that is more accurate than DAP, that provides information 
about the location of high skin doses, and is applicable over a wider dose range than 
EDR2 film. 
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 Chapter 6 - Skin Dose Modelling 
6.1 Introduction 
This chapter describes the development and validation of a mathematical model to 
calculate the dose distribution in the plane of the couch top, from cardiac 
catheterization procedures. The mathematical basis for the dose model is presented, 
and the software used to source, analyse and present the data is described. 
Peak skin doses calculated using the model are compared with the film measurements 
described in Chapter 5. Since fluoroscopic images were not stored, the model needed 
to estimate and include the dose contribution from fluoroscopy. Three approaches to 
this problem are described, and the results of each are compared with the film 
measurements. The clinical usefulness of the software is evaluated, and its limitations 
are discussed. 
Whilst den Boer et al (2001) and Chugh et al (2004) had previously developed 
systems for modelling the patient skin dose distribution, none were available 
commercially at the time of this study. Nor had the mathematical workings of such 
skin dose models been published in peer-reviewed literature. 
6.1.1 Objectives 
The aim of this study was to develop software to calculate and display the dose 
distribution in the plane of the couch top, for individual cardiac catheterization 
procedures. The specific objectives were: 
x To construct a mathematical model to calculate the dose distribution in the 
plane of the couch top, from exposure and projection data stored in the image 
files; 
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 x To write software enabling this dose distribution to be calculated and 
displayed for individual cardiac catheterization procedures; 
x To assess the accuracy and reliability of the model, by comparing calculated 
doses with the film measurements described in Chapter 5; 
x To improve the models accuracy, by including an estimated contribution from 
fluoroscopy. 
6.2 Method 
The dose calculation software was developed using Matlab version 7 (The 
Mathworks, Inc., Natick, Massachusetts). Its function was to extract the relevant data 
from the image files for a selected cardiac catheterization procedure, calculate the 
dose distribution in the plane of the couch top, and present this as a graphical display. 
The computational code used to achieve this is presented in Appendix I. All of the 
image files were in DICOM standard format (National Electrical Manufacturers 
Association, 2004), with one file for each acquisition run. 
The simplest form of the dose model considered only the acquisition run data, which 
was stored in the image files. This will be referred to as Version 1 (Acquisition 
Only), and is described in Section 6.2.2. 
Clinical procedures also involve fluoroscopy. However, the fluoroscopic images were 
not stored, so that no exposure or projection data were available for the fluoroscopic 
component of the procedure. Where extensive fluoroscopy is performed over a limited 
range of projections, this could lead to considerable errors in skin dosimetry. Three 
options for estimating and including the contribution from fluoroscopy were 
investigated. These are referred to as versions 2 to 4, and described in Section 6.2.3. 
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 6.2.1 Data Input 
On starting up the software, the user was prompted to browse the image server, and 
select the directory containing the desired procedure. Each of the image files in that 
directory was then interrogated, to obtain the stored exposure and projection data, 
which was written to a structure array. 
Table 6.1 shows this data, for one coronary angiogram. Each row corresponds to one 
file, i.e. one acquisition run. The columns contain the data fields: acquisition run 
number (Run), number of frames in that run (Frames), imaging protocol (Protocol), 
X-ray tube potential (kVp), tube current (mA), pulse width (ms), primary and 
secondary angles describing the orientation of the imaging unit in degrees (Ang1 and 
Ang2), source to image distance in millimetres (SID) and detector field size in 
millimetres (II). 
Run Frames Protocol kVp mA ms Ang1 Ang2 SID II 
1 53 12.5 FPS Coronary 71 613 7 -0 -22 953 170
2 80 12.5 FPS Coronary 84 862 7 42 -32 992 170
3 90 12.5 FPS Coronary 74 713 7 42 16 925 170
4 68 12.5 FPS Coronary 73 703 7 -32 21 945 170
5 75 12.5 FPS Coronary 80 893 7 -32 -18 994 170
6 70 12.5 FPS Coronary 76 778 7 41 -0 985 170
7 71 12.5 FPS Coronary 71 685 7 -35 -0 984 170
8 26 12.5 FPS Coronary 66 475 7 -32 -0 986 230
9 103 12.5 FPS Coronary 70 643 7 -32 -0 986 230
Table 6.1: Example exposure data extracted from image files. kVp, tube potential (kV); mA, tube current (mA); 
ms, pulse width (ms); Ang1, left-right gantry angulation (degrees); Ang2, cranio-caudal gantry angulation 
(degrees); SID, focal spot to detector distance (mm); II, field size at detector face (mm). 
Ang1 relates to left-right rotation of the gantry, as shown in Figure 6.1(a). It is 
positive for left anterior oblique and left lateral views, when the detector is towards 
the patients left-hand side. Ang2 describes cranio-caudal rotation, as shown in Figure 
6.1(b). It is positive when the detector is closer to the patients head. 
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 Ang1
Centre of 
Rotation
(a) 
 
Ang2
Centre of 
Rotation
(b) 
Figure 6.1: Views (a) along the patient couch, and (b) across the patient couch, showing the centre of rotation of 
the X-ray tube and detector, and angles Ang1 and Ang2. 
The model required a number of additional input values, which are described below. 
These were determined for the Philips Integris H5000F cardiovascular imaging unit 
referred to in Chapters 4 and 5. 
centreheight - The height of the centre of rotation of the gantry, measured from the 
floor. This was permanently fixed at 107 cm. 
radius - The distance from the X-ray focal spot to the centre of rotation. This was 
fixed at 77.5 cm. 
couchheight - The height of the couch above the floor. This could be adjusted during 
clinical procedures, and was not recorded in the DICOM files. A typical value of 87 
cm was chosen, based on the recorded SIDs and measured field sizes for a selection 
of the dosimetry films described in Chapter 5. The model assumed, for simplicity, that 
no couch panning was used. 
ESDRphantom  A standardised measure of dose rate at the X-ray beam entrance site of 
a Perspex phantom. This quantity was determined as follows. 
A calibrated Radcal 9010 series dose meter (Radcal, Monrovia, California) was 
positioned with its 60 cc ionisation chamber on the imaging couch, centred in the X-
ray beam. A 25 cm stack of Perspex was positioned just above it, supported at either 
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 side by a further 2 cm Perspex, as shown in Figure 6.2. The couch height was set to 67 
cm above the focal spot, and the SID to 100 cm. The 23 cm field size was selected. 
An acquisition run was performed using the default clinical acquisition mode 12.5 
FPS Coronary, and the entrance dose rate to the Perspex was measured. The 
displayed exposure factors were 70 kVp, 608 mA and 7 ms. 
Detector
Perspex
Ionisation Chamber
X-ray Tube
67 cm
(fcd)
25 cm
2 cm
Imaging Couch
6 cm
 
Figure 6.2: Set-up for determination of entrance dose rate to Perspex phantom. 
 
The measured dose rate (ESDR) was normalised for tube potential (kVp), current (mA), 
pulse time (ms), number of frames per second (frame rate), and distance in 
centimetres from the focal spot to the ionisation chamber (fcd), as shown in Equation 
6.1.  
rateframemsmAkV
fcdESDR
ESDR
p
phantom uuu
u 
2
2
 
Equation 6.1 
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 For the imaging unit used in this study, ESDRphantom had a value of 5.97x10
-5
 
mGycm
2
/(kVp
2
mAms) per frame. 
6.2.2 Dose Calculation 
This section describes the function of the simplest form of the dose model, Version 1 
(Acquisition Only). The other versions used the same basic structure, with some 
modifications as described in Section 6.2.3. 
The dose calculation plane was defined by a grid of points at 1 mm intervals in a 
plane at the height of the couch top, extending from 30 cm to +30 cm in the x (cross-
couch) direction and 20 cm to +20 cm in the y direction (parallel to couch axis). It 
was described by an array (xfilm(i,j), yfilm(i,j), couchheight), where i and j indexed 
matrix elements in the x and y directions respectively. Figure 6.3 shows the 
orientation of the calculation plane relative to the patients back. Positive x was 
defined towards the right-hand side of the patient, and positive y towards the patients 
head, so that the dose map appeared as though viewing the patient from behind. It 
should be noted that the exact position of the patient was not known when performing 
the dose calculations. 
+x
+y
-x
-y
 
Figure 6.3: Diagram showing orientation of the calculation plane relative to the patients back. 
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 For each acquisition run, the position of the focal spot (xspot, yspot, zspot) was calculated 
using Equation 6.2 to Equation 6.4. The angle conventions used in these equations are 
illustrated in Figure 6.4. 
   2cos1sin AngAngradiusxspot uu  
Equation 6.2 
 2sin Angradiusyspot u  
Equation 6.3 
   2cos1cos AngAngradiushtcentreheigzspot uu  
Equation 6.4 
-z
+x
-y
Centre of Rotation 
(0,0,centreheight)
Ang2
Ang1
radius
Focal Spot
(xspot,yspot,zspot)
 
Figure 6.4: Angle conventions used to define focal spot position (Equation 6.2 to Equation 6.4). 
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 The distance ffd(i,j) from the focal spot to each point in the calculation plane was then 
determined using Pythagoras law. 
           21222 ,,, spotspotfilmspotfilm ztcouchheighyjiyxjixjiffd   
Equation 6.5 
For a single acquisition run, the dose at each point in the plane, in the absence of 
beam collimation, would be: 
   jiffd
FramesmsmAkV
ESDRjidose
p
phantom
,
,
2
2 uuuu  
Equation 6.6 
where kVp, mA, ms and Frames are the values obtained from the DICOM file for that 
particular run. 
The imaging unit had both circular and square primary collimators, resulting in a 
radiation field shape that was approximately square, with the corners clipped off. For 
simplicity, the dose model assumed only square collimation, with a side length 
defined by the nominal field size. No data were available regarding the use of the 
secondary collimators or equalisation filter, so these were assumed not to have been 
used. 
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 The geometry used to calculate beam collimation is shown in Figure 6.5. The angle 
(T) between the central axis of the X-ray beam and its collimated outer edge was 
calculated from the recorded field size (II) and SID, using Equation 6.7.  
field size
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Figure 6.5: Geometry for calculating beam collimation. 
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2
tan 1T  
Equation 6.7 
SIDcoll was defined as the distance from the focal spot, to any of the four corners of 
the collimated field at the detector face. It was calculated from field size (II) and SID 
(both in centimetres), using Pythagoras law. 
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Equation 6.8 
The positions of the field corners (k = 1 to 4) at the detector face (xcoll(k), ycoll(k),  
zcoll(k)) were calculated using Equation 6.9 to Equation 6.11, with positive and 
negative values of T added to angles Ang1 and Ang2 in turn. 
   Tru 2sin AngSIDyky collspotcoll  
Equation 6.9 
     TT ruru 2cos1sin AngAngSIDxkx collspotcoll  
Equation 6.10 
     TT ruru 2cos1cos AngAngSIDzkz collspotcoll  
Equation 6.11 
The four corners of the collimated field were then translated from the detector face 
onto the plane of the couch top, by means of scaling. 
        spotspotcoll spotcollspotcouch ztcouchheighzkz
xkx
xkx u
  
Equation 6.12 
        spotspotcoll spotcollspotcouch ztcouchheighzkz
yky
yky u
  
Equation 6.13 
To apply the collimation, the values of the dose array defined in Equation 6.6 were set 
to zero at all locations outside the trapezium formed by these four points.  
The total dose array TotalDose(i,j) for the procedure was constructed by summing the 
collimated dose arrays from each acquisition run. It was then displayed as a filled 
contour map, with annotations indicating the patients name and procedure date, as 
well as the maximum dose value. The colour scale of the map was automatically set to 
match the range of dose values present. 
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 6.2.3 Contribution from Fluoroscopy 
The three methods for including an estimated contribution from fluoroscopy are 
outlined below. Each required a measure of total DAP or fluoroscopy time. These 
were displayed on the imaging console, and manually logged in a database at the end 
of each procedure. 
Version 2 (Fluoro Correction via DAP) 
The total dose array for the acquisition runs TotalDose(i,j) was calculated as described 
in Section 6.2.2. Dose-area-product in Gycm
2
 was also calculated for each acquisition 
run, using Equation 6.14. 
2
2
3.11000 ¹¸
·
©¨
§uuuuuu SID
II
FramesmsmAkV
ESDR
DAP p
phantom
 
Equation 6.14 
where kVp, mA, ms, Frames, II and SID are the values obtained from the DICOM file 
for that particular run. The factor of 1000 converted the dose units from mGy to Gy. 
Since backscatter from the patient is typically around 30%, in the diagnostic X-ray 
energy range (Jones & Wall, 1985; Dosimetry Working Party of the Institute of 
Physical Sciences in Medicine, 1992), the factor of 1.3 was included to eliminate the 
backscatter component of ESDRphantom. Measurements made with and without 
backscattering material as part of the film calibration study of Chapter 4 showed the 
backscattered fraction to vary between 0.29 and 0.37, across the range of beam 
conditions investigated. 
The DAP from individual acquisition runs was then summed to give acquisition DAP 
for the whole procedure (DAPAcquisition). The total dose array TotalDose(i,j) was 
multiplied by the ratio of displayed DAP for the whole procedure (DAPTotal), to 
calculated acquisition DAP, to generate the fluoroscopy-corrected dose map. 
    ¸¸¹
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¨¨©
§u 
nAcquisitio
Total
CorrectedFluoro
DAP
DAP
jiTotalDosejiTotalDose ,,  
Equation 6.15 
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 Version 3 (Fluoro Correction via Fluoroscopy Time) 
The entrance dose rate to the Perspex phantom was re-measured in the default 
fluoroscopy mode (Low Fluoro), as described in Section 6.2.1. It was found to be 
approximately 40 mGy/min. The displayed exposure factors were 85 kVp and 21.5 
mA. 
This standard fluoroscopic dose rate was multiplied by the fluoroscopy time (FT) in 
minutes, to estimate the total dose due to fluoroscopy. This was then divided by the 
number of acquisition runs (Runs), and added to the un-collimated dose array for each 
run. Thus, Equation 6.6 was modified to 
    Runs
FT
jiffd
FramesmsmAkV
ESDRjidose
p
phantom
uuuuu 40
,
,
2
2
 
Equation 6.16 
The remainder of the calculation was performed as described in Section 6.2.2. 
Version 4 (Fluoro Correction via Concentration Factor) 
This version sought to predict peak skin dose from displayed DAP for the whole 
procedure, coupled with a concentration factor describing how the maximum value 
of the dose map related to the integral dose over the whole of the map. 
The total dose array TotalDose(i,j) for the acquisition runs was calculated as described 
in Section 6.2.2. Its maximum value (Dosemax) was determined. The doses at all points 
in the array were also summed, to give integrated dose over the whole calculation 
plane. Concentration factor (CF) was defined as the ratio of maximum dose to 
integrated dose. 
 ¦ 
ji
jiDoseTotal
Dose
CF
,
max
,
 
Equation 6.17 
This was then multiplied by displayed DAP (DAPtotal). 
In order to determine the relationship between this new index and peak skin dose, the 
resulting values were plotted against the measured peak skin doses from Chapter 5, 
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 for those films that showed no saturation. A regression line was fitted to the data, and 
constrained to pass through the origin. Its gradient O was 5.53 x 10-6. 
Finally, the peak skin dose (PSD) for each procedure was calculated using Equation 
6.18. 
O
TotalDAPCFPSD
u  
Equation 6.18 
6.2.4 Comparison of Calculated and Measured Doses 
In order to evaluate the software, dose maps were calculated for each of the 
procedures that were included in the film dosimetry study of Chapter 5. The dose 
maps calculated using Version 1 (Acquisition Only) were visually compared with 
their corresponding films. The area of the dose map covered by the film was roughly 
identified by the shape and intensity of the radiation fields appearing on each. In ten 
cases (five coronary angiograms and 5 coronary angioplasties), the peak skin dose 
identified by the dose map was beyond the edge of the film. These cases were 
excluded from the analysis. The remaining sample consisted of 14 coronary 
angiograms and 25 coronary angioplasties. 
For each version of the dose model, calculated peak skin doses were compared with 
those measured on film. For saturated films, calculated peak skin doses were plotted 
as a histogram. For films that showed no saturation, calculated and measured values 
were compared using Bland-Altman plots (Bland & Altman, 1986; Bland & Altman, 
1999). 
6.3 Results 
6.3.1 Example Dose Map 
Figure 6.6 shows a dose map generated by Version 1 of the software. A visual 
comparison with the corresponding dosimetry film (Figure 6.7) demonstrated that it 
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 correctly identified the region of maximum dose, in the top right-hand corner. The 
fields visible on the dose map corresponded reasonably well in shape and intensity 
with some of those seen on the film. However, fields arising from fluoroscopic 
exposures were seen only on the film, since the model had no access to projection 
information for fluoroscopy. 
 
Figure 6.6: Example output from dose model. 
 
Figure 6.7: Dosimetry film for the patient whose calculated skin dose map is shown in Figure 6.6, shown at the 
same scale. 
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 In this example, the radiation fields on the dose map appeared to cover a larger area 
than those on the film. Possible reasons for this include difference in couch height 
between the typical value used by the model and the actual value for the procedure, 
differences between nominal and actual radiation field sizes, and any couch panning 
that took place during the procedure. 
6.3.2 Doses of More than 1 Gy 
Six of the angioplasty films showed localised areas of saturation, indicating that these 
patients had received skin doses of 1 Gy or more. Figure 6.8 shows the calculated 
doses for these six cases, for each version of the dose model. 
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Figure 6.8: Calculated doses for procedures that resulted in film saturation, using each version of the dose model. 
Although Version 1 (Acquisition Only) generally calculated doses of at least 800 
mGy for these procedures, in one case a dose of only 332 mGy was computed. On 
applying any of the fluoroscopy correction methods, this patients calculated dose 
increased to more than 1 Gy. When corrected by fluoroscopy time or concentration 
factor (Versions 3 and 4), the model successfully identified all procedures that 
resulted in film saturation. Version 2 (Fluoro Correction via DAP) predicted one of 
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 these patients to have a peak skin dose of 928 mGy, and all others to have maximum 
doses of more than 1Gy. 
Versions 2, 3 and 4 all calculated peak skin doses of more than 2 Gy for two of the 
patients in the study. 
6.3.3 Doses of Less than 1 Gy 
Figure 6.9 to Figure 6.16 compare calculated and measured doses for all the 
procedures that did not result in film saturation, i.e. for which measured doses were 
less than 1 Gy. 
For each version of the dose model, calculated peak skin doses were first plotted 
against measured values. The error bars show the overall uncertainty in the film 
dosimetry measurements, as described in Chapter 4. Bland-Altman plots were then 
constructed, to show the differences between calculated and measured values. In each 
case, the mean difference and 95% limits of agreement are shown. 
For Version 1 (Acquisition Only), calculated values were on average 98 mGy lower 
than measured values. Each of the methods for including fluoroscopy brought the 
mean difference between calculated and measured peak skin dose closer to zero. Each 
version of the dose model had limits of agreement between 259 and 273 mGy from 
the mean. 
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Figure 6.9: Calculated versus measured peak skin doses, for Version 1 (Acquisition Only). The line of equality is 
shown. Error bars indicate overall uncertainty in the film measurements, as described in Chapter 4. 
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Figure 6.10: Bland-Altman plot comparing calculated and measured peak skin doses, for Version 1 (Acquisition 
Only). The mean difference and 95% limits of agreement are shown. 
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Figure 6.11: Calculated versus measured peak skin doses, for Version 2 (Fluoro Correction via DAP). The line of 
equality is shown. Error bars indicate overall uncertainty in the film measurements, as described in Chapter 4. 
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Figure 6.12: Bland-Altman plot comparing calculated and measured peak skin doses, for Version 2 (Fluoro 
Correction via DAP). The mean difference and 95% limits of agreement are shown. 
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Figure 6.13: Calculated versus measured peak skin doses, for Version 3 (Fluoro Correction via Fluoroscopy 
Time). The line of equality is shown. Error bars indicate overall uncertainty in the film measurements, as 
described in Chapter 4. 
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Figure 6.14: Bland-Altman plot comparing calculated and measured peak skin doses, for Version 3 (Fluoro 
Correction via Fluoroscopy Time). The mean difference and 95% limits of agreement are shown. 
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Figure 6.15: Calculated versus measured peak skin doses, for Version 4 (Fluoro Correction via Concentration 
Factor). The line of equality is shown. Error bars indicate overall uncertainty in the film measurements, as 
described in Chapter 4. 
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Figure 6.16: Bland-Altman plot comparing calculated and measured peak skin doses, for Version 4 (Fluoro 
Correction via Concentration Factor). The mean difference and 95% limits of agreement are shown. 
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 6.4 Discussion 
6.4.1 Acquisition Only 
The simplest version of the dose model, Version 1 (Acquisition Only), used only the 
acquisition run data stored in the image files, and did not attempt to include 
fluoroscopy. For films that showed no saturation, calculated peak skin doses were on 
average 98 mGy lower than measured values, but the two methods agreed to within 
270 mGy of the mean, 95% of the time. 
For those procedures that had resulted in film saturation, i.e. for which the peak skin 
dose was 1 Gy or more, calculated doses were generally above 800 mGy. However, 
the calculated peak skin dose for one of these patients was only 332 mGy. The 
fluoroscopy time for this procedure had been particularly long, at 25 minutes. On 
inspecting the film, it was apparent that most of the radiation exposures had been 
performed in a single projection. In such cases, ignoring the contribution from 
fluoroscopy causes the peak skin dose to be greatly underestimated. Although this 
patient had received a skin dose of at least 1 Gy and may be at risk of deterministic 
effects, the model would not have identified her as being at risk. 
6.4.2 Estimated Contributions from Fluoroscopy 
Three options for including an estimated contribution from fluoroscopy were 
explored. Each assumed that fluoroscopic exposures were performed using the same 
projections in about the same proportions as the acquisition runs. This is not 
necessarily true, but in the absence of fluoroscopic projection data, it seemed to be the 
most logical approach. 
In Version 2 (Fluoro Correction via DAP), all of the values in the dose map were 
multiplied by the ratio of displayed DAP for the whole procedure, to calculated DAP 
for the acquisition runs. 
Version 3 (Fluoro Correction via Fluoroscopy Time) used the displayed fluoroscopy 
time and a standard dose rate to add a fluoroscopic contribution to the dose associated 
with each acquisition run. 
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 Version 4 (Fluoro Correction via Concentration Factor) calculated a concentration 
factor for the dose map. It then multiplied the concentration factor by displayed DAP 
and divided by a constant, to estimate the peak skin dose for the whole procedure. 
Each of versions 2 to 4 improved the models reliability in identifying patients who 
had received peak skin doses of more than 1 Gy. Versions 3 and 4 estimated peak skin 
doses of more than 1 Gy for all six of those patients. Version 2 produced peak skin 
dose estimates of more than 1 Gy for five of them, and 928 mGy for the sixth. 
For peak skin doses of less than 1 Gy, all three versions showed mean differences 
between calculated and measured values of less than 30 mGy. In each case, the 95% 
limits of agreement were within about 270 mGy from the mean. 
Versions 2 and 4 both used displayed DAP to estimate the contribution from 
fluoroscopy. As described in Chapter 4, the measured DAP at the couch top was 
around 33% lower than the displayed value. The dose model did not apply this 
correction factor, because the uncorrected DAP gave better agreement between 
calculated and measured peak skin doses for Version 2 (Fluoro Correction via DAP). 
A possible explanation for this is that the actual field sizes were smaller than their 
nominal specifications, which were used in the dose model. In Version 4 (Fluoro 
Correction via Concentration Factor), the DAP correction factor would be absorbed 
into the constant O. 
For Version 4, agreement between predicted and measured peak skin doses was 
guaranteed by the fact that the same data were used to calculate O and to predict peak 
skin doses. Agreement may not be as good for patient procedures not included in this 
sample. 
Perhaps the most reliable way to correct for fluoroscopy would be to multiply the 
values in the dose map by the ratio of displayed DAP for the whole procedure, to 
displayed DAP for the acquisition runs. This last quantity was displayed on the 
imaging unit during procedures, but was not recorded, and could not be accessed 
retrospectively. It is hoped that in future, summary dose information including total 
DAP, acquisition DAP and fluoroscopy time will be transferred automatically to the 
image server, but such functionality was not available at the time of this study.  
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 6.4.3 Clinical Usefulness 
For each procedure, the dose modelling software provided an estimate of peak skin 
dose, and a rough indication of its location on the patients skin, thereby fulfilling the 
recommendations for dose recording set out in ICRP Report 85 (International 
Commission on Radiological Protection, 2000) and the relevant FDA guidelines 
(Food and Drug Administration, 1995). This dosimetric information could be made 
available to the cardiologist, to inform patient counselling and follow-up care. 
The level of accuracy provided by versions 2, 3 and 4 of the dose model should be 
sufficient for identifying patients who may be at risk of skin injuries. The FDA point 
out that highly accurate assessment of skin dose is not necessary. Rather, what is 
important is being able to recognise when a dose threshold may have been exceeded 
(Food and Drug Administration, 1995). 
The dose modelling approach requires far less involvement from clinical staff than 
other dosimetric methods, leaving them to concentrate on other aspects of patient 
care. It does not depend on any advance preparation, such as positioning of dosimeters 
prior to commencing the procedure. The software used mostly data that was 
automatically stored by the imaging unit. The only additional data required was 
displayed DAP or fluoroscopy time. Since these were recorded routinely, peak skin 
dose could be estimated for any patient. Unlike film dosimetry, there was no upper 
limit on the doses that could be assessed. 
The fact that calculated peak skin doses for two patients exceeded 2 Gy emphasised 
the need for routine skin dose monitoring in the cardiac catheterization laboratory. 
Since 8% of the angioplasties in this study were associated with skin doses of at least 
2 Gy, it is possible that cumulative doses approaching the 6 Gy threshold for main 
erythema occasionally occur, particularly among those patients who undergo more 
than one catheterization procedure in the space of a week or two. 
6.4.4 Limitations 
The accuracy of the dose model was limited by the quantity of information available. 
Where essential parameters were not recorded, assumptions had to be made. 
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 The cardiovascular imaging unit used in this study stored only acquisition runs and 
not fluoroscopic image sequences. This meant that no information was available 
regarding fluoroscopic projections. Version 1, which ignored the contribution from 
fluoroscopy, was liable to greatly underestimate peak skin doses for procedures 
requiring extended fluoroscopy from a limited number of projections. Versions 2, 3 
and 4 estimated the contribution from fluoroscopy by assuming that the same 
projections were used in the same proportions as for acquisition. This may not be a 
true reflection of clinical practice in all cases. A further weakness of Version 3 
(Fluoro Correction via Fluoroscopy Time) was that it assumed the same skin dose rate 
regardless of the radiographic projection or the size of the patient. 
The imaging unit stored no information about the position of the couch. It was 
therefore necessary to assume a certain couch height, and to ignore any couch 
movement in the horizontal plane. A variation in true couch height of 5 cm from that 
used in the model would correspond to an error in calculated dose of about 12%. 
Since couch position was unknown, it was not possible to identify the exact positions 
of the radiation fields on the patients skin. 
No data were available regarding the use of the secondary collimators or the 
equalisation filter. It was therefore assumed that these were never used. This may 
substantially affect dosimetric accuracy in regions where two or more fields overlap. 
Radiation field sizes may also have been overestimated by assuming only square 
primary collimation and nominal instead of actual field sizes. However, it is unlikely 
that accuracy could be much improved unless the secondary collimators and 
equalisation filter were taken into account. 
The manufacturers of cardiovascular imaging equipment should be encouraged to 
develop facilities for recording and accessing the above information. This is essential 
if dosimetric accuracy is to be improved. 
As with film dosimetry, the model considered only those radiation beams that passed 
through the plane of the couch, and ignored any contributions to skin dose from lateral 
views. It could potentially be improved by using a three-dimensional model of the 
patient, and estimating skin doses over the whole surface of the thorax. However, this 
would require couch positioning data, to achieve a worthwhile degree of accuracy. 
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 6.5 Summary 
A mathematical model was developed, to calculate the dose distribution in the plane 
of the couch top from cardiac catheterization procedures, using the exposure and 
projection data stored in the image files. Software was designed to extract the relevant 
data, perform the calculations, and display a dose map for each procedure. Peak skin 
doses were calculated for those procedures that were included in the film dosimetry 
study of Chapter 5. 
The original version of the software used only the information stored in the image 
files, i.e. only exposure and projection data for the acquisition runs. Peak skin dose 
was greatly underestimated for one patient, who had received a dose of at least 1 Gy 
during a procedure that involved extensive fluoroscopy in one projection. 
Three methods for including an estimated contribution from fluoroscopy were 
explored. Each required displayed DAP or fluoroscopy time as an additional input. 
All three successfully identified those patients who had received skin doses of 1 Gy or 
more. 
For those procedures that did not result in film saturation, calculated and measured 
peak skin doses were compared using Bland-Altman plots. Each version of the 
software was found to agree with film measurements to within about 270 mGy. 
The software was found to be a potentially useful tool for patient dosimetry in the 
cardiac catheterization laboratory. Unlike film dosimetry, there was no limit on the 
magnitude of the doses that could be evaluated. The output dose map gave an 
indication of the magnitude and position of the peak skin dose on the patients back, 
in line with the recommendations for dose recording proposed by the International 
Commission on Radiological Protection and the US Food and Drug Administration. 
This should allow the clinician to offer informed counselling and aftercare to patients 
who may be at risk of deterministic skin injuries. 
The main limitations of the dose model arose from the lack of information about 
couch position and beam limitation. Improvement of dosimetric accuracy is dependent 
upon manufacturers developing facilities for recording and accessing this data.
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 Chapter 7 - Barium Enema Dose 
Reduction 
7.1 Introduction 
Chapters 7 and 8 together describe an optimisation strategy applied to barium enema 
imaging. A baseline survey of local imaging practice was first performed, and the 
results compared with published studies. This identified a number of potential dose 
reduction techniques, which were considered in consultation with clinical staff. 
Having decided to introduce copper filtration, the effects of a small amount of copper 
on dose and image quality were predicted using phantom measurements. The copper 
was introduced into clinical practice, and the dose survey repeated to determine its 
effectiveness. Following successful dose reduction, a more detailed study was 
performed to determine the optimal quantity of copper for barium enema 
examinations. A copper thickness of 0.3 mm was chosen, following phantom 
measurements. Its suitability for clinical imaging was verified by means of a visual 
grading analysis study. 
This chapter describes the initial stages of the investigation. It begins by outlining the 
clinical background to barium enema imaging, and reviewing the literature on patient 
radiation doses. It then describes the baseline survey, and the local imaging protocol. 
Several methods for dose reduction are proposed, and the merits of each are 
considered. The initial series of phantom measurements are described, and the 
effectiveness of 0.1 mm copper in reducing patient DAP is examined. 
Some of the figures quoted in Chapters 7 and 8 differ slightly from those previously 
presented in a paper by the author (Morrell et al, 2004). The reasons for this are as 
follows. Firstly, the survey data in the paper included some patients who had fewer 
than six screen-film radiographs. It was subsequently decided that these incomplete 
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 examinations should be excluded from the dose surveys. Secondly, the percentages of 
patients likely to be affected by saturation of the fluoroscopic exposure factors 
(Chapter 8) were re-calculated for the thesis, using a simpler method and larger 
sample sizes. 
7.1.1 Clinical Background 
The double contrast barium enema examination is performed to identify the cause(s) 
of pain in, or dysfunction of, the colon. It is effective in the diagnosis of carcinomas 
and diverticular disease, and in identification of colonic polyps. It involves both 
fluoroscopic imaging and multiple radiographs of the abdomen. Hence, patients may 
receive high effective doses of radiation. 
The walls of the large bowel are coated with a barium contrast agent, and then imaged 
from several different projections, in order to visualise the detailed structure of each 
part of the bowel wall. An example image is shown in Figure 7.1. 
 
Figure 7.1: Example barium enema radiograph. 
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 7.1.2 Literature Review 
The National Radiological Protection Board (NRPB) estimate that barium enemas 
account for 13% of the UK Collective Effective Dose from medical X-rays (Hart & 
Wall, 2002). Their national dose survey in 1985 (Shrimpton et al, 1986) and its 
subsequent reviews in 1995 (Hart et al, 1996) and 2000 (Hart et al, 2002) found dose 
area products for enemas to be substantially greater than those for other barium 
examinations. The introduction of colon cancer screening in the UK could further 
increase the number of patients being referred for enema. 
Studies of various sizes have sought to assess radiation doses to patients during 
barium enema examinations. The most practical measure of patient dose and that most 
commonly used is dose area product (DAP). Table 7.1 shows a selection of data from 
the literature, including mean DAPs, fluoroscopy times and numbers of radiographs. 
The data is presented in order of increasing DAP. Where no values for fluoroscopy 
time or number of radiographs are given, this information was not available from the 
source material. Some of the studies included more than one X-ray facility, and 
showed considerable variations in mean DAP between individual X-ray rooms. 
The studies associated with the lowest doses were at hospitals where local practice 
had previously been reviewed, and dose reduction measures applied. Horton et al 
(1992) had minimised the fluoroscopy time by using a standard protocol to coat the 
patients bowel with barium as thoroughly as possible before making any exposures. 
Smiddy et al (1996) had reduced the fluoroscopic current to 0.5 mA. Dose reduction 
techniques reported by other authors include reducing the number of radiographs 
taken (Booth et al, 1998), and removing the anti-scatter grid during the fluoroscopic 
parts of the examination (Seymour, 1997; Lloyd et al, 1998). Each of these methods is 
associated with a reduction in the number or quality of the images available to the 
operator and/or reporting clinician. 
The use of copper filtration in addition to the existing aluminium has been 
recommended by Geleijns et al (1997), Hansson et al (1997), Kohn et al (1988), and 
Pärtan et al (2000). A recent survey of hospitals in the West of Scotland found that 
units employing copper filtration were associated with some of the lowest mean DAPs 
(Martin, 2004). 
Chapter 7  Barium Enema Dose Reduction 135
 Publication Sample 
Size 
DAP 
(Gycm
2
)
Fluoroscopy 
Time (min) 
Number of 
Radiographs 
Horton et al (1992) 50 10.4 0.9 11 
Smiddy et al (1996)  < 20 13.7 -- 10 
Pärtan et al (2000) 36 14.1 2.3 15 
Hart & Wall (1994) 19 15.0 -- 8.4 
Martin (2004) 563 15.2 2.2 12.9 
Hetherington et al (1998) 5687 17.2 2.2 11 
Broadhead et al (1995) 5150 17.4 2.8 9.5 
Hart & Wall (1995) 18 18.3 3.4 10.4 
Crawley et al (1998) 1020 18.9 -- -- 
Geleijns et al (1997) 1733 21.0 -- -- 
Hart et al (2002)
* 
49967 23.5 2.2 4

Hart et al (1996)
* 
14545 25.8 2.3 10 
Lampinen & Rannikko (1999) 89 27.8 3.0 11.2 
Warren-Forward et al (1998) 1374 29.2 1.9 7.7 
Martin & Hunter (1994) 503 30.8 2.1 10.3 
Carroll & Brennan (2003) 151 31.3 -- -- 
Yakoumakis et al (1999) 22 35.4 6.4 7.3 
Calzado et al (1991) 124 48.9 3.9 9.5 
Kemerink et al (2001) 150 51 9.7 16 
Ruiz-Cruces et al (2000) 42 56.8 3.8 7.7 
Delichas et al (2004) 42 60.6 3.4 10 
Table 7.1: Mean DAP, fluoroscopy time and number of radiographs from published surveys, presented in order of 
increasing DAP. The studies marked with a * are national dose surveys carried out in the UK by the National 
Radiological Protection Board (NRPB).  The mean number of radiographs quoted for the most recent NRPB survey 
() refers only to screen-film radiographs. The majority of hospitals surveyed obtained at least some of their images 
using a digital spot device. 
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 7.1.3 Objectives 
The objectives of the study were: 
x To perform a survey of barium enema practice at Nottingham City Hospital, to 
establish the local imaging protocol, to obtain baseline patient radiation dose 
measurements, and to compare local practice with published studies; 
x To identify potential opportunities for dose reduction, and to investigate their 
suitability for, and effectiveness in, the clinical environment. 
7.2 Method 
7.2.1 Baseline Survey 
The survey was carried out in a dedicated examination room, the main components of 
radiographic equipment being a Philips Super 80 CP generator, with a Philips 
Scopomatic 66 image intensifier, a Philips SRO 25 50 under-couch X-ray tube and a 
Philips SRO 33 100 over-couch X-ray tube (Philips Medical Systems, Best, The 
Netherlands). For the conventional radiographs, Fuji Super HR-L 30 film (Fuji Photo 
Film Co. Ltd., Tokyo, Japan) was used in conjunction with Kodak Lanex Fast screen 
cassettes (Eastman Kodak Company, Rochester, New York). The films were 
processed in a Kodak X-OMAT M6B processor, with Photosol developer and fixer 
(Photosol Limited, Basildon, UK). All of the imaging equipment was subject to 
regular quality control checks, as recommended by the Institute of Physics and 
Engineering in Medicine, Report 77 (1997). 
Each X-ray tube was fitted with a VacuDAP 2003 DAP meter (Vacutec, Dresden, 
Germany). These were networked to a computer, using a custom-built node box and 
DAPNet software, both supplied by Southern Scientific (Southern Scientific Ltd., 
Sompting, UK). A barcode reader was used to input the patients identification 
number from the request card, and this was then linked to the DAP for each 
examination. The DAP meters were calibrated to within 5% at 80 kVp, throughout the 
study. 
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 The total filtration provided by each X-ray tube and its housing was 2.5 mm 
aluminium equivalent at 80 kVp. The DAP meters provided a further 0.2 mm 
aluminium equivalent filtration. 
Dose area product data from the under-couch and over-couch X-ray tubes were 
collected for all patients throughout a six-week study period. Additional information 
was collected by questionnaire, and included patient identification number and 
examination date, patient height and weight, total fluoroscopy time, number of digital 
spot and screen-film radiographs. This data was manually transferred into an Excel 
2000 spreadsheet (Microsoft Corporation, Redmond, Washington), and matched with 
the DAP values by means of the patient identification numbers. 
Any records that had not been fully completed on the questionnaire were discarded. In 
a number of cases, the fluoroscopy time recorded by the DAP meter did not match 
that written on the questionnaire, suggesting that the DAP meter had not always been 
started and stopped at the beginning and end of each examination. Any examinations 
showing a discrepancy of more than 20 seconds between the two values were 
excluded from the analysis. Incomplete examinations having fewer than 6 over-couch 
radiographs were also excluded. 
7.2.2 Imaging Protocol 
The examinations were generally performed according to a standard protocol, which 
is described below. At the time of the study, enemas were performed by any of two 
gastrointestinal (GI) consultant radiologists, four specially trained radiographers, and 
several radiology registrars. 
The walls of the large bowel were coated with Polibar barium sulphate suspension 
(E-Z-EM Limited, Bicester, UK). The colon was then inflated with air. During these 
processes, fluoroscopy was performed at intervals, to track the progress of the barium. 
The operator asked the patient to turn over, and tilted the couch as necessary, to 
ensure complete coating of the bowel wall. The exposure factors for fluoroscopy were 
automatically controlled by the imaging unit. 
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 Radiographs were then taken from several projections, in order to obtain a clear view 
of each part of the bowel, unobscured by overlying structures. Figure 7.2 is a 
schematic diagram showing the various regions of the large bowel. 
 
Figure 7.2: Diagram of large bowel. (Reproduced with permission, from http://www.training.seer.cancer.gov; 
funded by the U.S. National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program, via 
contract number N01-CN-67006, with Emory University, Atlanta SEER Cancer Registry, Atlanta, Georgia, 
U.S.A.) 
Digital spot images were taken using the image intensifier, and printed to film. The 
exposure factors were automatically determined. The following four images were 
taken as standard: 
x Left posterior oblique (LPO) view of sigmoid colon 
x Posteroanterior (PA) view of splenic flexure 
x Posteroanterior (PA) view of hepatic flexure 
x Right lateral (RLAT) view of caecum and rectum 
Additional spot images were taken if the operator considered visualisation of any part 
of the bowel to be inadequate. 
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 Six standard screen-film radiographs of the abdomen were then taken using the over-
couch tube. These views were: 
x 1 x Prone 
x 1 x 30O cranial angled prone 
x 2 x 30O anterior oblique, one from each side 
x 2 x decubitus films, one with the patient lying on their right side, and one on 
their left side. 
The screen-film radiographs were taken at 96 kVp, unless the patient was particularly 
large, in which case this was increased to 102 kVp. An automatic exposure control 
device was used to control the tube current and exposure time for the prone and 
anterior oblique views. For the decubitus films, the exposure factors were selected 
manually, using the values from the previous exposures as a guide. A compensation 
filter was often used for the decubitus films. 
7.2.3 Dose Modelling 
Patient entrance skin dose is known to vary approximately exponentially with the 
thickness of the patient. In order to predict the effects of dose reduction techniques, 
patients were modelled as uniform cylinders of density 1 g/cm
3
, as described by 
Chapple et al (1995). An equivalent diameter de in centimetres was calculated for 
each patient, using Equation 7.1, where weight is the patients weight in kilograms 
and height is the patients height in centimetres. 
height
weight
d e u
u S
1000
2  
Equation 7.1 
The validity of this model was checked by plotting the natural logarithm of the dose-
area-product against equivalent diameter, for each of the patients in the baseline 
survey, and calculating the Pearson correlation coefficient between the two quantities. 
Entrance surface doses for fluoroscopic, digital spot and screen-film exposures were 
determined using 34 cm by 34 cm Perspex phantoms, ranging in thickness from 18 cm 
to 28 cm, to match the spread of patient equivalent diameters. All dose measurements 
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 were performed using a calibrated Radcal 9010 dose meter, with a 60 cc ionisation 
chamber (Radcal Corporation, Monrovia, California). 
For the under-couch exposures (fluoroscopy and digital spot images), the ionisation 
chamber was placed directly on the couch, with the Perspex supported 2cm above the 
couch as shown in Figure 7.3. The explorator was positioned at its maximum height. 
Phantom entrance surface doses for digital spot imaging and dose rates for 
fluoroscopy were measured for both of the field sizes in clinical use (10 inch and 14 
inch diameter).  
Explorator
2 cm 
Perspex
Ionisation 
Chamber
X-ray Tube
Couch
Image 
Intensifier
Cassette 
Carriage
Perspex 
Phantom
98 cm
52 cm
 
Figure 7.3: Set-up for under-couch phantom exposures. 
The DAP (in Gycm
2
) associated with each digital spot exposure or each minute of 
fluoroscopy was then calculated, using Equation 7.2, where Dose was the measured 
dose in Gray, and FieldSize was the nominal field size at the detector, in square 
centimetres. The factor of 1.3 was included to remove the contribution from 
backscatter, and the squared term adjusted the field size to that at the dose measuring 
point. 
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Equation 7.2 
For the over-couch (screen-film) exposures, the ionisation chamber was positioned on 
top of the Perspex (Figure 7.4). The distance between the focal spot and the exit 
surface of the Perspex was 100 cm. The field size was set to 30 cm x 40 cm at one 
metre, since 35 cm x 45 cm films were generally used for screen-film radiographs.  
Couch
Perspex 
Phantom
X-ray Tube
100 cm
Ionisation 
Chamber
 
Figure 7.4: Set-up for over-couch phantom exposures. 
The DAP for each exposure (in Gycm
2
) was calculated using Equation 7.3, where 
Dose was the measured dose in Gray, and P was the Perspex thickness in centimetres. 
The factor of 1.3 was included to remove the contribution from backscatter, and the 
squared term adjusted the field size to that at the dose measuring point.  
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Equation 7.3 
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 For each imaging mode and field size, the natural logarithm of the DAP or DAP rate 
was plotted against Perspex thickness. Regression lines were fitted to the data, and the 
gradient and intercept of each was calculated. These were then combined with each 
patients equivalent diameter, fluoroscopy time and number of radiographs of each 
type, to calculate a predicted DAP for each examination, as described in Section 
7.3.2. The results of the phantom measurements were also used to estimate the 
contribution of each part of the examination to the total DAP, for a typical procedure. 
7.2.4 Dose Reduction 
Several options for dose reduction were considered, in the light of the baseline survey 
and dose modelling results. These were discussed at a joint meeting with the local 
Radiation Protection Adviser, one of the gastrointestinal (GI) consultant radiologists, 
and the superintendent radiographer responsible for barium studies. It was assumed 
that all operators were already following good practice in terms of radiation protection 
measures such as collimating the radiation beam to the area of interest, and 
positioning the image intensifier close to the patient. The options considered were: 
Reducing the fluoroscopy time. Horton et al (1992) reduced patient doses by 
minimising the use of fluoroscopy during the barium filling phase. The GI consultant 
radiologist involved in the present study considered fluoroscopy in this early part of 
the examination to yield important diagnostic information, and was concerned that 
any substantial reduction in fluoroscopy time could compromise the diagnostic 
accuracy of the examination. 
Reducing the number of images taken. Again, the GI consultant radiologist was 
concerned that reducing the number of views would result in loss of diagnostic 
information. Whilst a smaller image set would be sufficient in some cases, the 
benefits of procedural standardisation were thought to offset those of this small dose 
reduction. The use of a standard imaging protocol was thought to encourage 
consistency of practice among the various staff groups who perform enemas, improve 
the accuracy and speed of reporting, and facilitate teaching, audit and research. 
Exchanging some screen-film radiographs for digital spot images. The dose area 
product from a typical screen-film radiograph was found to be about 33% greater than 
that from a typical digital spot image (Table 7.4). It was therefore proposed that more 
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 of the radiographs could be taken using the digital spot device. However, this used a 
circular field of view, with a maximum diameter of only 14 inches (i.e. 35 cm). 
Compared to a rectangular 43 cm x 35 cm film cassette, coverage was less well 
matched to the shape of the colon. Thus, it seemed likely that more digital spot images 
would be required to cover the same field of view as the screen-film cassette, making 
this unlikely to be a viable method for dose reduction. 
Changing from screen-film to computed radiography (CR). This was unlikely to 
allow a dose reduction, as the screen-film system in use had a nominal speed of 
around 600, whereas the local CR system needed to run at an equivalent of 400 speed 
in order to obtain images with the same noise level. There was also a practical reason 
against using CR, in that the reader in use at the time took several minutes to process 
each plate when they were loaded in rapid succession. This would increase the 
examination time, adding to the patients discomfort and potentially reducing patient 
throughput. 
Using additional beam filtration. This method was chosen, since it would routinely 
reduce doses for all patients, without cutting down on the number of views available 
to the operator or reporting clinician, and whilst maintaining standardisation of the 
imaging protocol. Increasing the beam filtration can have a detrimental effect on 
image contrast, so it was necessary to verify that it would not adversely affect the 
diagnostic quality of the images. 
Entrance surface doses and dose rates to Perspex slabs of various thickness were re-
measured for fluoroscopic and digital spot exposures, with an additional 0.1 mm 
copper filtration.  
The effect of this additional filtration on fluoroscopic image contrast was determined 
using a Leeds TO.10 contrast detail test object (Leeds Test Objects Limited, 
Boroughbridge, UK). The test object was positioned inside the cassette carriage, and 
the explorator locked at its maximum height. A 1.5 mm copper plate was placed on 
the couch, such that it completely intercepted the X-ray beam. Fluoroscopic images 
obtained with and without the additional 0.1 mm copper filtration were scored by two 
independent observers, and their scores averaged. Threshold contrasts relating to the 
mean observer scores were determined using the Leeds test object manual (Cowen et 
al, 1992), and a contrast detail diagram was plotted. 
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 The additional filtration was then introduced into clinical practice by selecting the 
appropriate filter setting on each X-ray tube. This consisted of 0.1 mm copper, along 
with 1.0 mm aluminium, to absorb the low energy emissions from the copper. The 
patient dose survey was repeated, as described in Section 7.2.1. 
7.3 Results 
7.3.1 Baseline Survey 
Table 7.2 summarises the results of the baseline survey. Complete data sets were 
obtained for 59 patients. The mean patient weight was 69 kg. 
Measured Parameter Mean (95% CI) Median 
Fluoroscopy Time (minutes) 1.8 (1.6  2.0) 1.6 
Number of Digital Spot Images 4.6 (4.4  4.9) 4.0 
Number of Screen-Film Radiographs 6.0 6.0 
Under-Couch DAP (Gycm
2
) 12.0 (10.4  13.9) 9.5 
Over-Couch DAP (Gycm
2
) 5.7 (5.0  6.6) 5.2 
Total DAP (Gycm
2
) 17.7 (15.6 - 20.3) 15.3 
Table 7.2: Summary of baseline survey results. The ranges shown in brackets indicate 95% confidence intervals, 
calculated using Coxs method. 
Exactly six over-couch radiographs were taken for all examinations. Each of 
fluoroscopy time, number of digital spot images, under-couch, over-couch and total 
DAP followed log-normal distributions. The 95% confidence intervals were therefore 
calculated using Coxs method (Zhou & Gao, 1997). The upper and lower confidence 
limits for parameter x were defined by Equation 7.4, where P denotes the mean of the 
bracketed function, V the standard deviation, and n the sample size. 
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Figure 7.5 is a frequency histogram of total DAP. Its long right-hand tail is 
characteristic of a log-normal distribution.  
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Figure 7.5: Frequency histogram of total DAP. 
7.3.2 Dose Modelling 
Figure 7.6 is a scatter plot of ln(DAP) against patient equivalent diameter. A 
regression line has been fitted. The square of the Pearson correlation coefficient (R
2
) 
was 0.43, implying that variations in patient diameter accounted for 43% of the 
variations in ln(DAP). 
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Figure 7.6: Ln(DAP) versus patient equivalent diameter. 
Figure 7.7 and Figure 7.8 show the relationship between the natural logarithm of DAP 
or DAP rate, and Perspex thickness, for each imaging mode and field size 
investigated. Regression lines were fitted to this data, and their gradients and 
intercepts are shown in Table 7.3. The final column of the table shows the equations 
used to calculate predicted DAP contributions for each imaging mode and field size. 
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Figure 7.7: Relationship between ln(DAP rate) and Perspex thickness, for fluoroscopy. 
Chapter 7  Barium Enema Dose Reduction 147
  
-2.0
-1.5
-1.0
-0.5
0.0
0.5
1.0
16 18 20 22 24 26 28 30
Perspex Thickness (cm)
L
n
(D
A
P
) 
(G
y
c
m
2
)
Digital Spot (14 inch)
Digital Spot (10 inch)
Screen-Film Radiograph
 
Figure 7.8: Relationship between ln(DAP) and Perspex thickness, for digital spot and screen-film radiographs. 
 
Imaging Mode & Field Size Gradient 
(a) 
Intercept 
(b) 
Contribution to Total 
DAP (Gycm
2
) 
Fluoroscopy (14 inch) 0.129 -0.86  bdaFT e uuu exp
2
1
 
Fluoroscopy (10 inch) 0.129 -1.20  bdaFT e uuu exp
2
1
 
Digital Spot (14 inch) 0.143 -3.55  bdaDSI e uuu exp
2
1
 
Digital Spot (10 inch) 0.149 -4.02  bdaDSI e uuu exp
2
1
 
Screen-Film Radiograph 0.170 -4.03  bdaSFR e uu exp  
Table 7.3: Gradients and intercepts of regression lines relating ln(DAP) or ln(DAP rate) to Perspex thickness, for 
each imaging mode and field size. The equations in the final column show how the DAP contribution of each field 
size and mode was calculated, for a patient of equivalent diameter de undergoing FT minutes of fluoroscopy, 
followed by DSI digital spot images and SFR screen-film radiographs. It was assumed that the 10 and 14 inch field 
sizes were each used for half of the fluoroscopy and half of the digital spot images. 
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 The predicted and measured dose area products for each examination are shown in 
Figure 7.9. There was a strong correlation between the two, with a squared Pearson 
correlation coefficient of 0.77. The mean predicted DAP was 21.4 Gycm
2
. 
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Figure 7.9: Predicted DAP versus measured DAP, for the examinations in the baseline survey. 
Table 7.4 shows the measured and predicted contributions of each part of the 
examination to the total DAP. The measured contributions were based on the mean 
DAP values listed in Table 7.2. The predicted contributions were calculated using the 
equations in Table 7.3, with an equivalent diameter of 24 cm, and the median values 
of fluoroscopy time and numbers of radiographs quoted in Table 7.2. 
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 Component of Examination Measured DAP 
Contribution (%) 
Predicted DAP 
Contribution (%) 
Fluoroscopy 58 
Digital Spot Images }     68 14 
Screen-Film Radiographs 32 28 
Total 100 100 
Table 7.4: Measured and predicted contributions of each part of the examination to total DAP. 
7.3.3 Dose Reduction 
On adding 0.1 mm copper filtration, fluoroscopic entrance dose rates and digital spot 
doses to the 24 cm Perspex phantom were reduced by 34%. 
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Figure 7.10: Contrast detail diagram for mean TO.10 scores with and without additional 0.1 mm copper filtration. 
Error bars indicate standard errors of 11% indicated by Marshall et al (1992). 
Figure 7.10 shows the contrast detail diagram for the TO.10 image scores with and 
without an additional 0.1 mm copper. The error bars show the standard error of 11% 
indicated by Marshall et al (1992), for one independent viewing by each of two 
independent observers. At each detail size, individual observer scores varied by up to 
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 1 disc from the mean. On introducing the 0.1 mm copper filter, there was no 
difference in mean observer scores for the larger discs. At two of the smallest detail 
sizes, one fewer disc was seen, indicating slightly higher threshold contrast. 
The repeat dose survey included 428 examinations. The mean patient weight was 71 
kg. A summary of the fluoroscopy times, numbers of images and dose area product 
data is shown in Table 7.5. The 95% confidence intervals were calculated using Coxs 
method (Zhou & Gao, 1997). No change in clinical image quality was observed by the 
operators performing or reporting the examinations. 
Measured Parameter Mean (95% CI) Median 
Fluoroscopy time (minutes) 1.7 (1.6  1.8) 1.5 
Number of Digital Spot Images 4.9 (4.7  5.0) 4.0 
Number of Screen-Film Radiographs 6.1 6.0 
Under-Couch DAP (Gycm
2
) 7.1 (6.7  7.4) 6.1 
Over-Couch DAP (Gycm
2
) 4.1 (3.8-4.4) 3.3 
Total DAP (Gycm
2
) 11.2 (10.6  11.7) 9.6 
Table 7.5: Summary of the results of the repeat dose survey, using 0.1 mm copper additional filtration. The 
ranges shown in brackets indicate 95% confidence intervals, calculated using Coxs method. 
7.4 Discussion 
7.4.1 Baseline Survey 
The baseline survey found a mean dose-area-product of 17.7 Gycm
2
, with a 95% 
confidence interval of 15.6 to 20.3 Gycm
2
. This was considerably lower than many of 
the published values presented in Table 7.1, and the UK national reference dose of 31 
Gycm
2
 (Hart et al, 2002). 
Only five of the studies in Table 7.1 had demonstrated mean DAPs below the lower 
95% confidence limit, and these were generally at centres where radical dose 
reduction measures had been applied. Horton et al (1992) had minimised the use of 
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 fluoroscopy during the barium filling phase, Smiddy et al (1996) had adopted a very 
low fluoroscopic current, and Pärtan et al (2000) had introduced 0.3 mm copper 
filtration. Martin (2004) had included a number of new facilities, which had dose 
minimisation features such as low dose rate pulsed fluoroscopy and copper filtration. 
The fact that other investigators had used such techniques to reduce their mean DAPs 
below that found in the baseline survey suggested that there was also potential for 
dose reduction at Nottingham City Hospital. 
The mean fluoroscopy time of 1.8 minutes was relatively short, compared with most 
of the studies reported in Table 7.1 This may be one reason for the relatively low 
mean DAP found in the present study. 
The mean number of radiographs was 10.6. This corresponded fairly closely with the 
national mean of 10 radiographs found in the NRPB dose survey of 1990 to 1995 
(Hart et al, 1996). The value quoted in the NRPBs 2000 review (Hart et al, 2002) 
included only screen-film radiographs, although most of the hospitals surveyed used 
digital spot imaging for at least some views. It was therefore not valid to compare 
total numbers of radiographs with this figure. 
The mean patient weight of 69 kg exactly matched that for adult barium enema 
patients in the 2000 review of the NRPB national dose survey (Hart et al, 2002). 
7.4.2 Dose Modelling 
The strength of the correlation between ln(DAP) and patient equivalent diameter 
suggested that the cylinder model should offer a fairly realistic approach to predicting 
the effectiveness of dose reduction techniques. This was confirmed by the strong 
correlation between measured and predicted dose area products for the examinations 
in the baseline survey. The mean predicted DAP was 21.4 Gycm
2
, which was 21% 
higher than the measured value of 17.7 Gycm
2
. The cylinder model tends to 
overestimate the radiation path length through the patient for anteroposterior (AP) and 
posteroanterior (PA) views, and underestimate it for lateral and oblique views. The 
fact that mean predicted DAP was higher than mean measured DAP may be explained 
by the fact that more AP and PA views than laterals and obliques were used in clinical 
practice. 
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 According to the dose model, fluoroscopy accounted for 58% of the total DAP for a 
typical examination. The six screen-film radiographs contributed a further 28%, and 
the four digital spot images only 14%. Thus, on average, the DAP for each screen-
film radiograph was 1.33 times that for a digital spot image. The predicted under-
couch and over-couch DAP contributions compared well with the mean values from 
the baseline survey. 
7.4.3 Dose Reduction 
The method chosen for dose reduction was the addition of 0.1 mm copper filtration to 
the under-couch and over-couch X-ray tubes. This allowed the existing imaging 
protocol to be maintained, without any loss in the number of images available to the 
operator or to the reporting clinician. 
Entrance dose and dose rate measurements to a 24 cm Perspex phantom, representing 
patients of median size, predicted a 34% reduction in DAP, on adding 0.1 mm copper 
to the existing filtration of 2.5 mm aluminium. The only observed differences in 
contrast detail detectability were reductions in visibility of 1 disc for two of the 
smallest detail sizes. This was no greater than the inter-observer variation in scores. 
Thus, it seemed reasonable to expect that there would be no perceptible difference in 
clinical image quality.  
After selecting the 0.1 mm copper filters on both X-ray tubes, the mean DAP for 
patient examinations fell to 11.2 Gycm
2
. This was a reduction of 37%, in good 
agreement with the phantom predictions. The reduction in DAP was statistically 
significant, since the 95% confidence intervals with and without 0.1 mm copper did 
not overlap. The mean fluoroscopy time and number of radiographs of each type were 
not significantly different from those measured in the baseline survey, indicating that 
the reduction in DAP was attributable mainly to the introduction of the copper. The 
new mean DAP was lower than almost all of the published values listed in Table 7.1. 
A formal study of clinical image quality was not carried out at this stage, but the GI 
consultant radiologist was confident that there was no difference in the appearance of 
the clinical images, and no changes were reported by any of the other staff who 
perform or report barium enemas.  
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 The option of changing from screen-film imaging to computed radiography (CR) was 
rejected, as it would require an increase in patient dose. However, as a result of the 
national PACS (Picture Archiving and Communications Systems) programme, the 
Radiology department is likely to go filmless in the near future, making the switch 
to CR a necessity. In the longer-term future, film, CR and image intensifiers are all 
likely to be replaced by direct digital detectors. These have been shown to be more 
efficient than screen-film systems (Strotzer et al, 1998a; Strotzer et al, 1998b; 
Aufrichtig, 1999; Strotzer et al, 2000; Volk et al, 2000; Ludwig et al, 2002; Geijer, 
2002). Whilst current flat detector technology offers only slightly improved efficiency 
relative to image intensifiers, future developments are likely to bring further 
improvements in their performance. The eventual move to direct digital imaging 
should therefore provide a further opportunity for dose reduction. 
Although selective removal of the anti-scatter grid was not considered in this study, it 
may offer a feasible method for further dose reduction. Its success would depend on 
individual operators being disciplined about removing and replacing the grid as each 
examination progressed. 
7.5 Summary 
The baseline survey found a relatively low mean DAP of 17.7 Gycm
2
. This was due at 
least in part to the short mean fluoroscopy time of 1.8 minutes. The literature survey 
highlighted several dose reduction methods that had been successfully employed at 
other hospitals. This suggested that there was also potential for local dose reduction. 
In order to select Perspex phantoms suitable to the size of the patients in the sample, 
patients were modelled as uniform cylinders with an equivalent diameter calculated 
from their height and weight. The dose contributions from the fluoroscopic, digital 
spot and screen-film exposures were determined using Perspex phantoms of varying 
thickness. There was a strong correlation between predicted and measured DAP, for 
the examinations in the baseline survey. The predicted under-couch and over-couch 
DAP contributions were found to compare well with measured values. 
Several dose reduction methods were considered, in consultation with clinical staff. 
These included reducing the fluoroscopy time or the number of images taken, 
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 exchanging some of the screen-film radiographs for digital spot images, changing 
from screen-film to computed radiography for the over-couch views, and introducing 
additional beam filtration. The use of copper filtration was chosen, as allowing routine 
dose reductions for all patients, without requiring any change to the standardised 
imaging protocol. 
The effects of adding 0.1 mm copper filtration were predicted using entrance dose 
measurements to Perspex phantoms, and contrast detail tests. The reduction in 
entrance doses and dose rates to a 24 cm phantom was 34%. There was no measurable 
change in detectability of the details in the Leeds TO.10 test object. 
On introducing the 0.1 mm copper filter in clinical practice, the mean DAP fell by 
37% to 11.2 Gycm
2
. The operators reported no difference in the quality of the clinical 
images. Thus, copper filtration was shown to be a practical and effective method of 
dose reduction in barium enema imaging. 
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 Chapter 8 -  Barium Enema 
Optimisation 
8.1 Introduction 
This chapter describes the second part of the barium enema study. Here, the aim was 
to determine the optimal quantity of copper for barium enema examinations, i.e. that 
which would reduce patient doses as far as practicable without compromising 
diagnostic accuracy. 
A brief literature review considers copper thicknesses used by other investigators, and 
summarises their approaches to image quality assessment. 
The effects of various copper filters on dose and image quality were predicted using 
Perspex phantoms and a contrast detail test object, and the optimal copper thickness 
chosen. The effects of the additional filtration on X-ray tube loading were considered, 
and compared with the tube heat capacities and cooling rates, to ensure that neither 
tube would be in danger of overheating. 
The new filter was then introduced in the clinical setting, and the dose survey of 
Chapter 7 repeated. Clinical images obtained with the old and new filter settings were 
compared by means of visual grading analysis. The diagnostic adequacy of each 
examination was assessed by an experienced radiologist. Since the risk of radiation-
induced cancer is related more closely to effective dose than to DAP, typical effective 
doses were estimated for each of the filter settings. 
8.1.1 Literature Review 
Of those authors who have recommended the use of copper filtration for double 
contrast barium enemas, Geleijns et al (1997) recommended using at least 0.1 mm, 
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 whilst Kohn et al (1988) considered 0.2 mm to give acceptable image quality. 
Hansson et al (1997) successfully employed 0.3 mm for paediatric patients, and 
Pärtan et al (2000) reported using 0.3 mm for adults. Despite the considerable promise 
shown by this technique, at the time of the present study there were no reports of its 
adoption by UK radiology departments. After completion of this work, Martin (2004) 
reported the use of 0.2 mm copper in some Scottish hospitals. 
When introducing changes in imaging practice that have potential to affect image 
quality, it is essential to investigate the likely extent of these effects, and to ensure that 
the resulting images remain adequate for their clinical purpose. Initial estimates can 
and should be made using contrast detail phantoms. However, a rigorous assessment 
of changes in clinical image quality should also be made. 
Several investigators have compared clinical image quality for barium enemas using 
visual grading analysis. Hansson et al (1997) performed direct comparisons between 
paired images taken with and without a 0.3 mm copper filter, whilst Smiddy et al 
(1996), Persliden et al (1997) and Pärtan et al (2000) scored individual images on 
five-point quality scales. In these last two studies, observers were asked to give scores 
for noise, sharpness and contrast as well as their overall impression.  
The approach taken by Hansson et al (1997) had the great advantage that the two filter 
options could be compared directly for almost identical views of the same patient, 
eliminating other factors that might affect image quality. However, only one view was 
considered instead of the examination as a whole, and there was a slightly increased 
radiation burden to the patients involved in the trial. 
Hansson et al (1997) studied only paediatric patients, so their results were not 
necessarily generalizable to adults, where the filter may have a greater effect on 
contrast and noise, due to the larger average patient size. Pärtan et al (2000) studied 
adult patients, and concluded that 0.3 mm copper filtration was appropriate for the 
imaging equipment and protocol used at their facility. They did however recommend 
that each department determine their own optimal filter thickness, since the exact 
effects of the filtration on image quality depend on the performance of each piece of 
imaging equipment, and the exposure factors used in the clinical setting. 
In order to assess whether the images remained adequate for their clinical purpose, 
Persliden et al (1997) simply asked the observers whether they were confident to give 
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 a diagnosis based upon what they could see. Horton et al (1992) backed up observer 
opinion with an outcomes audit, performed 11 months after the original study. 
8.1.2 Objectives 
The objectives of this study were: 
x To determine the optimal thickness of copper filtration for adult barium enema 
examinations, with regard to its dose reduction efficiency, its likely effects on 
image quality, and the increased load on the X-ray tubes; 
x To verify the effect of this optimal filter on patient DAP and whole body 
radiation dose; 
x To ensure that its use did not compromise the diagnostic quality of the clinical 
images. 
8.2 Method 
This study used the same imaging equipment as described in Chapter 7. 
8.2.1 Phantom Measurements 
The effects of various copper filters on fluoroscopic dose rates and digital spot doses 
to the entrance surface of a Perspex phantom and to the image intensifier were 
measured concurrently, using two calibrated Radcal 9010 dose meters with 60 cc 
ionisation chambers (Radcal Corporation, Monrovia, California), as shown in Figure 
8.1. The first ionisation chamber was placed directly on the couch, and the second was 
taped to the underside of the cassette carriage. The Perspex was supported 2cm above 
the couch, and the explorator was positioned 5 cm above the Perspex. 
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Figure 8.1: Set-up for under-couch phantom exposures. 
The effect of each copper filter on entrance dose for over-couch exposures was 
measured using a single ionisation chamber positioned on top of the Perspex, with the 
distance from the focal spot to the Perspex exit surface set to 100 cm, as previously 
described in Chapter 7. 
The thickness of the copper filter was varied from 0.0 to 0.7 mm, with a Perspex 
thickness of 24 cm, chosen to represent patients of median diameter. Copper filters 
varying from 0.1 to 0.3 mm in thickness were also applied with phantoms ranging 
from 24 to 30 cm. As well as measuring doses and dose rates to the phantom and 
detector, tube potential and current or current-time product were noted for each 
exposure. 
Fluoroscopic image contrast was assessed using a Leeds TO.10 contrast detail test 
object (Leeds Test Objects Limited, Boroughbridge, UK), with a range of copper and 
Perspex thicknesses. The test object was positioned in the cassette carriage, and the 
explorator locked at its maximum height. Live fluoroscopic images were scored by 
two independent observers, who were blinded to the amount of copper and Perspex. In 
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 order to provide a single index of overall image quality, the number of visible details 
was summed over all the rows in the phantom. 
8.2.2 Tube Loading  
The heat generated in each of the X-ray tubes was estimated for a typical examination 
on a median sized patient, with and without the 0.3 mm copper filter in place. The 
heat (in Joules) generated in a standard medical X-ray tube is given by Equation 8.1, 
where kVp is the X-ray tube potential, mA is the tube current, and t is the exposure 
time (Dendy & Heaton, 1999). These exposure factors had previously been noted for 
fluoroscopic, digital spot and screen-film exposures of a 24 cm Perspex phantom. 
tmAkVpHeat uuu 95.0  
Equation 8.1 
Each examination was assumed to consist of 2 minutes of fluoroscopy, 5 digital spot 
exposures and six over-couch radiographs. For the under-couch exposures, it was 
assumed that the 10 inch field size was used throughout, with the image intensifier 5 
cm above the patient.  
The heating effects of a full days workload were compared with the heat capacities 
and cooling rates of each X-ray tube, as taken from the manufacturers specifications. 
A full days examination schedule included 12 patients. Each day was divided into 
three sessions, starting at 09:00, 11:00 and 14:00. Four patients were booked in each 
session, at fifteen-minute intervals. 
8.2.3 Clinical Validation 
Copper filters of 0.3 mm in thickness were then introduced as a clinical service 
development. The first 0.1 mm copper was selected on the filter wheel inside the 
housing of each X-ray tube, along with its accompanying 1 mm aluminium. A further 
0.2 mm copper were mounted between each X-ray tube and its DAP meter. For the 
under-couch tube, the copper was taped directly to the underside of the DAP meter. 
This was not possible for the over-couch tube, since the copper blocked the light beam 
used for setting X-ray field alignment and collimation. The copper was therefore 
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 taped to a thin sheet of Perspex, so that it could be slid in and out of the beam as 
required. The patient dose survey described in Chapter 7 was then repeated for a 
further 24 examinations. 
Whilst phantom measurements had shown little degradation in contrast on introducing 
0.3 mm copper filtration, the circular contrast details in the TO.10 test object offered a 
poor approximation to the clinical situation, where the subject of interest was a thin 
coat of contrast agent lining the intestinal wall. It was therefore important to verify 
that there was no significant effect on the diagnostic quality of clinical examinations. 
A visual grading analysis study was performed on the digital spot and screen-film 
radiographs for 20 examinations performed with no additional filtration, 21 with 0.1 
mm copper, and 21 with the 0.3mm copper filter. Examinations were selected 
sequentially. Those with fewer than six screen-film radiographs were excluded from 
the study. The images were retrieved from the film archive and randomised, before 
being presented to a gastrointestinal (GI) consultant radiologist for blinded scoring. 
Images were scored on a scale of 0 to 3 for perceived barium coating, where 0 
corresponded to no coating, 1 to poor, 2 to fair and 3 to good. For each 
examination, the sigmoid colon, splenic flexure and hepatic flexure were each 
allocated a score based on the digital spot images. The left colon, right colon and 
transverse colon were each allocated a score based on the screen-film radiographs. 
The scorer was also asked to suggest reasons for any scores below 3, and to classify 
each examination as diagnostic, non-diagnostic or indeterminate. 
The image quality scores for each filter combination were compared for each region 
of the bowel, using Kruskal-Wallis one-way analysis of variance by ranks (Siegel & 
Castellan, 1988). This is a powerful non-parametric test for k independent samples of 
ordinal data. A correction for tied rankings was applied. The null hypothesis was that 
of no statistically significant difference between the populations from which the three 
samples were drawn. 
In order to confirm the results, Wilcoxon-Mann-Whitney and Kolmogorov-Smirnov 
tests (Siegel & Castellan, 1988) were also performed for the samples with most and 
least filtration. These tests were chosen because they are the most powerful for two 
independent samples of ordinal data. 
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 8.2.4 Effective Doses 
Effective doses for each of the three filter settings were estimated using PCXMC 
version 1.4, a PC-based Monte-Carlo dosimetry package (Finnish Centre for 
Radiation and Nuclear Safety, Helsinki, Finland). The calculations were based on the 
standard imaging protocol described in Chapter 7, with the median fluoroscopy time 
of 1.6 minutes from the baseline survey. The exposure factors and entrance surface 
doses for each component of the examination were determined from measurements on 
a 24 cm Perspex phantom, described in section 8.2.1. All entrance surface dose 
measurements were divided by 1.3, to remove the contribution from backscatter. 
The standard adult phantom, with a height of 174 cm and a weight of 71.1 kg, was 
selected. The under-couch, circular radiation fields were approximated by square 
fields of equal area. It was assumed that the fluoroscopic projections and field sizes 
matched those used for digital spot images, and were used in the same proportion. The 
effect of the compensation filter for decubitus views was not taken into account. 
Each exposure was simulated using 15 energy levels, with 20,000 photons in each 
level. The effective doses from the individual exposures were then summed, to give 
estimates for the whole examination. 
8.3 Results 
8.3.1 Phantom Measurements 
Figure 8.2 shows the fluoroscopic entrance surface dose rates to a 24 cm Perspex 
phantom, with varying amounts of copper filtration, at the two field sizes used in 
clinical practice. The first 0.1 mm copper reduced the entrance dose rate by 34% for 
both field sizes, and each additional 0.1 mm gave a sequentially smaller dose 
reduction. Similar dose reductions were also obtained for digital spot, and 
conventional radiographic exposures. 
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Figure 8.2: Fluoroscopic entrance surface dose rates to a 24 cm Perspex phantom, with various copper filters, at 
the 14 inch and 10 inch field sizes. (Error bars indicate 4% uncertainty in calibration of dose meter.) 
Figure 8.3 shows the corresponding X-ray tube potentials for fluoroscopy. Tube 
potential increased steadily with increasing filtration, but did not reach its maximum 
value of 110 kV. 
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Figure 8.3: X-ray tube potentials for fluoroscopic exposure of a 24 cm Perspex phantom, with various copper 
filters, at the 14 inch and 10 inch field sizes. The tube potential was automatically controlled, and its maximum 
permissible value was 110 kV. 
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 When thicker phantoms were imaged, the tube potential and current saturated as 
copper was added. Once they had reached their maximum values, any increase in 
beam attenuation led to a reduction in input dose rate to the image intensifier. Table 
8.1 shows the thickness of Perspex at which the exposure factors saturated, for each 
copper filter, at the 10 inch field size. It also shows the percentage of patients in the 
surveys of Chapter 7 whose equivalent diameters exceeded each thickness, and for 
whom saturation was therefore likely to occur. 
Copper 
(mm) 
Perspex Thickness at which 
Exposure Factors Saturated (cm) 
Patients for whom Saturation 
Expected to Occur (%) 
0 27 5 
0.1 26 10 
0.2 26 10 
0.3 25 19 
0.4 24 33 
Table 8.1: Perspex thickness at which saturation occurred on 10 inch field, and the percentage of patients whose 
equivalent diameters exceeded this value, and for whom saturation might therefore be expected to occur. 
Table 8.2 shows the image quality scores for the two observers, at the 10 inch field 
size. On increasing the thickness of the Perspex, fewer details were seen. There was 
however no consistent trend in image scores with changing copper thickness. 
Copper (mm) Perspex 
(cm) 
0.1 0.2 0.3 
24 32, 30 33, 28 33, 32 
26 29, 29 28, 25 31, 27 
28 26, 29 21, 21 25, 20 
30 21, 16 19, 12 19, 21 
Table 8.2: Observer scores for the Leeds TO.10 test object, with varying amounts of copper and Perspex at the 10 
inch field size. (Observer 1, Observer 2.) 
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 On comparing Table 8.1 with Table 8.2, the image quality scores appeared to fall off 
sharply at about 2 cm Perspex beyond factor saturation. Assuming this to be the case 
up to 0.4 mm copper, Table 8.3 displays the Perspex thickness at which image 
contrast was expected to deteriorate, for each copper filter. The percentage of patients 
in the dose surveys of Chapter 7 whose equivalent diameters exceeded each value, 
and for whom contrast degradation was therefore likely to occur, is also shown. 
Copper 
(mm) 
Perspex Thickness at which Image 
Contrast Expected to Deteriorate 
(cm) 
Patients for whom Contrast 
Degradation Likely to Occur 
(%) 
0 29 1 
0.1 28 2 
0.2 28 2 
0.3 27 5 
0.4 26 10 
Table 8.3: Perspex thickness at which image contrast was expected to deteriorate for various copper filters (10 
inch field), and percentage of patients likely to be affected by this. 
8.3.2 Tube Loading 
For the under-couch tube, the heat generated during fluoroscopy and each of the 
digital spot radiographs was summed, to give the total heat load for an examination. 
Without any copper filtration, the exposure factors for a 24 cm Perspex phantom were 
89 kVp and 2.9 mA for fluoroscopy, and 88 kVp and 14 mAs for each digital spot 
image. Thus for two minutes (120 seconds) of fluoroscopy and five digital spot 
images, the heat generated would be 
> @ 35275514881209.28995.00.0,  uuuuu mmCuCUHeat  J, or 35 kJ. 
Equation 8.2 
With 0.3 mm copper filtration, the exposure factors were 98 kVp and 2.9 mA for 
fluoroscopy, and 97 kVp and 14 mAs for each digital spot image. The heat generated 
during each examination was therefore 
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 > @ 38849514971209.29895.03.0,  uuuuu mmCuCUHeat  J, or 39 kJ. 
Equation 8.3 
The heat capacity of the anode was 220 kJ. This was sufficient to absorb all of the 
heat generated by the four examinations in each session. If the examinations were 
performed at fifteen-minute intervals, the average rate of heat generation over a 
session, with the copper filter in place, would be 43 J/s. The maximum anode cooling 
rate of 450 J/s was more than sufficient to dissipate this heat. The tube heat capacity 
of 1250 kJ was more than sufficient to absorb all of the heat generated during the full 
day of twelve examinations, even if there were no significant tube cooling during the 
day.  
The over-couch radiographs were taken at 96 kVp. In the absence of the copper filter, 
the automatic current-time product for exposure of the 24 cm Perspex phantom was 8 
mAs. Thus the heat generated in the tube for the six radiographs in each examination 
was 
4378689695.00.0,  uuu mmCuCOHeat  J, or 4.4 kJ. 
Equation 8.4 
With the 0.3 mm copper filter in place, the current-time product increased to 12 mAs. 
This corresponded to a 50% increase in heat load. The heat generated during all 
twelve examinations in the daily list would be 79 kJ. This was well below the heat 
capacity of the anode, which was 230 kJ. 
On increasing the Perspex thickness from 24 cm to 30 cm, the tube output increased 
by up to 80%. As the anode and tube heat capacities were so far in excess of the 
projected daily heat generation with a 24 cm phantom, neither tube should be at risk 
of overheating, even if all the patients imaged in a day had equivalent diameters of 
around 30 cm. 
8.3.3 Clinical Validation 
Table 8.4 summarises the mean patient equivalent diameter, fluoroscopy time and 
number of digital spot and screen-film radiographs for the clinical surveys performed 
at each filter setting. The equivalent diameters were approximately normally 
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 distributed, so 95% confidence intervals were calculated as r 1.96 standard deviations 
from the mean. The fluoroscopy times and numbers of digital spot images were log-
normally distributed, so 95% confidence intervals were calculated using Coxs 
method (Zhou & Gao, 1997). For each quantity, the confidence intervals overlapped 
for all three branches of the study. 
Copper Patient 
Equivalent 
Diameter (cm) 
Fluoroscopy 
Time (min) 
Number of 
Digital Spot 
Images 
Number of 
Screen-Film 
Radiographs 
0.0 mm 22.9 (19.5-26.3) 1.8 (1.6-2.0) 4.6 (4.4-4.9) 6.0 
0.1 mm 23.3 (19.0-27.5) 1.7 (1.6-1.8) 4.9 (4.7-5.0) 6.1 
0.3 mm 22.4 (18.1-26.7) 1.8 (1.3-2.1) 5.2 (4.5-5.9) 6.0 
Table 8.4: Mean patient equivalent diameter, fluoroscopy time, number of digital spot and screen-film radiographs 
for the clinical studies at each filter setting. The ranges in brackets indicate 95% confidence intervals on the 
means. 
Table 8.5 shows the mean patient DAP for each filter setting, together with the 
percentage reduction in DAP relative to the baseline survey. The 95% confidence 
intervals were calculated using Coxs method (Zhou & Gao, 1997). 
Copper Mean Patient DAP (Gycm
2
) Reduction in DAP (%) 
0.0 mm 17.7 (15.6-20.3) -- 
0.1 mm 11.2 (10.6-11.7) 37 
0.3 mm 8.0 (6.2-10.1) 55 
Table 8.5: Mean patient DAP for each filter, and percentage reduction in DAP. The ranges in brackets indicate 
95% confidence intervals, calculated using Coxs method. 
In the visual grading analysis study, the majority of examinations in each filtration 
group were allocated some scores of less than three. Reasons suggested by the 
radiologist included patient obesity, retained fluid, poor distension of the bowel, 
overlying structures, and inappropriate printer settings for digital spot views. Since 
such a high proportion of examinations were affected, it was impractical to eliminate 
them from the study. Instead, it was assumed that such factors would contribute 
approximately equally to each arm of the study. 
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 The Kruskal-Wallis statistic for each region of the bowel, and the associated 
probability of the three samples coming from identical populations, are shown in 
Table 8.6. Since the probability was in excess of 0.05 for each region, the null 
hypothesis of no significant difference between the populations could not be rejected. 
Image Type Region Kruskal-Wallis Statistic Probability 
Sigmoid colon 3.151 .207 
Splenic flexure 4.548 .103 
 
Digital Spot 
Hepatic flexure 0.224 .894 
Left colon 0.440 .803 
Right colon 1.438 .487 
 
Screen-Film 
Transverse colon 0.201 .905 
Table 8.6: Kruskal-Wallis test statistic and associated probability, for each region of the colon. 
Neither the Wilcoxon-Mann-Whitney nor the Kolmogorov-Smirnov tests found any 
significant difference between the samples obtained with 0.3 mm copper, and without 
any additional filtration. 
All examinations but one were classified as diagnostic. The remaining one, which 
was performed using 0.1 mm copper filtration, was classified as indeterminate due 
to poor distension of the colon. 
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 8.3.4 Effective Doses 
The estimated effective dose for each filter is shown in Table 8.7, along with the 
corresponding percentage dose reduction. 
Copper Effective Dose (mSv) Reduction in Effective Dose (%) 
0.0 mm 3.0 -- 
0.1 mm 2.9 5 
0.3 mm 2.7 11 
Table 8.7: Effective dose for each filter, and percentage reduction in effective dose. 
8.4 Discussion 
8.4.1 Phantom Measurements 
Entrance doses and dose rates to the Perspex phantoms decreased with increasing 
copper thickness, across the full range of copper filters investigated. Each additional 
0.1 mm reduced the phantom entrance dose by a smaller amount than the last. This 
was partly due to the beam hardening effect of the copper itself, since an X-ray beam 
that has already had many of its low energy photons removed is less strongly affected 
by an additional layer of filter material. It was also partly due to the increase in X-ray 
tube potential as more filtration was added, since this again results in a more 
penetrating X-ray beam. 
The fluoroscopic tube potential increased steadily with increasing copper thickness. 
Although it did not reach its maximum value for a 24 cm phantom, saturation of both 
tube potential and current did occur for thicker phantoms. This resulted in reduced 
dose rates to the image intensifier, since the X-ray unit could no longer compensate 
for the increased attenuation. Once saturation had occurred, there was a measurable 
reduction in low contrast detectability when further attenuation was added. This 
proved to be the limiting factor in determining how much copper could be used. 
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 The contrast detail tests were performed using Perspex phantoms, in order to 
determine the effect of the copper filters for a range of patient equivalent diameters. It 
was not possible to determine absolute contrast values, since the Leeds test object 
manual (Cowen et al, 1992) only gave calibrated contrasts for X-ray beams attenuated 
with copper. The total number of details visible gave a simple index for comparing 
detection efficiency under the various exposure conditions, but offered no indication 
as to the sizes of details that could or could not be seen. 
The 0.3 mm copper filter was selected, since it seemed to provide the most 
appropriate balance between the benefit of dose reduction, and the risk of 
compromising image quality. The phantom measurements predicted that this would 
reduce DAP by around 56% relative to the standard filtration of 2.5 mm aluminium. 
The contrast detail study suggested that there may be an adverse affect on 
fluoroscopic images of patients with equivalent diameters of 27 cm and above, i.e. 
around 5% of patients. However, a number of other factors were also taken into 
account, and these are outlined in the following paragraphs. 
Those projections involving a long X-ray path through the patient (lateral and oblique 
views) would be most readily affected by factor saturation. However, the majority of 
clinical exposures were anteroposterior (AP) or posteroanterior (PA) projections, for 
which the ray path was shorter than the patient equivalent diameter. This meant that 
overall, saturation was likely to occur less frequently than predicted by the phantom 
measurements. 
The phantom study concentrated on the smaller, 10-inch field size, for which the 
exposure factors saturated more readily. The larger, 14-inch field was used for most of 
the clinical under-couch views. So again, phantom measurements would tend to 
overestimate the incidence of saturation.  
The clinical diagnoses were based mainly on the radiographs (both screen-film and 
digital spot). These should not suffer any reduction in detector dose, since the 
automatic exposure control devices terminated the exposure only after the required 
number of photons had arrived at the detector. There was however a danger of 
increased motion unsharpness, due to extended exposure times. 
The decision to implement 0.3 mm copper clinically was supported by the fact that 
both Hansson et al (1997) and Pärtan et al (2000) had compared barium enema 
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 images taken with and without a 0.3 mm copper filter, and neither had found any 
visual difference in image quality. 
8.4.2 Tube Loading 
The introduction of 0.3 mm copper filtration was estimated to increase the under-
couch X-ray tube loading by 10%, and the over-couch tube loading by 50%. The 
anode and tube heat capacities and cooling rates were sufficient to prevent either tube 
from overheating, when used with the local examination schedule. However, the 
effect on tube lifetime was unknown. 
8.4.3 Clinical Validation 
On increasing the thickness of the copper filter to 0.3 mm, the mean patient DAP was 
reduced to 8.0 Gycm
2
. This compared favourably with all of the studies listed in Table 
7.1. The new mean DAP was 55% lower than that measured in the baseline survey, in 
close agreement with the predicted DAP reduction of 56% and the figures of 55% at 
70 kVp and 59% at 100 kVp quoted by Pärtan et al (2000). 
The differences in mean patient DAP for the three filter settings were statistically 
significant, since there was no overlap in the 95% confidence intervals for any two 
filter combinations. There was no significant difference in fluoroscopy time, number 
of digital spot images or patient equivalent diameter, so that the reduction in dose may 
be attributed almost entirely to the increase in filtration. 
The Kruskal-Wallis test found no significant difference in image scores, for any of the 
three filter settings. Since the significance level was set at 5%, there was a 5% 
probability that the samples were in fact significantly different, and that this was not 
picked up by the test. However, neither the Wilcoxon-Mann-Whitney nor the 
Kolmogorov-Smirnov test found any significant difference between the samples with 
most and least filtration, confirming that there was no measurable difference in the 
appearance of the images. 
All examinations were classified as diagnostic, except for one in the 0.1 mm copper 
group. This one was rated indeterminate, due to poor gaseous distension rather than 
poor image quality. These results indicated that there was no difference in the 
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 radiologists confidence to make a diagnosis, on introducing up to 0.3 mm copper 
filtration. 
Again, none of the other operators performing barium enema examinations reported 
any problems with clinical image quality. Following the satisfactory outcome of the 
clinical validation, 0.3 mm copper filtration was implemented in routine clinical 
practice. 
8.4.4 Image Quality Considerations 
In this study, image scoring was based on perceived barium coating. This index was 
far from ideal, because it was difficult, if not impossible, to distinguish differences in 
imaging performance from actual differences in barium coating efficiency. However, 
it was the only parameter the GI consultant radiologist felt he could score with 
sufficient confidence. The reliability of the visual grading analysis scores could have 
been improved by recruiting additional experienced observers. Unfortunately, this was 
not possible within the time limits of the study, due to the high pressure of clinical 
workload in the radiology department. However, the use of only a single observer was 
a major weakness of the study. 
A number of the images in each filtration group showed poor perceived coating, 
which the consultant radiologist attributed to technical factors such as incomplete 
bowel preparation, inadequate inflation, or poor patient positioning.  He also noted 
that large patients appeared to have poorer coating in the right colon, but that this was 
probably real, and not an effect of contrast loss. Ideally, technically flawed 
examinations should be excluded from the study, but this was impractical since so 
many of the examinations were affected. Instead, it was assumed that these technical 
factors would contribute approximately equally to each branch of the study. 
Most visual grading analysis studies for barium enema examinations have used a five-
point scoring scale, which has slightly increased sensitivity compared to the four-
point system used in the present study (Smiddy et al, 1996; Persliden et al, 1997; 
Hansson et al, 1997; Pärtan et al, 2000). 
The key image quality issue is whether the images enable accurate diagnosis. Whilst 
visual grading analysis is a sensitive method for identifying changes in image quality, 
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 it gives no indication as to diagnostic adequacy. This study took the same approach as 
Persliden et al (1997), asking the observer whether or not the images were adequate 
for diagnosis. However, a subjective assessment of diagnostic adequacy is based only 
on what the observer sees. The image may contain important information that the 
observer cannot perceive and which, if visible, would alter the diagnosis. 
The possibility of performing a clinical outcomes audit was considered. However, it 
was decided that it would be impractical to perform a study large enough to achieve 
statistical significance. 
8.4.5 Effective Doses 
The estimated effective dose for a barium enema examination with no additional 
filtration was 3.0 mSv. This was comparable with the value of 3.5 mSv estimated by 
Martin (2004), using the same dosimetry software. 
On introducing 0.3 mm copper, the effective dose was reduced by 11%. Although less 
dramatic than the reduction in DAP, this was still worthwhile in terms of radiation 
protection, because effective dose is directly related to cancer risk. 
8.5 Summary 
This chapter addressed the question of how much copper filtration should be used, to 
optimise the balance between dose and image quality for barium enema examinations. 
Measurements using Perspex phantoms predicted a sequentially smaller dose 
reduction, for each 0.1 mm copper added. On imaging phantoms representing the 
largest patients, the fluoroscopic exposure factors saturated. This resulted in a reduced 
dose rate at the detector, and a corresponding reduction in low contrast detectability. 
Saturation occurred more readily as the quantity of filtration increased. 
The copper thickness chosen for clinical implementation was 0.3 mm. Although this 
had been recommended by two published studies, one on adult and the other on 
paediatric patients, its use had not been reported within the UK. The mean patient 
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 DAP was reduced to 8.0 Gycm
2
. This was a reduction of 55%, compared to the 
baseline survey. The corresponding reduction in effective dose was 11%. 
Clinical radiographs obtained using each of the three filter settings (0.0, 0.1 and 0.3 
mm copper) were graded according to perceived barium coating, by a GI consultant 
radiologist. The Kruskal-Wallis test found no significant difference between the 
image scores for the three groups. In addition, the Wilcoxon-Mann-Whitney and 
Kolmogorov-Smirnov tests found no significant difference between the two groups 
using the most and least filtration. The radiologist graded all examinations but one as 
diagnostic, and this exception he attributed to poor distension of the colon rather than 
poor image quality. 
The introduction of 0.3 mm copper was estimated to increase the X-ray tube loading 
by 10% for under-couch and 50% for over-couch exposures. This should not put 
either tube at risk of overheating, with the examination schedule employed locally. 
Following the success of the clinical validation, 0.3 mm copper filtration was 
introduced into routine clinical practice. 
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 Chapter 9 -  General Discussion 
9.1 Introduction 
This chapter summarises the research described in the thesis. The key findings are 
highlighted, and the main strengths and weaknesses discussed. The findings led to a 
number of new research questions, and the main avenues of future work are outlined 
here. 
The introductory chapters demonstrated the importance of patient dosimetry and 
optimisation in high dose fluoroscopic and fluorographic procedures. Both are legal 
requirements under European Union Directive 97/43/Euratom (The Council of the 
European Union, 1997), and the two are closely related. Patient dosimetry can help to 
highlight those procedures that are not optimised, and to identify areas where there is 
potential for improvement. An important part of the optimisation process is to assess 
the effects of changes in imaging practice on patient radiation dose, as well as 
ensuring that image quality remains adequate for its clinical purpose. 
In the barium enema study, patient doses were measured using an established 
technique, and steps were then taken to optimise local imaging practice. In the 
cardiology study, it was necessary first to develop a suitable technique for patient skin 
dosimetry, which could then be used to inform the optimisation process. The 
cardiology part of the thesis concentrates on this topic. 
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 9.2 Cardiology: Film Dosimetry 
9.2.1 Research Summary 
The most promising skin dosimeter identified by the literature review was Kodak 
EDR2 film. This was first characterised in detail, across the range of likely exposure 
and processing conditions. Its calibration curve was described using a novel equation, 
and variations in film response with changes in exposure and processing conditions 
were quantified. The film was then used to measure skin dose distributions for a 
sample of patients undergoing coronary angiography or angioplasty, and the peak skin 
dose was determined for each patient. The possibility of predicting peak skin dose 
from a combination of dose-area-product (DAP) and procedural complexity 
indicators was investigated. 
The film was found to saturate at around 1 Gy, under local processing conditions. 
This was somewhat lower than the saturation point of up to 1.5 Gy reported by 
Guibelalde et al (2003) and Vanõ et al (2003), who extended the films useful range 
using a dedicated processor with carefully controlled processing conditions. 
The new equation used to describe the film response curve gave a better fit to the 
measured data than any reported in the literature. Film response was fairly consistent 
with variations in X-ray tube potential, exposure rate, field size, film batch, and day-
to-day fluctuations in processor performance. However, it was found to be strongly 
dependent on the quantity of beam filtration. This aspect of film performance had not 
previously been studied. It is however an important consideration in the cardiac 
catheterization laboratory, where heavily filtered beams are often used in some 
imaging modes. 
It took some minutes for the emulsion to stabilise, following exposure. This effect was 
subsequently reported by Childress & Rosen (2004). 
The overall uncertainty in the films response was estimated to be 30 to +61 mGy, at 
160 mGy. This uncertainty increased with dose, and was assumed to vary linearly 
with the gradient of the calibration curve, making it around 280 to +570 mGy at 1 
Gy.  
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 For coronary angiography, all measured skin doses were well below 1 Gy. For 
coronary angioplasty, approximately a quarter of the films showed localised areas of 
saturation, indicating that those patients had received skin doses of about 1 Gy or 
more. This was in line with previous studies using thermoluminescence dosimeters or 
scintillation detectors, which all found some doses approaching or exceeding 1 Gy 
(Hwang et al, 1998; Verdun et al, 1998; van de Putte et al, 2000; Waite & Fitzgerald, 
2001). 
Mean dose-area-products were 26 Gycm
2
 for coronary angiography, and 57 Gycm
2
 
for coronary angioplasty. Both fell below the centre of the range of published values. 
It seems likely that those facilities operating at higher mean DAPs than those reported 
here will also have a higher incidence of skin doses exceeding 1 Gy.  
DAP was found to be an unreliable predictor of high skin doses. Prediction accuracy 
was improved by combining DAP with the number of lesions treated. However, 
dosimetry methods based on DAP cannot identify the location of the peak dose on the 
patients skin. 
9.2.2 Implications and Limitations 
Since the film saturated at 1 Gy, it was an inadequate dosimeter for coronary 
angioplasty, where doses of at least 1 Gy occured frequently. Although Guibelalde et 
al (2003) and Vanõ et al (2003) were able to increase the films saturation point by up 
to 50% compared to that reported here, it would still be inadequate for assessing doses 
of 2 Gy or more, i.e. those that may result in deterministic effects. 
In order to comply with the recommendations of the Food and Drug Administration 
(1995) and the International Commission on Radiological Protection (2000), a method 
for skin dosimetry was required that could assess skin doses above the 1 Gy saturation 
point of the film, and indicate the locations of any high dose regions on the patients 
skin. This was achieved by means of dose modelling software. Alternative approaches 
include specialist Gafchromic dosimetry films, or the extended dose range computed 
radiography plates that are now available for radiotherapy verification imaging. 
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 A further limitation of the film dosimetry study was that only those radiation fields 
passing through the film were captured. If the peak skin dose occurred on the patients 
side, it would go undetected. 
9.3 Cardiology: Skin Dose Modelling 
9.3.1 Research Summary 
A mathematical model was then developed, to calculate the dose distribution in the 
plane of the couch top, from the exposure and projection data stored in the image 
files. Software was designed to extract the relevant data from the image files, perform 
the necessary calculations and generate a dose map for each patient. Since no data 
were available for fluoroscopic exposures, three methods for including an estimated 
contribution from fluoroscopy were explored. Each required total DAP or fluoroscopy 
time as an additional input parameter. 
Dose maps were generated for all of the procedures included in the film dosimetry 
study. For those films that showed no saturation, peak skin doses calculated using 
each version of the software agreed with measured values to within about 270 mGy. 
The simplest version of the software ignored the contribution from fluoroscopy. As a 
result, it grossly underestimated the dose to one patient, whose film showed areas of 
saturation following a procedure that involved a long fluoroscopy time, with few 
imaging projections. Each of the fluoroscopy correction methods improved the 
models reliability in predicting skin doses of 1 Gy or more. 
9.3.2 Implications and Limitations 
Skin dose modelling proved to be a practical dosimetry method for cardiac 
catheterization procedures. Since it used the exposure and projection data stored in the 
image files, a skin dose map could be generated retrospectively for any patient. There 
was no upper limit on the doses that could be calculated, and no additional workload 
for clinical staff. The resulting dose map provided a convenient record of both the 
magnitude and the approximate location of the peak skin dose on the patients back.  
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 Although two groups had previously developed skin dosimetry software (den Boer et 
al, 2001; Chugh et al, 2004), none was available commercially at the time of the 
study. This thesis presents the mathematical workings of a skin dose model for the 
first time. 
The main limitations of the software arose from the lack of information regarding 
fluoroscopic exposures, couch position and beam limitation. Whilst it was possible to 
estimate the fluoroscopic contribution to the dose map, the accuracy of this estimate 
could vary considerably for individual procedures. It was necessary to assume that the 
couch position was fixed, and that the secondary collimators and equalisation filter 
were not used. These assumptions did not reflect clinical practice. Improvement of 
dosimetric accuracy is dependent upon manufacturers developing facilities for 
recording and accessing the above information. 
As with film dosimetry, the model only considered the dose distribution in a single 
plane. It could be improved by modelling the patients thorax in three dimensions. 
However, this would require couch positioning data, to achieve a worthwhile degree 
of accuracy. 
The most efficient way to make dose calculation software widely available to the 
cardiology community would be for manufacturers to incorporate it on their imaging 
units. However, given the apparent commercial failure of Siemens Caregraph 
software, manufacturers are unlikely to consider this worth their while unless the 
standards bodies insist on it. 
9.4 Barium Enema Optimisation 
9.4.1 Research Summary 
A baseline survey of local barium enema practice was carried out, and the results 
compared with a review of the literature. The mean DAP of 17.7 Gycm
2
 was lower 
than that found in most published studies. However, some investigators had 
successfully employed dose reduction techniques, which were then considered for 
local implementation. 
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 It was decided to introduce copper filtration, since this should allow routine dose 
reduction for all patients, without any change to the standardised imaging protocol. 
The effects on DAP and image quality of a small amount of copper (0.1 mm) were 
first predicted using Perspex phantoms and a contrast detail test object. There was no 
measurable difference in threshold contrast. The filter was then introduced in the 
clinical environment, and the dose survey repeated. Mean patient DAP was reduced 
by 37%. None of the operators performing the examinations reported any difference 
in the appearance of the clinical images. 
An investigation was then conducted to determine the optimal quantity of copper 
filtration for adult barium enema examinations. A series of phantom measurements 
demonstrated the effects of increasing copper thickness on both dose and fluoroscopic 
image quality. For phantoms representing the larger patients, increases in filtration 
caused the X-ray tube potential and current to saturate, leading to a reduction in 
contrast detail visibility. A filter thickness of 0.3 mm copper was chosen, as it seemed 
to give the most appropriate balance between the benefits of dose reduction and the 
risk of compromising fluoroscopic image quality. Only two published studies had 
employed such thick copper filters for barium enema examinations; one on adult 
patients (Pärtan et al, 2000), one on paediatrics (Hansson et al, 1997), and both 
outside the United Kingdom. 
The filter was then introduced in clinical practice, and the dose survey repeated. 
Clinical image series performed using each of the three filter settings were allocated 
scores for perceived barium coating efficiency by a gastrointestinal (GI) consultant 
radiologist. Scores for each region of the bowel were compared using Kruskal-Wallis 
analysis of variance by ranks, and no significant differences were found. In order to 
confirm this result, the scores for images obtained with the most and least filtration 
were also compared using Wilcoxon-Mann-Whitney and Kolmogorov-Smirnov tests, 
neither of which found any significant difference. The GI consultant radiologist rated 
all of the examinations as diagnostic, except for one in the 0.1 mm copper filtration 
group, which was rated indeterminate, due to poor gaseous distension of the colon. 
These results indicated that there was no perceptible difference in the visual 
appearance of the images, and that the introduction of the 0.3 mm copper filter did not 
affect the radiologists confidence in making diagnoses. 
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 Mean patient DAP was reduced by 55%, relative to the baseline survey. This agreed 
with the phantom measurements and with the findings of Pärtan et al (2000). The 
corresponding reduction in effective dose was approximately 11%. 
The introduction of 0.3 mm copper increased the under-couch tube loading by about 
10%, and the over-couch tube loading by about 50%. With the local examination 
schedule, this did not put either X-ray tube at risk of overheating. 
9.4.2 Implications and Limitations 
The optimisation strategy employed here has laid a strong foundation for future work. 
The baseline survey and comparison with published data provided a sound starting 
point for identifying potential dose reduction techniques. Experiments using Perspex 
phantoms were shown to give a realistic indication of the effects of changes in 
imaging technique on patient dose. Measurements of technical image quality enabled 
informed decisions about changes to clinical practice. These decisions were then 
backed up by verifying their effects on patient dose and clinical image quality. 
Copper filtration of up to 0.3 mm in thickness was shown to be a practical and 
effective means of dose reduction in barium enema imaging. The present study adds 
support to the limited existing evidence for this. Copper filters are now built into 
many new X-ray units, and their availability should be considered when specifying 
and purchasing new imaging equipment. 
The reliability of clinical image scoring was limited by the use of a single observer. 
Reproducibility can be improved considerably by employing multiple observers, and 
this should be done for future studies. Perceived barium coating efficiency was by no 
means an ideal index for assessing clinical image quality, since it was impossible to 
distinguish genuine poor coating from poor imaging performance. Other investigators 
have scored images against individual aspects of image quality (noise, contrast and 
sharpness), as well as the observers overall impression (Smiddy et al, 1996; Persliden 
et al, 1997; Pärtan et al, 2000). However, their scores could equally be affected by 
poor technical performance of the examination. 
Although the phantom experiments provided quantitative information about dose and 
technical aspects of image quality, a subjective judgement still had to be made 
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 regarding the most appropriate quantity of filtration. It could be argued that 0.4 mm 
copper may actually have been optimal, but the incremental benefits of dose reduction 
diminish as the filter thickness is increased, and the thicker filter would be more likely 
to have an adverse effect on clinical image quality. 
The study considered a number of dose reduction techniques, but only one was 
implemented. The intricate relationship between dose and image quality depends on 
many factors, all of which should be considered if the imaging technique is to be truly 
optimised. This is a very complex task, and small, individual steps such as those 
described in this study offer the most practical approach. 
9.5 Proposals for Further Work 
9.5.1 Improvements to Skin Dosimetry Software 
A number of modifications are required, to improve the performance of the skin 
dosimetry software in preparation for routine clinical use. 
At present, it is only capable of calculating dose maps for one particular imaging unit. 
It is intended that it will be used to calculate doses from at least three catheterization 
laboratories. To do this, it will need to identify which imaging unit was used, and 
apply appropriate geometry and standard dose rates for that unit. Since individual 
imaging units store exposure and projection data in different formats, and sometimes 
in different fields, customised functions are needed to convert it into a standard format 
that the dose model can use. 
The existing versions of the software assume that X-ray tube output is proportional to 
the square of the tube potential. Increasingly, a number of imaging modes are 
available that use different amounts of beam filtration. This strongly affects the 
relationship between tube potential and output. The software needs to recognise which 
filter was in place for each acquisition run, and apply an appropriate kVp/dose 
relationship. 
Subsequent to this study, it was found that SID (focal spot to detector distance) was 
sometimes stored as -1. Discussions with the service engineers indicated that this 
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 was an error code, used when the detector had been moved during the acquisition run. 
The software needs to substitute these error codes with either a typical, fixed value, or 
an interpolation of neighbouring SID values. 
At the time of writing, the software had to be run manually for each procedure. The 
corrections for fluoroscopic exposures relied upon manual input of DAP or 
fluoroscopy time stored in a separate database. This inevitably led to problems with 
erroneous or missing data. It is hoped that in the near future, summary dose 
information including DAP and fluoroscopy time will be automatically sent to and 
stored on the image server. This should allow the dose model to be completely 
automated  to extract all of the relevant data from the image files as each procedure 
is completed, to calculate the skin dose distribution, and produce a printed report if 
the peak skin dose exceeds 1 Gy.  
Those investigators who employed real-time dose mapping in the cardiac 
catheterization laboratory found it to be an effective tool for avoiding high skin doses 
(den Boer et al, 2001; Fletcher et al, 2002; Miller et al, 2002). Since the operators 
could see how the cumulative dose was distributed across the patients skin, they 
could often modify their projections, to ensure that dose thresholds for deterministic 
effects were not exceeded. However, such systems require dedicated computing and 
display facilities in each catheterization laboratory. Unfortunately the necessary 
resources are not currently available at Nottingham City Hospital, but real-time dose 
mapping is something that could be considered for the future. 
9.5.2 Patient Counselling and Aftercare 
Having developed a method for assessing skin dose, the next stage is to consider how 
that information may be used to provide appropriate counselling and aftercare for any 
patients who may be at risk of skin injuries. A survey will first be conducted, to 
determine the incidence of skin injuries following cardiac catheterization procedures. 
Patients whose peak skin doses exceed 2 Gy will be inspected for evidence of skin 
erythema before leaving the hospital. Each will be given information about potential 
skin effects, with instructions to contact the department should any symptoms appear. 
Patients thought to have received localised doses of more than 3 Gy will be offered a 
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 follow-up inspection after 2 weeks, in accordance with ICRP Report 85 (International 
Commission on Radiological Protection, 2000).  
If no skin injuries are seen over, say, a three month period, then it would seem 
reasonable to assume that the risks are negligible. If any evidence of skin injuries is 
seen, then protocols should be developed for providing risk information to patients as 
part of the consenting procedure, and for identifying and offering appropriate 
counselling and follow-up to those patients who may be at risk. This will require close 
collaboration with clinical staff. The project will also require backup from the 
dermatology department, since any evidence of skin injuries may necessitate referral 
to a dermatologist. 
Another important issue is the monitoring of patients who undergo multiple cardiac 
catheterization procedures, since it is thought that repeat exposures can result in 
cumulative effects. Consideration should be given to developing a system for 
identifying these patients and assessing their cumulative skin doses. 
9.5.3 Optimisation in the Cardiac Catheterization Laboratory 
The skin dosimetry work reported in this thesis has shown that many patients 
undergoing cardiac catheterization procedures are subjected to relatively high skin 
doses of 1 Gy or more. This underlines the need for optimisation programmes in the 
cardiac catheterization laboratory. 
In seeking to optimise radiographic practice, there are many different factors that must 
be considered. These include X-ray tube potential and current, beam filtration, pulse 
width, frame rate, detector dose rates and the use of anti-scatter grids. Additional 
beam filtration will be of particular interest, since this is such an effective method of 
reducing the dose to the patients skin. In addition, there is a vast array of parameters 
in the image processing and display software, which affect the appearance of the 
images. These govern functions such as noise reduction and edge enhancement, 
temporal filtering and display lookup tables. It may be that some of these parameters 
can be adjusted to compensate for changes in imaging conditions. Since these 
processes are highly complex, it will be necessary to work closely with the equipment 
manufacturers, to ensure that images are always displayed to their best advantage. 
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 The task of determining a fully optimised imaging protocol is enormous, since there 
are so many options to be explored, and many are interdependent. The most practical 
approach is to introduce successive small changes, and to assess the effects of each on 
dose and image quality. At each stage of the process, the effects of proposed changes 
will be predicted using Perspex phantoms, and image quality test objects designed to 
simulate iodine-filled blood vessels. The most promising options will then be trialled 
in the clinical setting, with close attention being paid to patient doses and clinical 
image quality. 
Another important issue in cardiology is the toxicity of the contrast agents used 
(McCullough et al, 1997; Baker & Baker, 2001; Lindholt, 2003). If imaging 
performance can be improved, it may be possible to reduce the volume or 
concentration of the contrast medium, which would in turn reduce the incidence of 
adverse reactions such as nephropathy. 
A recent innovation that is expected to have a considerable impact on catheterization 
laboratory practice is rotational angiography. Here, the X-ray tube and detector rotate 
around the patient during digital acquisition, so that many views are obtained for each 
contrast injection. This has potential to reduce the quantity of contrast media required, 
and may also have a beneficial effect on skin doses (Raman et al, 2004). Again, 
further study will be required to determine the best way to use this new technology in 
clinical practice. 
9.5.4 Defining Image Quality Criteria 
Perhaps the greatest challenge for optimisation is that of determining whether or not 
image quality is adequate for the clinical task. Outcomes audits are the most reliable 
method for doing this, but are slow and cumbersome. Visual grading analysis only 
allows the observer to assess whether the images look acceptable, or to compare them 
with a set of reference images. It cannot confirm whether all of the clinically 
important information contained in the image is visible to the observer. 
One possible solution would be a scoring system based on image quality criteria. 
Whilst the quality criteria developed so far have attempted to define the degree of 
visualisation required for various anatomical structures, the definitions were very 
much open to observer interpretation. A set of quality criteria that described in an 
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 exact and reproducible manner how well the clinician or radiographer needed to see 
certain structures, when viewing a certain type of image, for a specified clinical 
purpose, would be an invaluable optimisation tool. It could be based on verbal 
description, or on measurable quantities such as contrast and noise in specified 
regions of the image. 
The author is currently developing two pilot scoring systems, which will shortly be 
trialled for their usability, observer agreement and repeatability. One is a descriptive 
system based on an expanded version of the standard scoring method for the Leeds 
TOR(MAM) test object (Leeds Test Objects Limited, Boroughbridge, UK). The 
second is a system of visual score cards showing simulated vessels at various noise 
and contrast levels. The observer would select the one that most closely matched 
particular regions of the clinical image. It is hoped that this may improve 
reproducibility, by removing the verbal interpretation element from image quality 
assessment. The response of clinical observers to this system may indicate whether 
objective measures such as noise and contrast could be used to assess image adequacy 
for a particular clinical task. 
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  Appendix I: Matlab Scripts 
This appendix presents the Matlab scripts used to implement the dose model 
described in Chapter 6. The first script, GetRunData.m, extracted the exposure and 
projection data from the image files. This process was identical, regardless of which 
version of the dose model was being used. 
The second script, RunModel.m, calculated and displayed the dose map. The non-
highlighted text is the computational code for Version 1 (Acquisition Only). The other 
versions of the software required some additional commands. These are highlighted in 
yellow for Version 2 (Fluoro Correction via DAP), blue for Version 3 (Fluoro 
Correction via Fluoroscopy Time) and pink for version 4 (Fluoro Correction via 
Concentration Factor). 
GetRunData.m 
% Extract procedure identifiers and run data from DICOM headers of all image files, 
% for any single procedure done on Integris H5000F. 
  
% Ask the user to browse for the directory they wish to use, and change to this 
% directory. 
% Pull all the filenames for non-bitmap files out of that directory. 
% Count the files. 
% Clear the structures to which all data will be added. 
  
starting_directory = pwd; 
directory_name = uigetdir('Z:\','Please select the directory for the required 
examination.'); 
cd (directory_name); 
files = dir('*.'); 
numberfiles = length(files); 
clear ExamInfo; 
clear RunInfo; 
  
% Add procedure identifiers from first image file to "ExamInfo" structure. 
% Ignore the first two files (. and ..). 
% Patient's and physician's name are stored in structures. Pull out 
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 % the 'FamilyName' field from the structure. 
  
info = dicominfo(files(3).name, 'dictionary', 'C:\Matlab701 local 
patches\toolbox\images\images\dicom-dict.txt'); 
ExamInfo.Directory = directory_name; 
ExamInfo.ExamDate = info.StudyDate; 
ExamInfo.PatientName = info.PatientName.FamilyName; 
ExamInfo.Procedure = info.PatientID; 
ExamInfo.Sex = info.PatientSex; 
ExamInfo.BirthDate = info.PatientBirthDate; 
ExamInfo.Cardiologist = info.PerformingPhysicianName.FamilyName; 
  
% Trawl through all image files in the directory, extracting selected DICOM 
% header info and adding to "RunInfo". Ignore the first two files ("." and ".."). 
  
j=0; 
for i = 3:numberfiles 
    info = dicominfo(files(i).name, 'dictionary', 'C:\Matlab701 local 
patches\toolbox\images\images\dicom-dict.txt'); 
     
% If info.KVP is a field, add run info to RunInfo structure. 
% Otherwise, go to the next iteration (avoids photo-files, which don't contain this 
% info). 
     
    if isfield(info,'KVP') 
        j=j+1; 
        RunInfo(j).KVP = info.KVP; 
        RunInfo(j).ExposureTime = info.ExposureTime; 
        RunInfo(j).Current = info.XrayTubeCurrent; 
        RunInfo(j).PrimaryAngle = info.PositionerPrimaryAngle; 
        RunInfo(j).SecondaryAngle = info.PositionerSecondaryAngle; 
        RunInfo(j).Frames = info.NumberOfFrames; 
        RunInfo(j).Run = info.InstanceNumber; 
        RunInfo(j).Protocol = info.ProtocolName; 
        RunInfo(j).FieldSize = num2str(info.IntensifierSize); 
        RunInfo(j).SID = info.DistanceSourceToDetector;     
    end 
end 
  
% Return to original directory. 
  
cd(starting_directory); 
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 RunModel.m 
% Calculate a skin dose map looking at the patient's back, using run data 
% from RunInfo structure array. 
  
% Create a blank totaldose array. 
  
totaldose = zeros(401,601); 
DAPacq = 0; 
  
% Define position of gantry centre, and distance from this to focal spot. 
% Define couch height. 
% Define normalized entrance dose rate for phantom measurements. 
  
centreheight = 107; 
radius = 77.5; 
couchheight = 87; 
ESDRphantom = 5.97e-5; 
displayedDAP = input('Displayed DAP (Gycm^2) = '); 
screentime = input('Screening Time (min) = '); 
fluororate = 40; 
  
% Define the plane of the couch top. 
% Allow 30cm either side of centre in left-right direction. 
% Allow 20cm either side of centre in cranio-caudal direction. 
  
for i = 1:401 
    for j = 1:601 
        xfilm(i,j) = j/10-30.1; 
        yfilm(i,j) = 20.1-i/10; 
    end 
end 
  
% Find out how many elements are in each field of RunInfo structure array. 
  
runs = size(RunInfo,2); 
  
% For each projection, read the angulation information from the RunInfo structure 
% array and then calculate doses. 
  
for n = 1:runs    
      
    Ang1 = RunInfo(n).PrimaryAngle*pi/180; 
    Ang2 = RunInfo(n).SecondaryAngle*pi/180; 
  
% Calculate focal spot position, in cartesian coordinates. 
  
    xspot = radius * sin(Ang1) * cos(Ang2); 
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     yspot = -radius * sin(Ang2); 
    zspot = centreheight - radius * cos(Ang1) * cos(Ang2); 
  
% Calculate distance from focal spot to each point on film, using 
% element-by-element multiplication. 
% Calculate dose to each point on the film. 
  
    ffd = ((xfilm-xspot).^2 + (yfilm-yspot).^2 + (couchheight-zspot)^2).^(.5); 
    dose = ESDRphantom * ffd.^(-2) * (RunInfo(n).KVP)^2 * RunInfo(n).Current * 
RunInfo(n).ExposureTime *  RunInfo(n).Frames; 
    dose = dose + fluororate * screentime / runs; 
          
% Calculate parameters for collimation. 
% Start by reading the SID, and calculating theta and SIDcoll appropriate 
% to the field size. 
  
    SID = RunInfo(n).SID/10; 
    fieldsize = str2num(RunInfo(n).FieldSize)/10; 
    theta = atan(fieldsize/(2*SID)); 
    SIDcoll = sqrt(SID^2+2*(fieldsize/2)^2); 
    DAP = ESDRphantom/1000/1.3 * (RunInfo(n).KVP)^2 * RunInfo(n).Current * 
RunInfo(n).ExposureTime *  RunInfo(n).Frames * (fieldsize/SID)^2; 
         
 % Calculate positions of field corners, on the detector entrance surface. 
         
    ycollmax = yspot + SIDcoll * sin(Ang2+theta); 
    ycollmin = yspot + SIDcoll * sin(Ang2-theta); 
     
    xcoll1 = xspot - SIDcoll * sin(Ang1+theta) * cos(Ang2-theta); 
    xcoll2 = xspot - SIDcoll * sin(Ang1+theta) * cos(Ang2+theta); 
    xcoll3 = xspot - SIDcoll * sin(Ang1-theta) * cos(Ang2+theta); 
    xcoll4 = xspot - SIDcoll * sin(Ang1-theta) * cos(Ang2-theta); 
     
    zcoll1 = zspot + SIDcoll * cos(Ang1+theta) * cos(Ang2-theta); 
    zcoll2 = zspot + SIDcoll * cos(Ang1+theta) * cos(Ang2+theta); 
    zcoll3 = zspot + SIDcoll * cos(Ang1-theta) * cos(Ang2+theta); 
    zcoll4 = zspot + SIDcoll * cos(Ang1-theta) * cos(Ang2-theta);   
     
 % Calculate positions of field corners, on couch. 
      
    x1 = (couchheight-zspot) * (xcoll1-xspot) / (zcoll1-zspot) + xspot; 
    x2 = (couchheight-zspot) * (xcoll2-xspot) / (zcoll2-zspot) + xspot; 
    x3 = (couchheight-zspot) * (xcoll3-xspot) / (zcoll3-zspot) + xspot; 
    x4 = (couchheight-zspot) * (xcoll4-xspot) / (zcoll4-zspot) + xspot; 
     
    y1 = (couchheight-zspot) * (ycollmin-yspot) / (zcoll1-zspot) + yspot; 
    y2 = (couchheight-zspot) * (ycollmax-yspot) / (zcoll2-zspot) + yspot; 
    y3 = (couchheight-zspot) * (ycollmax-yspot) / (zcoll3-zspot) + yspot; 
    y4 = (couchheight-zspot) * (ycollmin-yspot) / (zcoll4-zspot) + yspot;    
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 % Zero all dose elements that are outside the collimated area. 
    
    for i = 1:401 
       for j = 1:601         
           if xfilm(i,j) < x1 
                   dose(i,j) = 0;                
           elseif yfilm(i,j) > (y3-y2)/(x3-x2) * (xfilm(i,j) - x2) + y2    
                   dose(i,j) = 0; 
           elseif xfilm(i,j) > x4 
                   dose(i,j) = 0;                 
           elseif yfilm(i,j) < (y4-y1)/(x4-x1) * (xfilm(i,j) - x1) + y1   
                   dose(i,j) = 0; 
           end     
       end 
    end 
    
% Add to total dose map, and close loop. 
  
    totaldose = totaldose + dose; 
    DAPacq = DAPacq + DAP; 
         
end 
  
totaldose = totaldose * displayedDAP/DAPacq; 
CF = max(max(totaldose))/sum(sum(totaldose)) 
  
% Plot this as a filled contour map. 
  
maxdose = max(max(totaldose)); 
contours = 0 : maxdose/15 : maxdose; 
dosedisplay = int2str(round(maxdose)); 
  
hold off 
contourf(xfilm,yfilm,totaldose,contours) 
hold on 
contour(xfilm,yfilm,totaldose,contours) 
  
colormap('hot') 
colorbar('vert') 
axis equal 
axis([-30 30 -20 20]) 
xlabel('Left <----> Right (cm)') 
ylabel('Inferior <----> Superior (cm)') 
set(gca,'XTick',[-30 -20 -10 0 10 20 30]) 
set(gca,'YTick',[-20 -10 0 10 20]) 
title('Skin Dose (mGy)' , 'Fontsize', 12) 
text(-20,27,[ExamInfo.PatientName, ' ', ExamInfo.ExamDate], 'Fontsize', 12) 
text(-30,-30,['Max Dose = ', dosedisplay, ' mGy.'], 'Fontsize', 12)
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 Appendix II: Journal Articles and 
Conference Papers 
This appendix lists journal articles and conference presentations prepared by the 
author, and relating to the work described in the thesis. 
Journal Articles 
Morrell R.E., Rogers A.T., Jobling J.C. and Shakespeare K.E. (2004). Barium 
Enema: Use of Increased Copper Filtration to Optimise Dose and Image Quality. 
British Journal of Radiology 77:116-122. 
Morrell R.E. and Rogers A. (2004). Calibration of Kodak EDR2 Film for Patient 
Skin Dose Assessment in Cardiac Catheterization Procedures. Physics in Medicine 
and Biology 49:5559-5570. 
Morrell R.E. and Rogers A.T. (2005). Film Dosimetry for Fluoroscopic Procedures: 
Potential Errors. Radiation Protection Dosimetry 114:147-149. 
Morrell R.E. and Rogers A.T. (2006). Kodak EDR2 Film for Patient Skin Dose 
Assessment in Cardiac Catheterization Procedures. British Journal of Radiology (in 
press). 
A further paper titled A Mathematical Model for Patient Skin Dose Assessment in 
Cardiac Catheterization Procedures is also in preparation. 
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 Conference Presentations 
Morrell R., Rogers A., Shakespeare K. and Jobling J. (2001). Dose Reduction for 
Barium Enema Examinations [Poster]. UK Radiological Congress; 21-23 May 2001; 
London, UK. 
Rogers A.T., Morrell R., Shakespeare K. and Jobling J.C. (2001). Optimisation in 
Barium Enemas: How Much Copper? European Congress of Medical Physics & 
Clinical Engineering; 12-14 September 2001; Belfast, UK. 
Jobling J.C., Rogers A., Morrell R. and Shakespeare K. (2002). Optimising Dose 
for Barium Enemas: How Much Copper? European Society of Gastrointestinal and 
Abdominal Radiology; 14-19 April 2002; Orlando, Florida. 
Morrell R.E. and Rogers A.T. (2004). Film Dosimetry for Fluoroscopic Procedures: 
Potential Errors [Poster]. Second Malmö Conference on Medical X-Ray Imaging: 
Optimisation Strategies in Medical X-Ray Imaging; 23-25 April 2004; Malmö, 
Sweden. 
Morrell R.E. and Rogers A.T. (2004). Calibration of EDR2 Film for Skin Dosimetry 
in Interventional Cardiology [Poster]. UK Radiological Congress; 6-8 June 2004; 
Manchester, UK. 
Morrell R.E. and Rogers A.T. (2005). Film Dosimetry in the Cardiac 
Catheterisation Laboratory. UK Radiological Congress; 6-8 June 2005; Birmingham, 
UK. 
Morrell R.E. and Rogers A.T. (2005). Skin Dose Modelling in the Cardiac 
Catheterisation Laboratory. UK Radiological Congress; 6-8 June 2005; Birmingham, 
UK. [Winner of IPEM Presidents Prize.] 
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